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Abstract
The characteristic EEG trait of patients with nocturnal idiopathic epilepsies during child-
hood is the spike and wave discharge. Cognitive dysfunction is prevalent among these
patients and is thought to be linked to disturbances in memory consolidation processes
that normally occur during slow wave sleep. Several genetic mutations of nicotinic recep-
tor subunits have been linked to these disorders. However, there is little known about the
underlying mechanisms or the spatiotemporal characteristics of this epileptiform activity
within the neocortex.
This thesis presents a rat in vitro model of the epileptiform activity synonymous with
nocturnal childhood epilepsies, that allows for pharmacological manipulation of receptor
subunits linked to these disorders. The application of DTC [10µM], a non-selective, com-
petitive nicotinic acetylcholine receptor antagonist, to an in vitro model of the cortical
delta rhythm induced two individual forms of paroxysm events - wave discharges and the
conventional spike and wave discharges.
Pharmacological manipulation of this model suggest that the epileptiform activity is me-
diated by excitatory currents which is consistent with the use of glutamate antagonists
as anticonvulsants. A blanket blockade of inhibition by a GABAA antagonist resulted in
severe discharges, hence hugely increasing excitatory response. Only partial disinhibition
is suggested to be required to generate epileptiform activity as nicotinic acetylcholine re-
ceptors and 5-HT3 receptors are located on dendrite targeting interneurons. Mapping of
unit activity revealed the difference between the two paroxysm events was recruitment of
superficial layers with simultaneous paroxysm events in delta frequency-generating Layer
V pyramidal cells.
It is proposed that the hyperexcitability responsible for the generation of the spike com-
ponent of a spike and wave discharge is mediated by the lack of excitatory tone in 5-HT3
and nicotinic acetylecholine receptor expressing inhibitory interneuron subtypes. The
disinhibition, spike generation and disruption of interplay between deep and superficial
layers of the neocortex is thought to be associated with synaptic plastic changes.
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Chapter1
General Introduction
This thesis details work conducted with the aim to better comprehend the neurobiologi-
cal and electrophysiological mechanisms related to electroencephalography recordings of
epileptiform activity present in nocturnal childhood epilepsies.
Chapter 1 presents a detailed introduction and literature review of the knowledge and
previous work of many in relevant fields relating to sleep, learning and childhood noctur-
nal epilepsies. Firstly, a brief history of sleep is presented with the theories which have
been popular through the years, as to why mammals sleep and the mechanisms of this
process. Following this, the current research into the neurobiology of sleep is detailed
concentrating on the role of neuromodulators as this knowledge will be utilised during
pharmacological experiments and later discussions. The next section briefly covers elec-
troencephalography (EEG) and how it can be utilised to study sleep and sleep disorders.
Due to the output of the EEG, as well as the electrophysiological recording methods
that are utilised within this thesis, a greater understanding of the neural oscillations is
necessary. Hence frequencies up to 100Hz, which are related to sleep, are subsequently
detailed. The next section describes our current understanding of how sleep links to
learning and memory processes. This is of particular interest as within the subsequent
section, there is considerable evidence presented of a link between childhood nocturnal
epilepsies and the epileptiform activity present during sleep and learning disabilities. The
aims, objectives and outline of this thesis conclude this chapter.
1.1 History of Sleep
Every human, animal and plant goes through a form of sleep/wake cycle every day of
their life. However, it is thought that sleep did not occur in the earliest forms of life
approximately 600 million years ago but had to evolve. It is thought that slow wave
1
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sleep (SWS) was not present in mammals until 180 million years ago, which is 70 million
years after mammal-like reptiles had evolved [Thorpy and Yager, 2001]. When ‘sleep’ is
thought of today, it includes both a dreaming state, also known as Rapid Eye Movement
(REM) sleep and a non-dream state, slow wave sleep. However, it is thought that it took
another 50 million years of evolution for REM to appear in sleep cycles. In these first
instances of sleep, it is most likely that a polyphasic sleep pattern existed, i.e. many short
naps throughout the light/dark cycle as this is still what most animals follow everyday.
However, with the evolution of primates came a biphasic sleep pattern which consists of
a core sleep period of approximately 6 hours and a short sleep, or nap at mid day lasting
approximately 30 minutes (figure 1.1). This is a similar pattern to what early man, i.e.
Homo erectus (from Asia, Africa and Europe) and Neanderthals (from Europe and Asia),
would have also followed. It wasn’t until 10,000 BC that monophasic sleep patterns were
thought to have developed in man where only one long period of sleep is needed during
the daily light/dark cycle as shown in figure 1.1 [Thorpy and Yager, 2001].
Biphasic Monophasic 
awake
asleep
Figure 1.1: Biphasic and Monophasic sleep patterns
In ancient times, many civilisations believed in gods and goddess of sleep and dream-
ing and would pray to them and give sacrifice if they were having trouble sleeping. In
ancient Egypt, the people prayed to Bes, the god of relaxation and sleep, and Imhotep,
the god of healing, medicine, learning and sleep. In ancient Rome, the people worshipped
Cuba, the goddess of children’s sleep, and Somnus, the god of sleep and dreams. Even
from this early point in history, people believed there was a link between health and sleep.
However, until relatively recently very little was known about how sleep is generated and
why it is so important for health. As a consequence perhaps, treatment of these early
sleep disorders was mainly through plants, oils, minerals and animal substances that were
ingested, inhaled or given as suppositories or enemas. Opium, also known as laudanum,
has been used to treat sleep disorders like insomnia as far back as the Sumerian age [Ag-
grawal, 1995].
Until the start of the 20th Century there were four main sleep theories:
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• Vascular (mechanical, anemic, congestive)
• Neural (Histological)
• Chemical (Humoral)
• Behavioural (psychological, biological)
Vascular Theory
In ancient Greece during the fifth century, Alcmaeon believed that sleep was due to
blood filling the brain, whilst waking was associated with the return of blood to the rest
of the body [Diels and Kranz, 1952]. Hippocrates, on the other hand, believed sleep was
caused by the blood leaving the limbs and collecting in the center of the body [Chadwick
and Mann, 1978]. Albrecht von Haller (1708-77) and Hermann Boerhaave (1667-1738)
agreed with Alcmaeon’s theory and that the increased blood flow to the head resulted
in increased pressure on the brain, thereby inducing sleep [Thorpy and Yager, 2001].
However, Johann Friedrich Blumenbach (1752-1840) was the first to observe the brain of
a sleeping subject in 1795 where he noted that the brain was pale during sleep, which
was contrary to the earlier vascular theories [Blumenbach, 1828].
The congestive theory of sleep became the most popular during the first half of the
19th Century. Johannes Evangelistica Purkinje (1787-1869), a neuroanatomist and pro-
fessor of physiology and pathology at Breslau, proposed that the brain pathways (corona
radiata) become compressed by blood congestion of the cell masses of the brain (basal
ganglia), hereby severing neural transmission and inducing sleep [Wagner, 1844]. How-
ever this congestive theory was finally contradicted in 1863 by John Hughlings Jackson
(1853-1911), an outstanding clinical neurologist, through observing the decreased blood
flow in the retinal arteries during sleep [Thorpy and Yager, 2001]. The most popular
alternative to the congestion theory was that sleep was due to insufficient blood flow to
the brain (anaemia), which was believed by many scientists, including Alexander Fleming
and Sir Leonard Erskine Hill. In 1896, Hill reported that there was no change in cerebral
blood pressure during sleep. He believed that the brain did not become either anaemic
or congested during sleep which lead to the vascular theory being discredited [Hill, 1866].
Neural Theory
In 1875, the first clear picture of a nerve cell and it’s processes were demonstrated by
Camillo Golgi (1843-1926) [Culebras, 2005]. This research was extended by many others
resulting in the discovery of neurons, axons and dendrites in the cortex. During the
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1890’s several scientists believed that during sleep there was a partial paralysis of the
neuron prolongations preventing communication between cells. Ramon Y Cajal (1852-
1934) believed that signal alteration by neuroglia could explain sleep as well as the
effect of hypnotic medications through inhibition [Hill, 1866]. This research later led to
the theories based upon synaptic transmission of neurotransmitters which became the
prominent neural explanation for changes in sleep and wakefulness, as described in more
detail later in this chapter.
Chemical Theory
The chemical theories were based on Aristotle’s theory that sleep was due to the effect of
fumes in the blood present after eating [Culebras, 2005]. The popular chemical theory was
that sleep was linked to the oxygen levels in the body and brain. This theory led to several
others on the accumulation of toxic substances, which included cholesterol and other toxic
waste products. In 1895, Raymond Emil Du Bois (1818-1896) proposed that sleep was
the result of carbon dioxide (CO2) toxicity [Culebras, 2005]. He believed that small
amounts of CO2 during wakefulness led to sleep and that large amounts of CO2 during
sleep evoked wakefulness [Du Bois, 1895]. These chemical theories remained popular until
the end of the 19th century. It is interesting to note that CO2 and neurochemicals such
as hormones and transmitters are now recognised as very much involved in generating
and modulating sleep, as will be discussed later.
Behavioural Theories
Based upon the previous work of Rolando and Flourens in which they discovered that
removing part of the cortex induced a sleep-like state, Charles Edouard Brown-Sequard
(1817-94) proposed that sleep was due to an inhibitory reflex [Brown-Sequard, 1889].
This was expanded upon by Heubel (1876), of Kiev University who proposed that sleep
was due to the loss of peripheral stimuli [Heubel, 1876]. Several researchers believed that
there was a specific organ of sleep. Initially this was thought to be the thyroid, however
this was disproved when insomnia wasn’t induced with thyroid removal. The Choroid
plexus was also considered as the sleep organ by Jonathon Osbourne in 1849 [Osborne,
1849]. Although the main focus during the second half of the 19th Century was the cause
of sleep, important contributions were also made to sleep disorder medicine, particularly
sleep apnea, nocturnal epilepsy, narcolepsy and insomnia.
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1.2 Neurobiology of Sleep
It has been suggested that consciousness can be considered in terms of neural correlates,
such that neural diseases and drugs that can mimic or alleviate the symptoms can pro-
vide insight into the mechanisms of consciousness [Perry et al., 1999]. From the work
of Morruzzi and Magoun, it has been demonstrated that there are two ascending path-
ways in the brain which are thought to dominate in mediating arousal and wakefulness,
the cholinergic and monoaminergic pathways [Aldrich, 1999, Krahn et al., 2009]. These
networks are responsible for the perception of sensory stimuli, the sense of consciousness
and the inhibition of sleep.
The cholinergic system is thought to be the most important neuromodulatory neuro-
transmitter system in the brain [Perry et al., 1999]. It originates in neurons of the basal
forebrain and the pedunculopontine (PPT) nuclei which project to the reticular and relay
nuclei of the thalamus. These nuclei projections open the gateway to the cerebral cortex
for peripheral sensory input. 90% of brainstem projections to the thalamus are choliner-
gic which is of interest due to the importance of the thalamus and its projections to the
cortex in conscious awareness [Perry et al., 1999]. During REM sleep, cortical activation
is present as it is during wakefulness [Krahn et al., 2009]. The monoaminergic system
consists of many ascending axons which are linked to monoaminergic neurotransmitters,
as shown in figure 1.2. Stimulation of the neurons listed in figure 1.2 activates the cere-
bral cortex thereby allowing the flow of information from the thalamus. These neurons
are also known to inhibit the ventrolateral preoptic (VLPO) nuceli, the primary genera-
tor of non rapid eye movement (NREM) sleep. The VLPO is believed to be important
in the control of circadian rhythms. The cortical activity seen during wakefulness and
REM sleep remains present in the absence of monoaminergic neuromodulator activity,
i.e serotonergic and noradrenergic whilst in the presence of cholinergic activity, hence it
has been suggested that the ascending cholinergic system alone has the ability to keep
the brain in an active state [Buzsa´ki et al., 1988]. Whereas, during SWS or NREM sleep,
where consciousness is absent or tremendously altered, there is a large amount of inhi-
bition in the thalamic and cortical neurons due to a decrease in excitatory projections
from the thalamus [Delacour, 1997].
A number of other neuromodulatory systems are also linked to modulation of the sleep/wake
cycle: glutamate released by thalamic and cortical projection neurons as well as by neu-
rons of the mesencephalic reticular formation [Delacour, 1997]; acetylcholine by neurons
in the basal forebrain and the PPT; noradrenaline by neurons in the locus ceruleus; sero-
tonin by neurons in the raphe nucleus; and histamine by neurons in the hypothalamus.
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γ-aminobutyric acid (GABA) which is released by interneurons is also thought to be
involved in the loop between the reticularis nucleus of the thalamus and the other thala-
mic nuclei [Delacour, 1997]. All of which will be considered in greater detail within the
following sections.
Figure 1.2: A schematic drawing depicting some of the key pathways of the
ascending arousal system. The yellow path depicts the group of cholinergic cells
which aid in thalamocortical transmission, whilst the red path indicated the regions
of the cortex activated by signals from monoaminergic mediated neurons, particularly
histamine, dopamine, serotonin and acetylcholine. Other neuromodulators which are
also thought to contribute to the signalling of this pathway are GABA and acetylcholine.
This network of pathways is thought to be ‘essential for the binding of multiple aspects
of sensory experience into a single framework of consciousness [Jones, 1998]. Adapted
from [Saper et al., 2005].
1.2.1 Neuromodulators associated with Sleep
Acetylcholine
Acetylcholine (ACh) is a neurotransmitter found in the central and peripheral nervous
system. It is known be a principle component of the ascending reticular activating system
and hence plays a large role in the regulation of sleep and wakefulness [Thorpy and Yager,
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2001]. The two major groups of ascending cholinergic neurons are located in the pontome-
dencephalic tegmentum and the basal forebrain. Along with the other neurons that make
up the reticular formation, the pontomedencephalic tegmentum neurons project to the
thalamus, the hypothalamus and the basal forebrain. From the thalamus, they project
to a diffuse area of the cerebral cortex which allows for widespread signal transmission
and activation. The maximum release of ACh into the thalamus is associated with fast
cortical activity during wakefulness and REM sleep. ACh depolarizes and excites thala-
mocortical neurons which stimulates the fast cortical activity of arousal and REM whilst
inhibiting the slow wave activity of NREM sleep. The fast cortical activity particularly
occurs in the gamma frequency range (30-80Hz). The basal forebrain neurons provide
connections to the hippocampus and the cortex. Hence these neurons have the capacity
to stimulate ubiquitous cortical activity. When acetylcholine receptors (AChRs) are ago-
nised using nicotine and muscarine, cortical activation is elicited, whereas when they are
antagonised, the fast cortical activity associated with sleep is diminished [Stickgold and
Walker, 2009a]. For example, Atropine, a muscarinic AChR antagonist, produces slow
wave activity in the cortex. ACh has subsequently been perceived to stimulate cortical
activity during REM sleep. From this, the cholinergic systems are known to play an
important role in REM sleep and arousal.
In a review by Crunelli and Hughes (2010), in vitro sleep rhythm studies in rats, mice
ferrets and cats were compared to similar animals in in vivo sleep studies. These studies
reported that the morphology of the local field potential activity was similar in ampli-
tude, however the activity was slower during in vitro experiments. This was also seen
during cellular activity of thalamic reticular nuclei neurons. Whereas the cellular activity
of thalamocortical neurons was very similar during both in vivo and in vitro studies. To
achieve the slow wave oscillation observed during sleep, the in vivo studies used various
anaesthetics to mimic sleep. However, during in vitro studies, it is not possible to use
an anaesthetic, instead modifications must be made to the calcium (Ca+2) concentra-
tion of the perfused solution [Rigas and Castro-Alamancos, 2007, Shu et al., 2003] or
the addition of the cholinergic agonist, carbachol is needed [Lorincz et al., 2007,Lorincz
et al., 2008,Cunningham et al., 2006] to evoke similar rhythms to those seen during SWS
sleep and under anaesthesia. Of particular interest is the use of Carbachol to induce the
slow oscillations observed during sleep. This is due to the presence of some cholinergic
mediated action being needed to induce sleep, as although high levels of ACh are seen
during waking states, a very low level is present during SWS, hence the need to apply a
small concentration of an AChR agonist.
ACh plays a large role in memory processes. Muscarinic-AChR antagonists have been
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shown to decrease memory consolidation whilst both short and long term memory pro-
cesses are enhanced by ACh. Long term potentiation is enhanced by ACh [Stickgold and
Walker, 2009a]. It also stimulates theta frequency oscillations which in turn, also en-
hances long term potentiation and neuronal plasticity. In recent studies [Granon et al.,
1995] [Chan et al., 2007], nicotinic AChRs (nAChRs) have also been linked to mem-
ory processes, particularly α7 and α4β2, which area involved in working and reference
memory and solely working memory respectively. It is well known that consolidation of
procedural memories are enhanced during REM sleep whilst declarative memories are
consolidated during SWS (see section 1.6). Thus, it is likely that nAChRs play a role in
both NREM and REM sleep.
In reviews penned by Delacour (1997) and Baars (1998), it has been shown that ACh is
greatly involved in attentional processes and conscious awareness. Cortical ACh is cur-
rently thought to have many roles: affects discriminatory processes; increases signal-noise
ratios; regulates the cortical processing of sensory inputs; controls the response to stimuli
and rates their level of significance; and limits the conscious stream [Perry and Perry,
1995,Warburton and Rusted, 1993,Perry et al., 1999,Delacour, 1997]. During slow-wave
sleep (SWS), these characteristics are reversed. The amplitude and signal-to-noise ratio
of sensory responses are decreased [Livingstone and Hubel, 1981], and spike trains become
randomised between interspike intervals: large populations of neurons burst simultane-
ously. As stated by Delacour (1997), ‘this temporal structure introduces distortions in
information transmission’. Modulation of the levels of cortical ACh may have an adverse
impact on these roles, similar to the behaviour of patients with autism-spectrum disor-
ders. ACh level modulation may also have an impact on learning and memory processes,
as previously described.
AChRs, both muscarinic and nicotinic, are membrane proteins and are composed of
a mixture of five subunits: alpha (α), beta (β), delta (δ), epsilon () and gamma (γ)(as
shown in figure 1.3). So far, 12 nicotinic-AChR (nAChR) (α2 - α10 and β2 - β4) and 5
muscarinic-AChR (mAChR) subunits (α1, β2, δ,  and γ) have been identified [Marini
and Guerrini, 2007]. Neuronal nAChRs are part of the family of excitatory ligand-gated
ion channels [Karlin, 2002] and have a very similar structure to the inhibitory ligand-
gated channels which consist of glycine and GABAA receptors. α7, α8 (only found in
avian species), α9 and α10 (only when co-expressed with the α9 subunit [Baker et al.,
2004]) subunits are distinguished by their ability to form robust homomeric receptors in
the absence of a β subunit. Each of these homomeric receptors has five binding sites.
It is not known how many of these sites need to be occupied by an agonist to open the
channel, however occupancy of only one binding site by an antagonist is needed to block
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Figure 1.3: The nAChR is a ligand-gated
ion channel. Five subunits surround central
pore which allows for the diffusion of sodium
(Na+) and potassium (K+) ions through the
membrane. [Encyclopedia-Britannica, ]
the channel from opening [Palma et al., 1996]. The remaining α and β subunits group to
form heteromeric receptors, i.e. α4β2, α3β2 and α3β4. Of all of the nAChR subtypes, α4,
α7 and β2 are the most ubiquitous in the mammalian central nervous system (CNS) with
α4β2∗ (where ∗ indicates the possible inclusion of unspecified subunits) and α7 nAChRs
having a complementary distribution [Wonnacott and Barik, 2007].
Neuronal nAChRs are highly expressed in the hippocampus, neocortex, thalamus and
midbrain neurons. nAChRs as previously stated, have been linked to memory pro-
cesses, therefore it is unsurprising that the hippocampus contains large numbers of
nAChRs. Whole-cell recordings have shown that these receptors are present on hip-
pocampal GABAergic interneurons as well as pyramidal cells in both the hippocampus
and the neocortex. Studies have indicated that most hippocampal interneurons possess
α7 containing nAChRs [Alkondon et al., 1997, Ji and Dani, 2000] whereas the nicotinic
currents evoked by subpopulations of neocortical interneurons are thought to be medi-
ated by non-α7 nAChRs. Neuronal presynaptic nAChRs have been shown to modulate
the release of many different neurotransmitters within the brain, although they are also
known to exist on somatodendritic regions and in perisynaptic or extra synaptic loca-
tions [Wonnacott and Barik, 2007]. The thalamus plays a key role in passing sensory
and motor information to the cortex. Additionally, abnormalities in the thalamo-cortical
circuitry can result in epileptic episodes or seizures [Raggenbass and Bertrand, 2002].
α4β2 nAChRs are highly expressed in the thalamus, hence they are thought to have a
role in thalamo-cortical circuitry. Activation of the β2 containing nAChRs can result in
an increase in GABA release from axon terminals thereby effecting the inhibitory synap-
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tic transmission in the thalamus. Mutations of the genes that encode the α4 or the β2
receptors can result in some forms of autosomal dominant nocturnal frontal lobe epilepsy
(ADNFLE, covered in greater detail in section 1.7.2).
The majority of neurons of the substantia nigra and ventral segmental area (VTA) of
the midbrain have been shown to possess β2 containing nAChRs, whereas α7 containing
nAChRs are thought to be present in less than half of those neurons [Klink et al., 2001].
The activation of somatic nAChRs in VTA neurons is thought to contribute to the release
of dopamine in the nucleus accumbens, however other mechanisms are also thought to
contribute, some of which are considered in the next section.
Dopamine
Dopamine (DA) is a catecholamine neurotransmitter and is produced in several regions of
the brain, including the VTA and the substantia nigra. DA neurons starting in the VTA
are proposed to be involved in arousal and maintenance of wakefulness unlike the nigros-
triatal system which generally do not play a direct role in sleep and wakefulness [Aldrich,
1999]. The depletion of DA is involved in the pathophysiology of Parkinson’s disease
(PD), whereas hyperdopaminergia is thought to play a part in generating endopheno-
types linked to schizophrenia. Due to the sleep disturbances seen in both schizophrenia
and PD, DA is considered to play a major role in regulating the sleep-wake cycle [Dzirasa
et al., 2006].
DA has been shown to have an important role in controlling REM sleep. Electrophys-
iological results have revealed an increase in bursting activity in the VTA DA neurons
during REM sleep. DA levels are also elevated in the prefrontal region during this stage
of REM sleep. Work by Sakai (1991) suggests that DA may directly regulate the activity
of REM active neurons located in the peri-Locus Coereleus alpha, likely through adren-
ergic α2 receptors. Work by Lu et al (2006) has exposed a previously unclassified group
of wake-active DA neurons in the ventral periaqueductal grey (vPAG) that may provide
the long-sought ascending dopaminergic waking influence [Stickgold and Walker, 2009b].
These vPAG DA neurons have been mistaken for dopaminergic neurons that originate
in VTA (A10 DA neurons) over the years, however anatomical and physiological char-
actertistics of the vPAG neurons now suggest that these cells form their own distinct
neuronal poulation. vPAG DA neurons are considered important when discussing sleep
as they project to the VLPO, which as stated previously, is a critical sleep-promoting
center of the brain. Although it is not yet understood how DA influences sleep and
arousal, it is most likely that due to the inhibition of VLPO sleep active neurons and the
activation of the basal forebrain and monoaminergic systems.
General Introduction 11
As with ACh, DA is generally considered to promote wakefulness and inhibit SWS. Lena
et al (2005) demonstrated that in rat in vivo studies, extracellular DA levels in the pre-
frontal cortex and the nucleus accumbens are greater during both wakefulness and REM
sleep, in comparison to SWS. DA receptors can be grouped into two distinctive groups,
D1-like and D2-like receptors [Beaulieu and Gainetdinov, 2011]. The D1-like receptors
consist of the D1 and D5 receptors [Tiberi et al., 1996], whereas the D2 subfamily com-
prises of D2, D3 and D4 receptors [Andersen et al., 1990]. The D1 subfamily are coupled
to the Gs protein and increase the intracellular levels of cyclic adenosine monophosphate
(cAMP) by activating adenylate cyclase. The D1 receptor is a postsynaptic receptor
and is the most ubiquitous DA receptor in the CNS [Monti and Monti, 2007]. Although
the D3-D5 receptors are found in much lower levels than the D1 and D2 receptors, DA
binds to them with nanomolar or submicromolar affinity constants compared to the mi-
cromolar ranges needed for D1 and D2 receptors. In the rodent brain, D1 receptors are
richly expressed in the caudate-putamen, the nucleus accumbens and the olfactory tu-
bercle [Murrin and Zeng, 1990]. In lower levels they are also expressed in other brain
regions such as the cerebral cortex, the thalamus and hypothalamus [Lachowicz and Sib-
ley, 1997]. D1 and GABAA (see below for more detail) receptors are generally present in
the same areas of the brain [Le Moine and Gaspar, 1998]. It is well established that the
activation of D1 receptors plays a large role in the inhibition of GABAergic transmission
an GABA neurotransmitter release [Eder et al., 2003,Fuxe et al., 1998,Liu et al., 2000].
The D5 receptor is also a postsynaptic receptor. Expression of the D5 receptor is mod-
erate in the hippocampus, hypothalamus and olfactory tubercule, however no mRNA
expression has been reported in brainstem structures [Monti and Monti, 2007]. The D2
subfamily are Gi/Go coupled, and decrease the cellular concentrations of cAMP by inhi-
bition of adenylate cyclase [Beaulieu and Gainetdinov, 2011]. The highest expression of
D2 receptors are found in the same areas as D1 receptors. They are also expressed in the
cerebral cortex, the basal forebrain, the hypothalamus and the rhombencephalon [Monti
and Monti, 2007]. D2 receptors are also present on neuron cell bodies. Unlike, the pre-
vious DA receptors, D3 and D4 receptors are present at much lower levels in the rodent
brain. D3 receptors are mainly expressed in the Islands of Calleja and the nucleus ac-
cumbens with lower levels present in the cerebral cortex, hippocampus, amygdala and
hypothalamus. However, no cells expressing the D3 receptor mRNA have been found in
the brainstem structures involved in the regulation of sleep and wakefulness [Monti and
Monti, 2007]. Lastly, D4 receptors are expressed in the frontal cortex, the hippocampus
and the hypothalamus.
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During a study to understand how pharmacological manipulations could effect the state
of awareness, Monti et al (1990) found that the antagonism of the DA D1-like receptor
in the rodent increased SWS and reduced wakefulness and REM sleep. SCH23390 has
also been demonstrated to produce sedation in the monkey and rabbit [Ongini et al.,
1985]. Whereas, SKF 38393, a selective DA D1 receptor agonist significantly increases
wakefulness and reduced SWS and REM sleep [Monti et al., 1990]. A double blind clin-
ical study by Eder et al (2003) characterized the effect of the D1 receptor antagonist
NNC-687 on sleep variables in healthy young men between 21 and 27 years. The D1
antagonist was shown to significantly increase the length of the first NREM sleep pe-
riod. Wakefulness and REM sleep were unaffected. The stimulation of adenylate cyclase,
which is coupled to the D1 receptor, depolarises neurons ascending to the thalamus, hy-
pothalamus and basal forebrain and neurons descending to the dorsal raphe nucleus and
locus coeruleus. The activation of these neuronal groups results in the stimulation of
cortical activation [Aloe et al., 2005]. Several studies by Monti et al published in 1988,
have shown that the systemic administration of D2 receptor agonists (apomorphine (D1
> D2), bromocriptine (D2 > D1), pergolide (D2 > D1) [Monti et al., 1988a] or quinpirole
(D2 > D3) ) into rodents induce biphasic effects. Low doses reduce wakefulness and in-
crease SWS and REM sleep which has been related to the predominant activation of the
D2 autoreceptor, whilst large doses induce the opposite effect (increase wakefulness and
decrease SWS and REM sleep) which has been related to the predominant facilitation of
the D2 postsynaptic receptor [Monti and Monti, 2007].
Serotonin
Serotonin (5-HT) and sleep research have had a varied relationship over the years. After
some initial research in 1955, it was thought that 5-HT was the principal sleep neuro-
transmitter due to its inhibiting effects on the mesencephalic reticular formation and the
locus coeruleus (LC) [Jouvet, 1999]. Both of which, in 1973, were thought to be the two
putative waking centres of the brain. However, in 1976 it was observed that the electrical
activity of dorsal raphe nuclei neurons (DRN, 5-HT neurons) increased during wakeful-
ness, decreased during slow-wave sleep and totally disappear during REM sleep [Lydic
and Biebuyck, 1988]. Thereby showing that there was a complex relationship between
5-HT liberation and sleep. More recent research postulates that the liberation of 5-HT
during wakefulness may lead to a cascade of postsynaptic genomic events which will trig-
ger sleep onset [Jouvet, 1999]. As of yet, the full relationship between 5-HT and sleep is
unknown and the role of the raphe nuclei remains elusive.
5-HT receptors are G protein coupled receptors and ligand gated ion channels found in
the central and peripheral nervous system. They mediate both excitatory and inhibitory
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neurotransmission of many neurotransmitters, including glutamate, GABA, dopamine,
noradrenaline and acetylcholine. There are 7 different classes of 5-HT receptors, des-
ignated 5-HT1−7. The 5-HT1, 5-HT2, 5-HT3 and 5-HT5 classes are made up on five
(5-HT1A−B−D−E−F ), three (5-HT2A−B−C) and two (5-HT3A−B and 5-HT5A−B) subtypes
respectively, whereas the remaining classes are currently known to have only one sub-
type each [Monti, 2011]. All, bar the 5-HT3 receptor subtypes, are G protein coupled
receptors. 5-HT1 [Monti and Jantos, 1992], 5-HT2 [Dugovic et al., 1989], 5-HT3 [Ponzoni
et al., 1993] and 5-HT7 [Hedlund et al., 2005] have all been linked to sleep processes.
5-HT1A receptors are located on the soma and dendrites of 5-HT neurons, at postsy-
naptic sites and non-5-HT cells of the DRN [Monti, 2011]. Most of the DRN cells are
GABAergic interneurons. Whilst the 5-HT1B receptors are thought to be located at
presynaptic (5-HT axon terminals) and postsynaptic (outside the DRN) sites. As with
5-HT1A, the 5-HT1B receptor has been characterized in the DRN where it is expressed in
non-5-HT neurons [Clark et al., 2006]. Systemic administration of the 5-HT1A agonist,
8-OH-DPAT has been shown to increase waking whilst reducing REM sleep. Within SWS
there was a delayed increase of highly synchronized sleep which Bjorvatn et al (1997)
classified as SWS-2. Another agonist, ipsapiron is also known to increase SWS in both
rats [Tissier et al., 1993] and humans [Seifritz et al., 1996]. Hence it is postulated that
5-HT1A receptors may facilitate sleep or sleep characteristics in at least some central
nervous system areas [Ursin, 2002]. A study by Boutrel et al (1999) reported 5-HT1B
knock-out mice display larger amounts of REM sleep than their wild-type equivalent
whereas no significant change is seen in wakefulness or SWS. Systemic administration
of CP-94253, a selective 5-HT1B agonist, significantly increased waking activity whilst
reducing SWS and REM sleep in the rat [Monti et al., 1995]. Hence it is thought that
the activation of the 5-HT1B receptor promotes the occurrence of waking activity and
negatively effects REM sleep.
5-HT2 receptors are located postsynaptically in many different brain region, the cor-
tex, thalamus and substantia nigra to name a few. Selective 5-HT2 agonists, specifically
5-HT2A and 5-HT2C, are known to increase wakefulness and decrease SWS and REM
sleep [Dugovic, 1993]. Whereas, the 5-HT2 receptor antagonist ritanserin is known to
promote sleep in both humans [Idzikowski et al., 1986] and rats [Dugovic and Wauquier,
1987], hence this would imply that the 5-HT2 receptor plays a role in waking activity.
However, in cats, ritanserin is known to reduce sleep [Sommerfelt and Ursin, 1993]. A
rodent study by Borbely et al (1988) showed that the power spectral data indicated that
the sleep resulting from the antagonist administration was different from natural sleep.
Work by Steriade et al (1993), suggests that the arousing effect of 5-HT2 receptor may
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be mediated by the thalamic reticular nucleus and the sleep spindle generating cells of
the cortex and reticular nucleus. Hence it is thought that serotonin acting on thalamic
5-HT2 receptors may play a role in spike activity and waking.
In 1992, Adrien (1992) proposed that the 5-HT3 receptor did not play a major role
in sleep or wakefulness. However, in 1993, Ponzoni et al reported that the injection of
the selective 5-HT3 agonist m-choloro-phenylbiguanide (m-CPBG) into the lateral ventri-
cle or the bilateral injection into the nucleus accumbens increases waking and decreases
SWS. REM sleep remained unchanged during the latter described injection. However,
the effect of the 5-HT3 agonist can be blocked by the selective 5-HT3 antagonist MDL
72222 [Ponzoni et al., 1993,Ponzoni et al., 1995]. Ponzoni et al also reported that the sys-
temic administration of MDL 72222 and another antagonist, ondansetron, significantly
increased SWS and/or REM sleep, respectively. Ponzoni speculated that the effects seen
due to the stimulation of the 5-HT3 receptors are linked to the increased release of other
neurotransmitters, particularly dopamine [Ponzoni et al., 1995]. The 5-HT3 receptor is
a member of the superfamily of ligand-gated ion channels, a family that also include
the neuronal nicotinic acetylcholine receptors (nAChRs), as well as the inhibitory neu-
rotransmitter receptors for GABA [Maricq et al., 1991]. The 5-HT3 and nAChRs share
similar attributes, particularly the α7 nAChR subunit [Eisele et al., 1993], i.e. topological
organisation, and activation and desensitisation reactions. As such, both the 5-HT3 re-
ceptor and nAChRs are inhibited by nanomolar concentrations of d-tubocurarine (DTC)
in a competitive fashion [Yan et al., 1999]. Chimeras containing the amino-terminal do-
main of the α7 nAChR and the carboxyl-terminal of the 5-HT3 receptor form functional
ligand-gated channels with ligand specificities characteristic of AChRs and the permeabil-
ity of 5-HT3 receptors [Eisele et al., 1993]. The work by Eisel et al (1993) would suggest
that 5-HT3 and AChRs have similar structures and signal transduction mechanisms [Yan
et al., 1999]. The study conducted by Yan et al (1999) suggested that the ligand binding
domain of the 5-HT3 receptor is formed by multiple parts of the extracellular domain
that are similar to regions of the AChR known to be involved in ligand binding.
Hedlund et al (2005) studied the changes in sleep state of 5-HT7 receptor knockout
mice. The knockout mice spent less time in REM sleep during the light period than
their wild-type counterparts. However, no different was seen in either group with respect
to waking activity and SWS duration. A rodent pharmacological study [Monti et al.,
2008], has tentatively proposed that the activation of projection GABAergic neurons in
the DRN resulting from a selective 5-HT7 receptor agonist, LP-44, may be responsible
for the inhibition of cholinergic cells in the laterodorsal and pedunculopontine tegmental
nuclei and the decrease in REM sleep [Monti, 2011].
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Histamine
Histamine (His) is a naturally occurring substance that is released during tissue damage
as well as acting as a neurotransmitter. Histominergic neurons are found exclusively in
the tuberomammillary nucleus (TMN) in the posterior hypothalamus with their axons
extending throughout the CNS. Histaminergic neurons’ are active during wakefulness but
are inactive during sleep, which is thought to be due to the suppression of histaminergic
neurons’ firing by high firing GABAergic inputs from the VLPO area [Tabarean et al.,
2007].
All aminergic nuclei cause excitatory projections, however the mechanisms for these exci-
tations vary. Nicotinic receptor-mediated cholinergic activity desensitizes histaminergic
neurons through the α7-type receptors [Uteshev et al., 2002] and it is thought that this
action represents a sensor for the central waking actions of nicotine [Haas et al., 2008]. No
muscarinic receptor-mediated effects, as of yet, have been noted in vitro. Noradenaline
does not have a direct effect on histaminergic neurons however it is known to control
GABAergic input via α2-type receptors hence controlling the inhibition of inhibitory
postsynaptic currents (IPSCs). See below for a more comprehensive introduction to role
of acetylcholine in sleep. Dopamine is known to excite histaminergic neurons through
an as yet undefined mechanism. Serotonin depolarises and hence excites the histamine
neurons via the activation of the Na+ - Ca2+ exchange [Eriksson et al., 2001]. Histamine
neurons may also be involved in CO2 mediated arousal [Johnson et al., 2005].
Of the four histamine receptors known, three are widely expressed in the brain (H1-
H3) whilst H4 receptors are predominantly found in the peripheral tissues, such as blood,
spleen, lungs and livers. H1 receptors occur throughout the CNS with a high density
in areas involved with arousal and waking, i.e. thalamus [Soria-Jasso et al., 1997], cor-
tex [Reiner and Kamondi, 1994] and aminergic nuclei [Stickgold and Walker, 2009c]. H1
receptor antagonists, antihistamines are prescribed for allergies and are widely known for
their sedative properties. This suggests that histamine is involves in sleep-wake regula-
tion particularly H1 receptors [Haas and Panula, 2003]. Experiments were undertaken
with H1 receptor knock-out mice, however no significant changes were observed in the
sleep-wake pattern but the waking response usually seen with H3 receptor antagonists
had been eliminated. Activation of H2 receptors blocks Ca
2+ activated K+ conductance
which is responsible for the firing and long-lasting after-hyperpolarization after action po-
tentials. H3 receptors are located on the TMN cell body, dendrites and axon. They are
also present on many nonhistaminergic varicosities, such as those containing glutamate,
acetylcholine, dopamine, noradrenaline, serotonin, GABA and various peptides [Stick-
gold and Walker, 2009c]. Histamine is known to depress the glutamatergic perforant
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pathway by 30% in rats. It also suppresses the glutamatergic corticostriatal and the
dopaminergic nigrostriatal pathways.
Noradrenaline
Noradrenaline (NA), also known as Norepinephrine, is a catecholamine with multiple
roles throughout the central and peripheral nervous system, as a hormone and a neu-
rotransmitter. Noradrenaline was once thought to enhance sleep however, it is now
considered to be an important agent in the activation of wakefulness [Thorpy and Yager,
2001]. The noradrenergic neurons of the LC are nearly always active during wakefulness,
becoming less active during NREM sleep and are practically silent during REM sleep.
It is probable that NA works in conjunction with acetylcholine to produce wakefulness,
however lesions of the LC have not led to substantial changes in the amount of waking
as may be expected from previous research [Aston-Jones et al., 2007].
Noradrenaline is a receptor ligand to either α1, α2 or β-adrenergic receptors. The ac-
tivation of α2 results in the decrease in intracellular Ca
2+ resulting in the inhibition of
neurotransmitter release. According to Jones (2009), NA promotes waking by inhibit-
ing sleep-promoting GABAergic neurons in the preoptic are and basal forebrain which
express α2 adrenergic receptors. These GABAergic neurons discharge during SWS and
REM sleep in a complimentary manner to the NA LC neurons.
1.3 Sleep Electrophysiology
The discovery of brain electrical activity in 1875 by Richard Caton was a major turning
point in the study of sleep. Caton revealed the action potentials in the brains of cats,
rabbits and monkeys. This discovery went largely unrecognised until 1929 when electri-
cal signals were recorded from the human brain by Berger, a German physician. These
recordings were called electroencephalograms (EEG), which aided in the demonstration of
fundamentally different electrographic signatures associated with sleep and wakefulness.
Figure 1.4 depicts an early EEG of general excitatory states [Penfield et al., 1942]. The
development of electroencephalography has led to increasingly sophisticated studies of
brain function and brain activity [Aldrich, 1999]. In 1937, the EEG was used to deter-
mine different sleep states resulting in Alfred L. Loomis, E. Newton Harvey and Garret
Hobart classifying five different stages of sleep. Rapid eye movement (REM) sleep was
first characterised as dreaming sleep in 1953 by Eugene Aserinsky and Nathaniel Kleit-
man, who demonstrated the presence of rapid eye movements during a dream stage of
sleep. However, in 1957 this discovery was furthered by the discovery of a recurring
pattern of REM and NREM sleep during overnight EEG monitoring by Kleitman and
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Figure 1.4: An early EEG. Effect of
general excitatory states. Normal
electroencephalograms as varied by
conditions of generalized excitation,
relaxation, drowsiness, light sleep,
and deep sleep. Taken from [Pen-
field et al., 1942].
William Dement.
An EEG signal is a measurement of currents that flow during synaptic events, predom-
inantly in the dendrites of many pyramidal neurons in the cerebral cortex [Sanei and
Chambers, 2007]. When the neurons are activated either via an excitatory or inhibitory
input, synaptic currents are induced within the dendrites. An electric field is generated
by the spatially separated voltage differences in the neurophil caused by this current
which is detectable from the scalp via EEG electrodes (figure 1.5). Scalp electrodes de-
tect signals from only the most superficial layers of the brain (i.e. cerebral cortex) due
to the attenuating effect of electrically inactive tissues between the signal origin and the
EEG electrode.
When discussing EEG activity, rhythms are often introduced as they are perhaps the
single most prominent feature detectable with EEG electrodes. Rhythmicity can be local
to a single neuron, regional involving several neighbouring neuronal circuits or remote
involving neuronal circuits which span many brain structures [Misulis and Head, 2003].
EEG rhythms are typically classified into seven frequency bands. These rhythms and
their relationship to in vitro studies will be covered in more detail in section 1.5.2. Sig-
nals are then further characterised by amplitude and morphology. Frequency refers to
how many successive peaks or troughs occur in one second and is measured in Hertz (Hz).
Amplitude refers to the magnitude change in electrical potential of peaks and troughs
and is measured in micro volts (µV). Morphology refers to the shape of the particular
EEG wave or group of waves, reflecting both their frequency and amplitude [Stickgold
and Walker, 2009e].
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Figure 1.5: Pyramidal cell dendrites
extend through many cortical layers.
When a large collection of cells simul-
taneously undergoes a similar excita-
tory or inhibitory activity, the result-
ing local field potential (the average
signal from this group of cells) is de-
tected by the EEG electrode record-
ing on the scalp. This signal needs to
be substantial enough to pass through
several layers of non-neural tissue.
Adapted from [Bear et al., 2006].
The position of the electrodes in standard EEG monitoring sessions results in even cover-
age across the scalp which allows for the majority of the cortex to be mapped (figure 1.6a)
due to the penetrating nature of the dendrites of the deep layer pyramidal cells. When
epileptologists discuss such conditions as Benign Epilepsy of Childhood with Centro-
Temporal spikes (see section 1.7.2) or Frontal Lobe epilepsy, they often refer to the EEG
which will show abnormalities in the central and temporal regions, for the former, and
as suggested in the frontal regions for the latter. Topographical maps can be used as a
visual aid when analysing results (figure 1.6b).
1.4 Stages of Sleep
The invention of the EEG allowed scientists to study sleep in ways that were not previ-
ously possible. Further studies of human sleep have demonstrated that sleep progresses
through a number of stages during which different traces are displayed. As mentioned
above, there are two main types of sleep. These are introduced in more detail here:
1. Non-REM Sleep (NREM). This is also known as Delta sleep, Slow wave sleep
(SWS) or Quiet Sleep.
2. Rapid Eye Movement (REM) Sleep. This is also known as active sleep or
paradoxical sleep.
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(a) (b)
Figure 1.6: a). Standard 10-20 electrode placement system. A - auricle (or ear),
C - central, F - frontal, T - temporal, P - parietal, O - occipital, Cz - central vertex, z
- midline. Adapted from [Hughes, 1994]. b). Topographic map showing activity in
right centro-temporal region in a 9-year old boy with Benign Epilepsy in Childhood with
Centro-Temporal Spikes. Adapted from [Tsai and Hung, 1998].
Figure 1.7: Architecture of sleep in a healthy adult. This is a simplified depiction
of a normal healthy adult during the different stages of sleep over the course of a night. In
humans, the first part of the night (early sleep) is characterised by high amounts of slow
wave sleep, whereas the latter half of the night is predominantly REM sleep. Adapted
from [Diekelmann and Born, 2010].
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1.4.1 NREM sleep
Non-rapid eye movement sleep is made up of four sleep stages, stages 1 and 2 are the
lighter stages of sleep, and stages 3 and 4 which are described as SWS. These sleep stages
show distinct EEG characteristics which are depicted in figure 1.8. Unlike REM sleep,
there is usually little or no eye movement during these stages. Stage 1 type sleep is seen
throughout the night thanks to the cyclic nature of sleep. It is initially characterised by
a theta rhythm replacing the awake alpha rhythm (see stage 1 in figure 1.8). Stage 2
type sleep sees no eye movement and the absence of dreams. EEG recordings typically
show sleep spindles and K-complexes (see stage 2 in figure 1.8). The K-complex can
occur spontaneously or can also be evoked by sensory stimulation, however the func-
tional meaning of the K-complex remains unknown [Gennaro et al., 2000]. It has been
shown that K-complexes are the result of a synchronized cortical network that causes
both excitatory and inhibitory actions on cortical neurons, hence creating a slow wave
oscillation (0.5-0.9Hz and 1-4Hz) which spreads through the cortex [Amzica and Steri-
ade, 1997]. Stages 3 and 4 form SWS which is characterised by the presence of specific
oscillations and neuromodulator activity. The most common field potential oscillations
observed during SWS are slow oscillations (delta rhythms) and spindles (see stages 3 and
4 in figure 1.8). The delta rhythms recorded come from dipoles originating in the neo-
cortex with a peak frequency of ∼0.8Hz [Molle et al., 2002]. However, there are multiple
possible sources of this activity, including locally generated networks (purely neocortical)
and distributed networks (thalamocortical [Steriade, 2003]). The origins of delta rhythms
are dealt with in more detail in section 1.10. These oscillations synchronize the neuronal
activity into down states of widespread hyperpolarization and subsequent up states of
depolarisation and increased neuronal firing [Diekelmann and Born, 2010]. Spindle ac-
tivity refers to the ∼10-15Hz oscillations observed in human sleep in both stage 2 and
SWS. It may be present in low voltage background EEG, superimposed on delta waves,
or temporally locked to a K complex [Gennaro and Ferrara, 2003]. During SWS, levels
of ACh are decreased compared to both REM and wakefulness.
1.4.2 REM sleep
The majority of REM sleep occurs within the latter half of the night as shown in figure 1.7.
REM is characterised by the presence of ponto-geniculo-occipital (PGO) waves, theta
activity and specific neuromodulator levels. PGO waves are phasic electrical burst of
neural activity which originate in the Pons and propagate to the lateral geniculate nucleus
in the hypothalamus and finally end in the occipital primary visual cortex, hence the
name. All of these cortical regions are involved in eye movement and visual processing.
General Introduction 21
Figure 1.8: Stages of NREM sleep.
These rhythms have been observed in rats and cats however are not reliably identified in
humans. Theta oscillations (4-8Hz) are predominantly seen in the hippocampus during
REM sleep. Cholinergic activity during REM sleep is similar or higher than the levels
seen during wakefulness. Levels of both NA and 5-HT are at a minimum during REM,
as previously discussed in section 1.2.1. Figure 1.9 shows a typical EEG recorded in a
healthy person during REM sleep.
Figure 1.9: REM Sleep. REM stage shows low voltage and mixed frequency of EEG,
sawtooth wave pattern (2-6Hz sharply contoured or serrated waves over the central area)
is often present. Taken from [Krahn et al., 2009]
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1.5 Neuronal Oscillations
1.5.1 Oscillations in vivo
The cerebral cortex is a dynamic system with the characteristics of a small world net-
work [Watts and Strogatz, 1998]. However, work by Kaiser et al (2010) has shown
that a hierarchical approach may be another method to understanding dynamic neural
networks.“Hierarchy” can be classified in several different ways and can be applied to
topological, temporal, spatial as well as functional properties of neural networks [Kaiser
et al., 2010]. Large networks of widely dispersed neurons are often involved in cognitive
and executive processes. These networks have many signals circulating through them
and it is thought that internal mechanisms control the selective routing of these signals.
Singer (2009) proposed that in order for a neuron to convey two messages simultaneously,
it would need to exploit two parallel independent coding strategies. The first encoded
message is in the discharge frequency of the neurons, also called the rate code. It is pro-
posed that the second encoded message is contained in the precise timing relationships
between individual spikes of distributed neurons (temporal code) [Singer, 2009]. It is
further proposed that these precise timing relations are established either by the timing
of external events (stimulus locking) or by internal timing mechanisms.
1.5.2 Classification of oscillations during sleep-wake cycle
Oscillatory patterns of neuronal responses are often studied in neuroelectrophysiology.
These oscillations are rarely detectable at the single cell level due to the tendency of
individual cells not to generate outputs on every oscillation cycle but they are easily
observed when large populations of neurons are recorded simultaneously (i.e. with EEG
scalp electrodes). Experimentally this can either be achieved through multi unit record-
ings or recordings of the local field potential [Singer, 2009], hence it is also referred to
as the population code. Work has shown that patterns of oscillation are often (though
not exclusively) generated by the chemical and electrical inputs to inhibitory interneu-
rons. Resulting inhibitory signals are passed to pyramidal cells which cause them to stop
discharging when inhibition is strongest and instead discharge at the relatively depo-
larised peaks between inhibitory events, causing firing synchrony in a local population.
Oscillations can be synchronised over large distances due to mutual coupling of the os-
cillatory networks via long-range excitatory cortico-cortical connections [Singer, 2009].
These oscillations have been separated into different groups dependent on the frequency
they oscillate at. These are: slow wave oscillations (<1Hz), delta (1-4Hz); theta (5-7Hz);
alpha (8-12Hz); beta (13-27Hz); gamma (30 - 80Hz); and ripples (>80Hz) (see figure 1.10
for a more detailed breakdown). Many in vitro studies use the change in oscillatory pat-
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tern as an indicator for the effect a drug has on cells in a network. For example, when
any N-Methyl-D-aspartate (NMDA) antagonist (Ketamine, DAP5 etc.) is bath applied
gamma frequency patterns are altered, which may be associated with cognitive disorders,
like Schizophrenia [Uhlhaas et al., 2008].
Figure 1.10: Multiple modal peak frequencies of persistent rhythms generated in isolated
neocortex it vitro. (Taken from [Roopun et al., 2008]).
Ripples (>80Hz)
High frequency oscillations are known as ripples or ‘high gamma’ waves. The ripples
frequency band is generally considered to span from 80-250Hz whilst fast ripples are
categorised as any rhythm greater than 250Hz. Ripples can be observed in both normal
and pathologic brain processes [Bagshaw et al., 2009] whereas fast ripples are generally
only identified in epilepsy patients and animal models [Staba et al., 2002]. Previous
studies have shown that ripples are present during all stages of sleep, predominantly
during SWS [Bagshaw et al., 2009, Grenier and Steriade, 2001]. However, these ripples,
which originate from the interaction between inhibitory interneurons and pyramidal cells
in CA1 of the hippocampus, are generally superimposed on hippocampal sharp waves
(fast depolarising events) [Diekelmann and Born, 2010]. Sharp waves are described as
large-amplitude local field potentials which occur irregularly in the CA1 region of the hip-
pocampus during a state of minimal interaction, i.e. SWS or immobility [Buzsa´ki et al.,
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1983]. Hippocampal sharp wave-ripples are present during the re-activation of hippocam-
pal pathways which were previously active during the preceding wakefulness [Wilson and
McNaughton, 1994]. Previous prefrontal cortex studies have found temporal correla-
tions during SWS between hippocampal ripples and spindle activity (see below for more
detail) which are thought to reflect the co-activation of hippocampal and neocortical
pathways [Siapas and Wilson, 1998]. Sirota et al (2003) also discovered a similar corre-
lation of neuronal discharges between the hippocampus and the somatosensory cortex.
Due to the simultaneous activation of the hippocampal and neocortical regions, this rela-
tionship is thought to be part of an important process in memory consolidation [Rauchs
et al., 2005,Wilson and McNaughton, 1994,Siapas and Wilson, 1998].
Fast ripples in the epileptic brain are thought to reflect action potential population
bursts of synchronously discharging neuronal clusters [Bragin et al., 2002].There is con-
siderable evidence for linking fast ripples with seizure onset in epilepsy patients [Grenier
et al., 2003]. Grenier et al (2003) also demonstrated that neocortical ripples are not only
associated with paroxysmal events such as spikes, but are also present at their onset.
This supports work by Bragin et al (2002), in which they state that the synchronization
of clusters of high interconnected neurons result in epileptiform bursts which eventually
lead to seizure activity.
Gamma Frequency Oscillations (30-80Hz)
Gamma frequency oscillations are generally considered to span from 30 to 80Hz, how-
ever they are often broken down into low (30-40Hz) and high (60-100Hz) as shown in
figure 1.10. Previous in vitro and in vivo studies have shown that there is a relationship
between slow wave sleep rhythms (delta oscillations) and gamma oscillations [Compte
et al., 2008,Steriade et al., 1996,Mena-Segovia et al., 2008, Isomura et al., 2006]. These
studies have shown that gamma oscillations preferentially occur during the ‘UP’ state,
characterized by rhythmic cycles of synaptically mediated depolarization, of the slow
wave and disappear during the ‘DOWN’ state, the hyperpolarizing phase [Valderrama
et al., 2012]. Several EEG studies have previously reported the lack of significant pha-
sic gamma activity observed during SWS [Fell et al., 2002, Molle et al., 2002], however
this is thought to be due to the spatial limitations of EEG and that gamma oscillations
are generally phase-locked over short distance but rapidly lose this synchronization over
distance. Valderrama et al (2012) have since reported on gamma activity during SWS
via the use of intracranial recordings which allow the analysis of short-range spatially
coherent activities that are not easily available with scalp recordings. These findings are
supported by work from the same group when using multi-electrode arrays in human
cortex during SWS [Le Van Quyen et al., 2010]. It has been suggested [Isomura et al.,
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2006] that gamma activity during the ‘UP’ state may aid in the transfer of previously
coded information via parahippocampal pathways [Le Van Quyen et al., 2010] whilst
activity during the ‘DOWN’ state may relate to a hippocampal replay and modification
of intrahippocampal and entorhinal cortical connectivity [Valderrama et al., 2012].
Beta Frequency Oscillations (12-25Hz)
The beta frequency range can be broken down into two individual ranges, sigma or spindle
(12-16Hz) and beta (16-25Hz) as shown in figure 1.10. Spindle oscillations as well as other
faster oscillations are grouped by slow wave oscillations (<1Hz). As stated previously in
section 1.4, sleep spindles characterise Stage 2 sleep, although spindle density generally
increases through the night [Fogel and Smith, 2011]. The spindle frequency range itself
can be split into two further ranges: slow (∼12-14Hz) and fast (∼14-16). Slow spindles
are generally observed in the frontal regions of the brain, whereas fast spindles are seen in
the posterior regions. These two frequency bands are thought to originate from separate
generators [Merica, 2000]. However, De Gennaro and Ferrara (2003) have argued that
instead of two spindle ranges there is in fact one spindle range and an anterior peak of
alpha activity. Beta rhythms are generally linked to muscle contractions and movement
however they are observed during SWS although on a much smaller magnitude than
spindle frequencies [Molle et al., 2002].
Alpha Frequency Oscillations (8-12Hz)
There are three types of alpha rhythm observed during the wake-sleep cycle. The first
presents during the relaxed mental state whilst the eyes are closed, but the subject
is not asleep or tired. This oscillation is centred over the occipital lobe and tends to
dissipate during drowsiness and stage 1 of sleep to be replaced by theta oscillations. The
second presents during REM sleep in the frontal-central region of the brain [Roth et al.,
1999]. The third occurs in SWS and spreads across the brain in a anterior-posterior
gradient [Pivik and Harman, 1995]. Alpha activity during or superimposed on delta
rhythms during SWS tends to be present when a patient is complaining of non-restorative
sleep and is generally observed in individuals with sleeping disorders, like narcolepsy and
sleep apnea [Jaimchariyatam et al., 2011].
Theta Frequency Oscillations (4-8Hz)
Theta oscillations are most commonly seen in the hippocampus, and is particularly strong
in the CA1 region of this structure. Theta oscillations are consistently present during the
initial stages of Stage 1 sleep and throughout REM sleep [Jouvet, 1969] whilst also being
associated with locomotor activity [Vanderwolf, 1969]. It has been proposed [Cantero
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et al., 2003] that theta oscillations might serve as an arousal mechanism for the transition
from sleep to wake. Although theta in the hippocampus has been greatly studied, it
does occur in other regions of the mammalian brain including the entorhinal cortex
[Mitchell and Ranck, 1980]. Unlike during rodent studies, the theta rhythm seen in
humans during REM sleep is composed of short 1 second bursts of activity and during
transitions to wakefulness [Cantero et al., 2003]. It has been widely suggested that
theta oscillations enhance the formation of long-term memories by aiding with long-
term potentiation process [Huerta and Lisman, 1996,Holscher et al., 1997]. Cantero et al
(2003) demonstrated during subdural EEG studies, a lack of functional coupling between
the hippocampal theta rhythm and the neocortical theta rhythm which strongly suggests
that the human rhythms have evolved from those observed in animal models and are now
independent and state-dependent rhythms. Very little theta rhythm activity is observed
during SWS in either the hippocampus or neocortical regions.
Delta Frequency Oscillations (1-4Hz)
Delta frequency oscillations are high amplitude rhythms and are usually associated with
SWS. The presence of these rhythms on an EEG aid in characterising stages 3 and 4 of
NREM sleep. There are two types of delta rhythms observed in vivo: the stereotyped
clock-like delta rhythm; and a cortical delta rhythm which continues after extensive tha-
lamectomy [Stickgold and Walker, 2009f].
The clock-like corticothalamic delta rhythm is generated intrinsically by the in-
terplay of IT and Ih currents in thalamocortical (TC) neurons [Stickgold and Walker,
2009g]. The IT current is a low threshold Ca
2+ current [Llinas, 1988] and the Ih current is
a cation current that is activated upon hyperpolarisation of thalamic relay neurons [Mc-
Cormick and Pape, 1990]. The corticothalamic delta activity can be synchronised by
corticothalamic volleys that activate the thalamic relay neurons. This in turn hyper-
polarises the TC neurons to a suitable membrane potential and results in delta rhythm
generation [Steriade et al., 1991]. Hence, the cortical neurons firing simultaneously result
in exciting the relay neurons, which occurs during the depolarisation of the slow oscilla-
tion, and hyperpolarising the TC neurons. This activity is then transferred back to the
cortex, hence completing the loop and shaping the delta rhythm [Steriade, 2006,Crunelli
and Hughes, 2010]. Steriade et al (1991) found that low cholinergic tone maintains the
corticothalamic delta rhythm, hence maintaining deep sleep. They found that the delta
rhythm is suppressed during the transition from deep sleep to wakefulness or REM sleep
and is predominantly due to the stimulation of cholinergic projections from the brain
stem. Therefore, elevated levels of ACh are thought to be deterimental to the generation
of the corticothalamic delta rhythm [Steriade et al., 1991].
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The cortical delta rhythm has been associated with noisy brain states during deep
sleep, i.e. sleep states where delta rhythms are co-expressed with numerous other higher
frequency bands like theta and gamma. Such a situation is also seen, albeit with lower
delta power, during wakeful states [Lakatos et al., 2005]. As stated in the previous sub-
sections, the cortical delta rhythm acts as a carrier for higher frequency oscillations and
is also thought to be linked to synaptic plasticity [Aeschbach, 2009]. However, little
is currently known about the cellular mechanisms mediating cortical delta oscillation.
Amzica and Steriade (1998), however, proposed that cortical delta may be driven by
the discharge of intrinsically bursting neurons. Carracedo (2010) found that the appli-
cation of a cholinergic agonist and a D1-like receptor antagonist evoked delta frequency
oscillations during in vitro experiments, similar to those seen in vivo.
Slow-wave Oscillations (<1Hz)
During NREM sleep the majority of cortical neurons have rhythmic fluctuations in mem-
brane potential, from a hyperpolarised state of silence to a depolarised state of intense
firing [Steriade et al., 1993c]. Intracellular recordings have shown that this activity was
present in almost all cortical neurons and the spiking activity could be phase-linked to
the <1Hz oscillation [Steriade et al., 1993c]. The slow wave oscillation is believed to orig-
inate in the cortex as it continues after extensive thalamectomy [Steriade et al., 1993b]
as well as existing in cortical in vitro slice preparations [Sanchez-Vives and McCormick,
2000]. One of the proposed mechanisms for the origin of slow wave oscillations is linked
to the spontaneous activity of layer V cortical neurons [Sanchez-Vives and McCormick,
2000]. Sanchez-Vives and McCormick (2000) proved that it was possible to generate
persistent slow wave oscillations in vitro by providing a bath medium that mimicked the
ionic composition of interstitial fluid in situ. The slow oscillation manifested in regular
spiking, intrinsically bursting and chattering pyramidal neurons as well as fast spiking
interneurons, which fired in phase with the local field. From it’s origin in layer V, the
rhythm propagated to layer VI after a short delay, and then onto layers II/III after a
further delay. The rhythm was abolished after the blockade of non-NMDA glutamatergic
ionotropic receptors. The blockade of NMDA receptors also blocked or greatly reduced
the slow wave oscillation. Hence glutamatergic transmission was needed to generate the
rhythm.
1.5.3 Pharmacology of in vitro delta oscillations
As stated previously, research by Carracedo (2010) demonstrated that cortical delta
rhythms could be evoked in acute brain slices through the perfusion of the cholinergic
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agonist, carbachol and the DA D1-like receptor antagonist SCH23390. It is this in vitro
model that is used as the main model from which to induce sleep-related pathological
activity in this thesis.
Induction of delta oscillation through cholinergic agonists
ACh is known to play an important role in the sleep-wake cycle as detailed in section 1.2.1.
Cholinergic transmission is typically reduced during SWS compared to wakefulness and
REM sleep, however it is not completely stopped. Replicating the low, but not ‘zero’
cholinergic tone characteristic of SWS via the application of a cholinergic agonist is
sufficient to evoke delta oscillations in vitro [Carracedo, 2010]. Some cholinergic mediated
action needs to be induced as, although high levels of ACh are seen during waking states,
a very low level is present during SWS. Hence the model determined by Carracedo (2010)
needed the application of a small concentration [4µM] of the AChR agonist, Carbachol.
Once the delta rhythm is stable, it continues to increase in amplitude whilst slowing in
frequency over several hours, as is generally observed in stages of NREM sleep during in
vivo studies throughout the night.
Effect of Dopamine on cholinergic transmission
As with ACh, DA acts to promote wakefulness and REM sleep and inhibits SWS as
was demonstrated by the extracellular studies carried out by Lena et al (2005). Ro-
dent in vivo studies have shown that antagonism of dopaminergic transmission by the
dopamine D1-like receptor antagonist SCH23390 increased SWS and reduced wakefulness
and REM sleep [Monti et al., 1990]. Monti et al (1990) also proposed that the activity
of the cholinergic pathways were enhanced by DA release. However, the manipulation
of dopaminergic transmission alone is not sufficient to evoke cortical oscillations in the
isolated brain slice. Di Cara et al (2007) demonstrated that the use of the D1-like recep-
tor antagonist SCH23390, reduced extracellular ACh levels in the frontal cortex and the
hippocampus. Whereas an increase in ACh levels were reported during the perfusion of
the D1 agonist SKF38393 [Del Arco et al., 2007]. This therefore suggests that DA can
mediate ACh levels, which when paired together more closely mimic the neurobiological
properties of sleep; thus, reproducing a more accurate model of delta oscillations during
SWS.
1.6 Sleep, Memory and Learning
There are many theories for the purpose of sleep. The most modern theories include:
brain detoxification [Inoue et al., 1995]; tissue restoration [Smith, 1985]; immune control;
General Introduction 29
energy conservation [Benington and Heller, 1995] and memory consolidation [Diekelmann
and Born, 2010,Born et al., 2006,Walker, 2008,Siegel, 2001]. With regards to this thesis,
the most relevant theory is that of memory consolidation. Memory consolidation can
be distinguished as three specific processes: Synaptic consolidation, which occurs within
the first few hours after learning [Dudai, 2004]; Systems consolidation, which occurs over
a larger amount of time, generally weeks or years, as the memories become indepen-
dent of the hippocampus [Roediger et al., 2007]; and reconsolidation, where consolidated
memories can become labile again during the reactivation of the specific memory path-
way [Tronson and Taylor, 2007].
The notion that sleep has had an important role in memory and hence learning, has
been around for over 200 years. This has become more specific over the last 15 years
with concentration on sleep dependent memory processing. As detailed in the previous
section, sleep can be simply broken down into two states, REM and NREM. NREM sleep
itself can be broken down into different stages, as previously shown, however when dis-
cussing memory consolidation, we refer to stages 3 and 4, where slow-wave sleep (SWS)
is observed. Likewise, memory is not considered to be a single phenomenon either but
can also be roughly separated into two memory types: declarative (episodic) memory
and non-declarative (procedural) memory. Declarative memories are accessible to con-
scious recollection. These include facts and episodes like learning vocabulary or recalling
events. Procedural memories are those that involve skills, habits or actions that result
from repeated practice and are not necessarily available for conscious recollection. For
example, tying your shoes or riding a bike and once practised, they require no conscious
effort.
In humans, SWS is known to dominate the early part of the nocturnal sleep cycle and
REM to dominate the later part. Several studies have shown that declarative memories
are consolidated during SWS and that procedural memories are consolidated during REM
sleep [Diekelmann and Born, 2010]. These studies support the ‘dual process hypothe-
sis’ where SWS and REM sleep facilitate different processes [Hobson and Pace-Schott,
2002]. A study by Plihal and Born (1997), reported that deprivation of SWS in the
first quarter of sleep selectively impairs performance on declarative memory task such as
paired-word associates. While deprivation of REM during the last quarter of sleep impairs
performance on procedural memory tasks, like mirror drawing. Whereas, other studies
that support the ‘sequential hypothesis’ have shown that SWS can improve procedural
memories and vice versa, REM can also improve declarative memories [Rauchs et al.,
2004,Huber et al., 2004,Rauchs et al., 2005]. The ‘sequential hypothesis’ follows the the-
ory that all stages of sleep are needed to consolidate a memory in a complementary and
General Introduction 30
sequential manner [Hobson and Pace-Schott, 2002]. As previously stated, consolidation
refers to the process of transforming the newly acquired and easily altered memories that
have been encoded during wakefulness, into substantial representations which become
absorbed into the network of existing long term memories. This consolidation process es-
sentially involves reviewing the new memories within the neural networks that were used
to encode them initially [Diekelmann and Born, 2010]. This occurs most efficiently during
sleep to ensure no crossover between the encoded memory and the consolidated memory,
and without the possibility of hallucination occurring during consolidation [McClelland
et al., 1995]. The reactivation of the encoded pathways generally occurs during SWS and
only in a minority of recorded neurons. During SWS, these reactivations (the re-firing of
neurons which were previously active during the initial encoding of the memory [Wilson
and McNaughton, 1994]) usually occur in the same order that they were originally ex-
perienced in [Foster and Wilson, 2006], albeit on a condensed timescale [Nadasdy et al.,
1999].
1.7 Sleep and Epilepsy
Sleep can be disturbed due to a variety of reasons, from change in temperature to sleeping
disorders like sleep apnea, however during this thesis, the most relevant and interesting
are epileptic seizures. Seizures occur when there is a misfiring of the synchronous rhythms
of the brain and the physical manifestation of a seizure can vary. They can manifest as
tonic or clonic movements, where tonic movements typically last less than 60 seconds
during which muscle tone of exterior muscles is increased while clonic movements are
convulsions. A seizure will also cause an alteration of mental state. The large amplitude,
hypersynchronous patterns of electrical activity associated with seizures can be observed
through the use of EEG, which assists in the classification of the epilepsy. As previously
stated, synchrony of the network is needed for the EEG to detect the signal, hence many
cells must undergo a similar disruption simultaneously. There are two distinctive periods
of neural activity with regards to epilepsy: ictal and interictal paroxysmal activity. Ictal
activity relates to the presence of an electrographic seizure during an EEG recording,
whilst interictal paroxysmal activity relates to the time between seizures when epilepti-
form activity continues to be detected, but only as brief, transient events. It is simple
to differentiate between the two states as interictal events do not associate with overt
epileptic activity. They can even be detected in patients with no history of epilepsy.
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1.7.1 Paroxysmal patterns
There are many different interictal paroxysmal patterns that consist of several compo-
nents. The first is a single random spike. According to IFSECN (1974)(International
Federation of Electroencephalography and Clinical Neurophysiology), a spike is a tran-
sient, clearly distinguished from the background activity, with a pointed peak and a
duration from 20 to under 70msec while the amplitude is variable [Niedermeyer and
da Silva, 2004a]. The appearance of these spikes does not always suggest a hidden or
overt paroxysmal event. Other questions need to be asked to distinguish the possible
reason of the spike. These investigations should include the wave morphology, the pa-
tients age, whether they are in a state of sleep or wakefulness and the location of spike
occurrence. Wave morphology can be used as an indicator of epilepsy, however the size of
the spikes does not always correlate with the size of the seizure. For example, Rolandic
spikes in children aged between 4 and 10 years are very prominent although the seizure
disorder is usually benign (i.e. seizures do not occur). There are many types of spikes
that are linked to age, for example spikes of an epileptic newborn may seem similar
to those observed in an elderly patient but with very different diagnoses. The level of
awareness of the patient, as stated previously, is very important as spikes may occur in
any state of awareness. However each different state may relate differently to the spikes.
The location of the spikes can help denote which seizure disorder the patient may have.
The types of spikes described below are each observed at a different location while all
relate to forms of seizure disorders.
Occipital spikes
Occipital spikes, also known as spikes and waves, predominantly show as an age-dependent,
EEG-defined, benign focal epilepsy manifesting as autonomic symptoms followed by brief
or prolonged partial motor seizures in younger children [Nass and Gross, 2001]. Older
children present with visual symptoms and headaches. However, occipital spikes are
not always benign. Nass et al (2001) reported that they also present in some children
with autism or autistic regression. These children exhibit severe language and behaviour
deficits. This probably results from the occipital maximal spike fields extending to pos-
terior temporal and parietal regions, as both are involved in language acquisition and
cognitive development. Occipital spikes, as the names suggests are detected in the occip-
ital region of the brain. This localised detection is only observed during interictal EEGs
during wakefulness however these spike wave complexes are detectable in other cortical
regions during sleep (i.e. central, temporal and frontal) [Caraballo et al., 2007].
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Centro-temporal spikes
Centro-temporal spikes are usually classified as high amplitude focal sharp wave dis-
charges in the central and temporal regions, and are either bilateral or unilateral [Smith,
2005]. Dalla Bernardina et al (2002) described the typical paroxysm as a focal negative
diphasic slow spike of medium to high voltage generally over 100µV, followed by a slow
wave located in the rolandic or centrotemporal regions with possible diffusion to sur-
rounding areas. Centro-temporal spikes (CTS) are not limited to children with epilepsy,
they have also been documented to occur in healthy children. Of the 3726 healthy chil-
dren aged between 6 and 13 years of age who participated in a meta study, Cavazzuti et al
(1980) found that mid temporal spikes were present in 50 (1.34%) of the children whilst
centroparietal spikes were recorded in 27 (0.72%). It is thought that the presence of CTS
spikes in healthy children suggests a genetic predisposition to epilepsy if no neurological
deficit or history of CNS problems are present [Niedermeyer and da Silva, 2004a]. A 2005
study conducted by Berroya et al reported that the mean spike frequency in sleep (45.6
per minute) was twice that during drowsiness, which was greater than twice the mean
spike frequency during wakefulness (33 children that had recordings taken during wake-
fulness, drowsiness and sleep). This study also found that during drowsiness and sleep,
the main effect was the increase in spike frequency rather than the spike location or the
number of foci detected and that little difference in morphology was detected between
the three states of awareness [Berroya et al., 2005]. Greater detail of the centrotemporal
spikes present in epileptic disorders is given in section 1.7.2, particularly Benign Epilepsy
of childhood with centrotemporal spikes (BECTS). Epilepsies with CTS are generally
considered to be at the lower end of the spectrum of those epilepsies that present with
paroxysm patterns [Loddenkemper et al., 2011]. The more severe manifestations of spike
wave patterns in epilepsy are present in continuous spike and waves during sleep which
is detailed below.
Continuous spike and waves during sleep
Continuous spikes and waves during sleep (CSWS) is an age-dependant epileptic en-
cephalopathy which only occurs in children and presents with neurocognitive regression,
seizures and displays an EEG component of usually generalised (near)-continuous spike
and wave complexes during a significant portion of REM sleep, which can also be known
as electrical status epilepticus during sleep (ESES) [Loddenkemper et al., 2011]. Gener-
ally, CSWS is considered to be the syndrome and ESES, the EEG pattern observed in
patients with CSWS; however it is common for the two names to be used interchangeably.
For this thesis, ESES will be used to describe the EEG pattern and CSWS will be used
to describe the syndrome.
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Loddenkemper et al (2011), stated that the ESES pattern can be defined as:
• The presence or the increase in amplitude of epileptiform discharges during sleep
[Bureau, 1995,Tassinari et al., 2000]
• Near-continuous, bilateral, or occasionally lateralised slow spikes and waves [Bu-
reau, 1995,Tassinari et al., 2000]
• Occurrence during a significant proportion of SWS, with the range varies dependent
on study from 25 to 85% [Bureau, 1995,Tassinari et al., 2000,Yasuhara et al., 1991]
As with CTS, the more frequency locations of epileptiform activity during wakefulness are
frontotemporal and centrotemporal regions, however it has also been proposed that to be
classed as ESES epileptiform activity should not be present during wakefulness [Hughes,
1994]. As is also seen with CTS and Occipital spikes, during sleep the focal epileptiform
discharges disperse and spiking becomes more generalised and more frequent, typically
with the maximum being detected in the frontal or central region [Loddenkemper et al.,
2011] as shown in Figure 1.11. However, during REM sleep the ESES pattern disap-
pears [Bureau, 1995]. These generalised spike wave discharges (SWD) occur at a 1.5-2Hz
rate. Although there has been instances where the typical SWD is devoid of the slow
wave, leaving only the spike to be present [Michelucci et al., 1987]. The occurrence of the
SWDs is generally partnered with the decrease in neurophysiological functions including
the absence of new learning. Similar encephalographic properties are observed in patients
with Lennox Gastaut Syndrome as well as the neurological deficits. This is described in
more detail in the following subsection. ESES is generally considered to eventually be a
self-limiting pattern that steadily disappears around 11 years of age which is on average
3-4 years after onset [Morikawa et al., 1995].
Many of the above spike and spike-related epileptiform patterns are associated with
a range of neurological disorders. Some of the more prominent examples of which are
introduced in the next section.
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1.7.2 Epilepsies and Neurological Disorders
The EEG pattern of the above spike wave variants are associated with many types of
epilepsies and neurological disorders as briefly outlined previously. Here, detailed exam-
ples of several such disorders are introduced:
Benign epilepsy of childhood with centrotemporal spikes
Benign epilepsy of childhood with centrotemporal spikes (BECTS), or Benign Rolandic
Epilepsy is the most common idiopathic childhood epilepsy syndrome. It is called ‘be-
nign’ because it generally has a good outcome - nearly all children with it will outgrow
it during puberty. BECTS is first discerned between the ages of 3 and 13 years and
commonly stops spontaneously around the age of 16. The syndrome is defined by: brief,
simple, partial, hemifacial motor seizures frequently having associated somatosensory
symptoms [Neubauer et al., 1998]. Nocturnal seizures often become generalized and are
the most frequent form of seizure in this syndrome. Despite its the benign nature in terms
of epilepsy, BECTS can be accompanied by specific cognitive disorders and low academic
achievement [Pinton et al., 2006]. Pinton et al (2006) observed that of a group of 18
children with BECTS, IQ, verbal functions and memory were all considered normal for
their age, however drawing and visuo-spatial skills, attention and visuo-spatial memory
were significantly lower than would be normal for their age group. Reading, numeracy
and spelling ability were all significantly delayed by one or more academic years in over
50% of the test subjects.
The EEG characteristic of BECTS are blunt, high-voltage shaped centrotemporal spikes
often followed by slow waves as shown in figure 1.11b (also shown in figure 1.6b). Cen-
trotemporal spikes, unlike BECTS itself, have been reported to follow an autosomal
dominant path of inheritance with incomplete penetrance and age dependency and as
such may be used to indicate an increased risk of developing BECTS [Neubauer, 2000].
Evidence for genetic linkage in BECTS has been found in the q14 region of chromo-
some 15, which is the location of the neuronal AChR α7 subunit (CHRNA7) [Neubauer
et al., 1998]. Mount et al (1999) , discovered that the gene of a cation-chloride cotrans-
porter (KCC4) is also located on chromosome 15q14. Cation-chloride co-transporters
play a major role in controlling GABAA and glycine receptor mediated responses whilst
also showing close interactions with glutamatergic signalling [Blaesse et al., 2009]. This
relationship with glutamergic signalling may result in the transformation of normal
delta oscillations into a tonically activated pattern during both waking and dreaming
sleep [Steriade, 1994]. There is also evidence that there is no linkage to chromosome
locations 6p21 (EJM1) [Whitehouse et al., 1993], the fragile X site 20q13 (EBN1) and
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8q24 (EBN2) [Neubauer et al., 1997]. This is considered important as these locations
have previously been linked to other epileptic disorders with similar nocturnal spike wave
EEG traits (see below), suggesting a multiplicity of primary pathologies may converge
to generate such spike and wave patterns.
Fragile X syndrome
Fragile X syndrome (FXS) is the most common cause of inherited retardation affect-
ing ∼1 in 4,000 males and 1 in 8,000 females [Berry-Kravis, 2002]. Clinical features of
FXS include: moderate to severe mental retardation; dysmorphic facial features; post
pubertal macro-orchidism; behavioural abnormalities and seizures. Seizures are present
in 10-20% of individuals with full mutation FXS and typically of the complex partial
type [Porri and Korff, 2010]. The EEG trait of FXS is sudden bursting (paroxysmal)
discharges of EEG spikes, mainly localised in the central or centro-temporal regions, with
higher prevalence during sleep (i.e. rather similar to BECTS above). Porri et al ’s (2010)
EEG research revealed slow background activity with left fronto-temporal and bilateral
occipital spikes during sleep. The morphology of these spikes were also similar to those
seen in BECTS [Musumecia et al., 1991,Musumeci et al., 1999].
Evidence suggests that dysregulation of the metabolic glutamate receptor arising from
absence of the FMR1 protein, results in the activation of a voltage-gated inward current
with a net increase in the excitability of neuronal circuits [Hagerman and Stafstrom,
2009]. This inward current may be the cellular basis for epileptogenic behaviour induced
by activation of the metabotropic glutamate receptor 5 subtype [Bianchi et al., 2009].
The dysregulation of glutaminergic neurons in FXS can disrupt the normal actions of
inhibitory GABAergic neurons. Hence, further increasing neuronal hyperexcitability by
the downregulation of GABA receptor subunits and altering enzyme expression linked to
the metabolism of GABA [D’Hulst et al., 2009].
Lennox-Gastaut syndrome
Lennox-Gastaut syndrome (LGS) is a form of childhood-onset epilepsy that appears be-
tween the ages of 2 and 6 years of age and is very difficult to treat. LGS occurs in between
1-5 children in every 100 who present with epilepsy, thus being the most common cause
of intractable childhood epilepsy. Unlike other epilepsies, many forms of seizures can
occur in LGS. The most commonly occurring seizure types are: tonic, which typically
lasts less than 60 seconds during which muscle tone of exterior muscles is increased, 90%
of which occur nocturnally. Atypical absences are also prevalent in this syndrome. As
with other epilepsies, slow (1-2.5Hz) spike wave complexes (mostly around 2/sec) can be
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Figure 1.12: Generalised slow
spike wave complexes (mostly
around 2/sec) in a child with
severe epileptic seizure disor-
der (Lennox Gastaut syndrome).
Taken from [Niedermeyer and
da Silva, 2004a].
observed using an EEG as shown in figure 1.12. [Siddiqui et al., 2007]. Clinical trials
are currently being undertaken by Foletti et al (Institution de Lavigny, Switzerland) to
explore the positive effects of melatonin administration to adults with LGS. Foletti et
al have hypothesized that melatonin can reduce the epileptic activity observed via EEG
during sleep whilst also stabilizing the structure of sleep. This hypothesis is supported by
research from Peled et al (2001) who suggest that melatonin decreases seizure activity,
particularly nocturnal seizures, in children with intractable epilepsy. There are several
preliminary reports that indicate that melatonin possesses anti-epileptic properties at-
tributed to its potent free radical scavenging properties [Peled et al., 2001,Kabuto et al.,
1998]. Studies have shown that approximately 50% of those with LGS show no neuro-
logical deficit nor any evidence of brain disease [Gastaut and Gastaut, 1976,Zimmerman
et al., 1977]. The remaining 50% show a wide variety of infantile brain lesions, which
are usually linked to neurological deficits such as forms of cerebral palsy [Niedermeyer
and da Silva, 2004b]. Mental retardation ranges from the most extreme to the slightest
amount. There is a direct correlation between the age of onset and the level of mental
retardation, however no mental retardation may be seen in those that present after the
age of 10.
Rett Syndrome
Rett Syndrome (RTT), originally known as cerebroatrophic hyperammonemia, is a neu-
rodevelopmental disorder of the grey matter of the brain that almost exclusively affects
females. It is considered to be one of the most common causes of complex disability in
girls [Smeets et al., 2011]. Originally characterized by Andreas Rett in 1954 and pub-
lished in 1966, however it was only internationally recognised in 1983 after a Swedish
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clinical study led by Bengt Hagberg [Hagberg et al., 1983] shared Rett’s findings. As
the syndrome progresses, the child can lose purposeful use of their hands which then
leads onto apraxia. Most girls with RTT also have a varying degree of speech absence
and generally display autistic-like behaviours. The dyspraxia and short attention span
of these girls along with their lack of interest in play make it very difficult to gauge their
developmental progress [Smeets et al., 2011]. EEG abnormalities are almost always seen.
Spikes are common over the central regions, particularly during sleep. These spike wave
complexes are similar to those seen in BECTS: centro-temporal spikes. However, unlike
in BECTS, there have been cases where these CTS have been blocked or attenuated by
passive finger movements [Niedermeyer and Sakkubai, 1990]. In 1999, it was discovered
that a mutation of the MECP2 gene, located at the Xq28 site on the X chromosome, was
responsible for Rett syndrome [Amir et al., 1999]. Hence, RTT was the first neurodevel-
opmental disorder related to a defective transcription of methylated DNA [Smeets et al.,
2011].
Childhood absence epilepsy
Childhood absence epilepsy (CAE) is an idiopathic generalised epilepsy characterised by
absence seizures. These show as a loss of awareness accompanied by bilateral, symmet-
rical, 2.5-4Hz spike and wave complexes in the EEG [Everett et al., 2007, Cerminara
et al., 2012]. CAE is first observed in school-going children. They typically have 10-200
episodes a day brought on by hyperpnea, an abnormal increase in the rate and depth of
breathing [Fehrenbach et al., 2007], in the form of absences and atypical absences [Sid-
diqui et al., 2007]. Children with CAE were thought to outgrow their disorder with little
lasting effect to behaviour and cognitive ability, however recent studies have shown this
not to be the case [Pavone et al., 2001,Caplan et al., 2008]. Caplan et al (2008) reported
that when a cohort to 69 children aged 9.6 years were compared against an age and gen-
der matched control group, 25% had subtle cognitive deficits, 43% linguistic difficulties,
61% a psychiatric diagnosis and 30% clinically relevant child behaviour checklist scores.
Everett et al (2007), have provided genetic evidence to indicate that CACNG3 is a
susceptibility locus for CAE. The CACNG3 gene encodes the voltage-dependent calcium
channel γ3 subunit, thus mutations in this gene cause increased channel activity resulting
in increased neuronal excitability. Cerminara et al (2012), have recently reported on rare
cases where the child suffered from both CAE and BECTS. While these are two distinct
epileptic conditions, recent observations in animal models suggest that they would be
pathophysiologically related and that genetic links could play a large role [Cerminara
et al., 2012].
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Landau-Kleffner syndrome
Landau Kleffner Syndrome (LKS) is also referred to as ’children with midtemporal spikes,
progressive aphasia and seizures’ [Niedermeyer and da Silva, 2004b]. LKS is the most
studied form of syndrome associated with CSWS. LKS is found in children approximately
5 years old. Speech patterns and vocabulary deteriorate and eventually become limited
to a few words. Inter-ictal EEG shows SWDs, predominantly over the left midtemporal
region, but generalised spike-wave bursts do occur with these discharges becoming atten-
uated during non-REM sleep [Metz-Lutz and Filippini, 2006].
In a high proportion of children with LKS, phonological short term memory is impaired
and is linked to one-ear extinction involving the channel on the opposite side of the head
that the SWDs are observed on during an active epileptic period [Metz-Lutz and Fil-
ippini, 2006]. Other cognitive deficits observed in LKS include: verbal and non-verbal
short term memory and loss of language. A recent study by Lesca et al (2012), pro-
posed that there are several genomic regions or genes (ATP13A4, CDH9, CNTNAP2,
CTNNA3, DIAPH3, GRIN2A, MDGA2, SHANK3 ) that are linked to LKS. Most im-
portantly these genes or regions are also associated with autism disorders or involved in
speech or language impairment.
Autosomal dominant nocturnal frontal lobe epilepsy
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is a dominantly inherited
disorder with high pentrance (70-80%) characterised by clusters of short motor seizures
during SWS. These seizures vary from simple arousal from sleep to dramatic hyperki-
netic events and only a minority experience these seizures during wakefulness [Kurahashi
and Hirose, 2002]. Interictal EEG recordings are usually normal however 12-65% of pa-
tients have frontal lobe epileptiform abnormalities, mainly during sleep [Panayiotopoulos,
2008, Olandi et al., 1998]. These abnormalities are generally not seen in succession, like
those observed in BECTS (figure 1.11b) instead they are single occurrences. Picard et al
(2009) reported reduced intellect in 45% of 11 subjects. Executive tasks were particularly
affected. In cases of severe ADNFLE, there is approximately a 25% [Derry et al., 2008]
chance of a degree of mental retardation in comparison to typical affected individuals
who measure as normal intelligence.
Gene mutations relating to ADNFLE are rare, however several mutations have been
identified in different families in the genes encoding subunits of neuronal nAChRs: α4
(CHRNA4) [Marini and Guerrini, 2007, Steinlein et al., 1995] and β2 (CHRNB2) [Sid-
diqui et al., 2007]. In the families that show no linkage to the previous genes, they
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show strong linkage to chromosome 15 (15q24) near α3 (CHRNA3), α5 (CHRNA5), β4
(CHRNB4) [Marini and Guerrini, 2007, De-Fusco et al., 2000]. Picard et al (2006) re-
cently performed a positron emission tomography (PET) study in a group of ADNFLE
patients with known mutations and showed significant regional changes in brain nAChRs
density. Such findings point towards an over activated cholinergic pathway ascending
from the brainstem [Picard et al., 2006]. An additional finding of this study was a de-
crease of receptor density in the prefrontal cortex, which was hypothesized to reflect
progressive neuronal loss caused by seizure activity [Picard et al., 2006]. Steinlein et
al (2012) suggested that nAChR may be responsible for the increased risk for major
neurological systems such as mental retardation and marked cognitive deficits.
1.7.3 Learning disabilities and Epilepsy
As previously discussed in Section 1.6, memory consolidation is thought to occur during
sleep, particularly SWS and REM. Over the past 10 years, there have been many papers
published discussing how the disruption of sleep may have a negative effect on the cog-
nitive development of individuals with epilepsy [Parisi et al., 2010]. The data discussed
in these papers are mainly related to nocturnal EEG epileptiform activity, such as those
observed in childhood nocturnal epilepsy syndromes. As has been briefly described, cog-
nitive dysfunction is prevalent in most childhood epileptic disorders, whether they are
malignant or benign. Table 1.1 summarises the previously detailed syndromes and the
cognitive dysfunction observed in affected individuals.
In patients with epilepsy it is common for the polysomnogram to show elevated states
of sleep fragmentation and a greater proportion of wakefulness and light sleep. This is
paired with a decrease in stages 3 and 4 (SWS) and REM [Touchon et al., 1991] in which
memory consolidation occurs. However, it has also been documented that SWDs during
interictal activity may also result in marked sleep instability [Parisi et al., 2010]. These
epileptic bursts are known to elicit arousal, whether by physiologic movement, muscle jerk
or an epileptic attack [Parrino et al., 2006]. Parisi et al (2010) proposed that if nocturnal
epileptiform activity regularly occurs in a specific area involved in learning, it may hinder
neuroplasticity processes. This theory is supported by the impairment of language skills
in LKS following persistent left frontotemporal epileptiform activity, and the impairment
on executive tasks observed in ADNFLE [Picard et al., 2009]. Interestingly, a transient
version of this effect was documented by Aarts et al in 1984. A study of 46 participants
with subclinical EEG discharges were asked to perform two short term memory tests, one
verbal and one non-verbal. When discharges were present, performance was disrupted in
comparison to when the discharges were not present (the control). Therefore if this dis-
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ruption were to occur during the consolidation process during sleep, particularly SWS, it
is proposed that there will be a long term effect on memory and hence, learning. Holmes
and Lenck-Santini’s work corroborates this theory. In a 2006 paper, they suggested that:
“Interictal spikes can result in transitory cognitive impairment with the type
of deficit dependent on where in the cortex the spike arises. We suggest that
interictal spikes, particularly if frequent and widespread, can impair cognitive
abilities, through interference with waking learning and memory, and memory
consolidation during sleep.”
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1.8 Aims and Objectives
This chapter has reviewed and outlined the current understanding of the neurobiology of
sleep, epileptic and neurological disorders related to sleep and the physiological functions.
Sleep has been studied extensively using EEG and both in vivo and, fairly recently, in
vitro. As has the pathophysiology of epilepsy and neurological disorders related to sleep.
However, the mechanisms behind the EEG traits observed in these disorders is currently
lacking. The aims of this thesis are therefore as follows:
• To establish an in vitro model of the SWD observed in both childhood epilepsies
and neurological disorders related to sleep.
• To elucidate the pharmacological properties of the SWD
• To study the activity of individual neurons during delta rhythms interspersed with
SWDs and establish the contribution of specific types of neuron to the phenomenon
in order to determine the cellular basis of the pathology and the interactions be-
tween local neuronal populations in superficial and deep layers of the neocortex.
• Finally, to design a method of improving the current in vitro recording methods to
allow for better understanding of the interactions between local neuronal popula-
tions.
1.9 Thesis Outline
Chapter 2 details the methods and procedures followed during experiment preparation,
the equipment and recording techniques employed in the accruement of data and the
analytical procedures exercised to both the online data and post hoc data.
Chapter 3 details the nature of seizure discharges associated with sleep by referring to
clinical data and studies. Once an understanding is achieved of the epileptiforms present
within nocturnal epilepsies then an in vitro model can be investigated.
Chapter 4 presents work carried out with the aim of understanding the competitive,
non-selective nicotinic acetylcholine receptor antagonist, d-tubocurarine also known as
DTC. The chapter presents the results from extracellular studies, including laminar pro-
files and epileptiform activity from the somatosensory region of the rodent cortex. The
chapter concludes in a discussion on the possible mechanisms of DTC and it’s inducement
of epileptiform activity.
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Chapter 5 focusses on the research conducted to understand which receptor subunits
are responsible for an increase in power of delta frequency oscillations and the induce-
ment of epileptiform activity similar to that present in EEG recordings of nocturnal
childhood epilepsies.
Chapter 6 presents a number of intracellular recording studies designed to uncover the
neuronal subtypes and their input and output characteristics during DTC-induced epilep-
tiform activity. This chapter also utilised the spatiotemperal recording capabilities of
multichannel electrode arrays.
Chapter 7 details some of the current recording methods available in electrophysiology.
This background information then supports the work and research presented with the
aim of fabricating a solid state electrode array for intracellular recordings. A mechanical
efficacy study and an electrical efficacy study are detailed in this chapter.
Chapter 8 summaries the aims and outcomes from each individual chapter. It also briefly
details the Future work which could follow this thesis.
Chapter2
Electrophysiological Methodology
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2.1 Animal Provision
The majority of slices used in the course of this thesis were taken from young adult male
Wistar rats, aged between 2 months and 4 months old, weighing >150grams. These were
supplied by Charles River (Margate, UK). Adult male C57 mice were also supplied by
Charles River. Animals were maintained on a 24-hour light dark cycle with free access
to food and water with environmental enrichment.
2.2 Animal Procedures
All procedures involving animals were carried out in accordance with the UK Animals
(Scientific Procedures) Act 1986. Rats and mice were first anaesthetised by brief in-
halation of isofluorane at a sufficient concentration to induce light anaethesia within 2
minutes of exposure, typically 3-4mls in a 5 litre bell jar. Animals were removed from the
bell jar once the righting reflex had been overcome. Animals were given an intramuscular
injection in the gluteal region with 0.3mls ketamine (dose ∼100mg/kg rat, ∼300mg/kg
mice, Pfizer, Inc. NY, USA) and 0.3mls of 2% Xylazine (dose ∼10mg/kg, ∼30mg/kg,
Animalcare, York, UK). When all responses to noxious stimuli, such as toe pinch and
corneal reflexes, had completely subsided, the anterior thoracic wall was removed to ex-
pose the heart. A catheter was inserted into the left atrium and was mechanically perfused
with ∼50ml of oxygenated sucrose-modified artificial cerebrospinal fluid (sACSF, see Sec-
tion 2.5) at a rate of approximately 0.6-0.8mls/sec. The right atrium was perforated prior
to perfusion to permit exsanguination during the sACSF perfusion. The intracardial per-
fusion of sACSF was undertaken to improve the viability of neurons [Kuenzi et al., 2000]
and [Aghajanian and Rasmussen, 1989].
2.3 Preparation of Cortical slices
The animal’s spinal cord was severed and an incision was made along the midline of
the headline to expose the skull of the animal. The skull was dissected in the midline
along the sagittal suture in a caudal to rostral direction. The skull bones were carefully
removed, and the brain cleared of any adherent dura matter. The cerebrum, along with
the cerebellum and medulla were extracted from the skull cavity and placed in ice cold
oxygenated sACSF. The brain was trimmed of the cerebellum, hindbrain and frontal
lobes (figure 2.1).
The caudal side of the tissue block was promptly glued to the plate of the Leica VT1000
microtome (Leica Microsystems, Nussloch GmbH, Germany) and was immersed in ice-
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Figure 2.1: Dorsal view of the rat brain [Popesko et al., 1990]
cold oxygenated sACSF. The tissue block was cut in the coronal plane into 450µm thick
slices. Individual slices were collected in a petri dish containing oxygenated ice-cold
sACSF. Only slices containing the hippocampi were collected to allow for simple location
of the primary Somatosensory region. The slices were then dissected coronally along
the midline and saggitally, lateral to the lateral posterior thalamic nucleus as shown in
figure 2.2.
Figure 2.2: Schematic of coronal slice dissection [Paxinos and Watson, 1998]
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2.4 Slice Maintenance
After slicing, tissue was relocated to a holding chamber, which maintained slices at room
temperature in oxygenated ACSF. After slices had equilibrated for approximately 45
minutes, two slices were transferred to an interface recording chamber for the duration of
experiments and were placed on a bilayer of lens cleaning paper. Slices were maintained
at ∼32±1◦C, at the interface between continuous perfusion of NaCl-based ACSF (see
Section 2.5) and 100% humidified carbogen gas (95% O2/5% CO2) atmosphere. ACSF
was circulated through the chamber using a Gilson Minipuls 2 peristaltic pump (Gilson,
Inc. WI, USA) at a rate of 2-3mls/min. Spare slices were stored in a holding chamber
at the interface between oxygenated ACSF and humidified carbogen gas at room tem-
perature. The remaining tissue slices maintained in the holding chamber and the slices
in the recording chamber remained healthy for approximately 10 hours.
2.5 Drug Stocks and Materials
Sucrose-modified artificial cerebrospinal fluid (sACSF) was composed of [in mM]: sucrose,
252; NaHCO2, 24; KCl, 3; NaH2PO4, 1.25; MgSO4, 1;CaCl2·H2O, 1.2; glucose, 10. All
salts were obtained from BDH Laboratory Supplies (Poole, UK), except MgSO4, which
was obtained from Sigma Aldrich (MO, USA) and NaHCO2 and Sucrose, which were
obtained from Fisher Scientific (MA, USA). Artificial cerebrospinal fluid (ASCF) was of
an identical composition except sucrose was replaced with an equiomolar concentration
[126mM] of NaCl.
In general, stock drug solutions were made by dissolving the drug salt in distilled ultra
pure H2O. Drugs that were insoluble in distilled water were dissolved in dimethylsulfox-
ide (DMSO; Sigma Aldrich, MO, USA). Drug solutions were added directly to the ACSF
reservoir perfusing the bath at known concentrations. In the case of stocks prepared in
DMSO, the final DMSO concentration was never above 0.1% v/v. The drugs/chemicals
and concentrations at which they were used in the course of this thesis are listed in
Table 2.1.
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2.6 Recording Techniques
Micropipettes for extracellular field potential recordings were made from thin wall borosil-
icate glass capillaries (1.2mm O.D. x 0.94mm I.D.) containing an inner filament (Harvard
Apparatus Ltd., Edenbridge, Kent, UK) using a Narishige PP-83 electrode puller (Nar-
ishige, Japan). Micropipettes were filled with the same ACSF solution perfusing the
recording chamber. The tip resistance of extracellular electrodes ranged between 2-6MΩ.
Sharp microelectrodes for intracellular recording were made from standard wall borosili-
cate glass capillaries (1.2mm O.D. x 0.69mm I.D.)(Harvard Apparatus Ltd.) containing
an inner filament (Harvard Apparatus Ltd.) using a model P-97 Flaming/Brown-type
horizontal puller (Sutter Instruments Co., Novato, CA, USA). Sharp microelectrodes
were filled with [2M] potassium acetate. The tip resistance of intracellular electrodes was
in the range 50-250MΩ. Cells were recorded in standard bridge-mode mode.
Once the slices in the recording chamber had fully equilibrated to 32◦C, extracellular
electrodes were placed in layer V of the primary somatosensory cortex. Viewing the
slices under a microscope allows electrodes to be accurately positioned by the use of a
manipulator. Control recordings of activity were taken prior to the addition of pharma-
cological agents, to ascertain whether later oscillatory activity was an effect of the drugs
applied. Electrodes remained in the same position throughout the stabilisation period
of the oscillations and then the pharmacological experiments. Carbachol and SCH23390,
the main delta-oscillogenic compounds utilised in this thesis, were bath applied to the
circulating ACSF and evoked a persistent oscillation. The oscillations evolved over ap-
proximately a 2 hour period at which point oscillations were deemed stable when three
delta power recordings over 15 minutes varied less than 10%. Once stability had been
achieved, pharmacological manipulations or laminar profiles were performed.
For spatial analysis experiments, electrode arrays were used once delta activity had been
established and confirmed through the use of glass micro electrode recordings. Multi-
electrode recordings of local field potentials and unit activity were detected using three
dimensional silicon electrode grids, specifically Utah Electrode Arrays (UEAs) (Cyberki-
netics Inc, USA). These grids were composed of a 10 x 10 array of 1.5mm long silicon
microneedles that projected out from a 4mm x 4mm x0.25mm thick substrate, with each
individual electrode having an impedance ranging from 230-370kΩ. UEAs were mounted
onto a Teflon head stage holder (Molecular Devices) using epoxy, which were then in-
stalled onto a 3D patch manipulator (Scientifica, UK). To ensure that the electrode tips
were in the same plane as the surface of the slice in the recording chamber, the electrode
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assembly was aligned to the upper surface of the recording chamber in both the x and y
axes. The UEA was then located over the are of interest in the slice and lowered onto
the surface of the slice to give a penetration of no more than 50µm into the slice.
2.7 Data Acquisition
2.7.1 Glass microelectrode recording
The signals detected from the slices were first amplified by pre-amplifiers present within
the headstages. Extracellular signals were recorded in current-clamp mode, band-pass
filtered at 0.0005-0.2kHz and amplified by an Axoprobe-1A amplifier (X10 Axon Instru-
ments Inc., Union City, CA, USA). Intracellular recordings were recorded in DC mode
and low-pass filtered at 2kHz using an external Brownlee Precision Instrumentation Am-
plifier (Brownlee Precision Co. CA, USA). 50Hz mains noise was eliminated from the
raw signal by adaptive filtering via Humbugs (Quest Scientific Instruments Inc., North
Vancover, Canada). Data was subsequently redigitised at 5kHz by an Instrutech ITC-16
A/D board (Instrutech Corp., NY, USA). Data was stored on an Apple Macintosh G4
computer using AxoGraph X software (Axon Instruments) for off-line analysis.
2.7.2 Multi-electrode array recording
Utah electrode arrays were connected to a 128 channel Cerebus digitiser/amplifier follow-
ing analogue pre-amplification. Data was collected online from the array using Central
(Blackrock Microsystems Inc, USA), digitised at 30kHz, and then saved for offline anal-
ysis in Neuroexplorer (Nex Technologies, Littleton, USA). The time series data from
each channel was saved continuously after filtering (0.1-500Hz) and down sampled to
2kHz. In addition to this data, timestamps for unit data and the digitised template for
each detected spike were also saved for post-hoc analysis. Spike detection parameters
were manually set and performed online during data collection using a combination of
threshold crossing and 2-window template matching. Unit time stamps and local field
potential (LFP) time series were exported to Matlab (The MathWorks Inc.) for further
offline analysis.
2.8 Data Analysis
Data were analysed offline using Axograph X (Axon Instruments Inc., Union City, CA,
USA), Minitab 16 (Minitab Inc, USA), Microsoft Excel (Microsoft Corp.), SigmaPlot
11.0 (Systat Software Inc, USA) and Matlab R2011b (The Mathworks Inc., Natick, MA,
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USA) software packages. Microsoft PowerPoint (Microsoft Corp.) was used for the
presentation of data. The properties of oscillations were defined by several parameters:
• the modal peak frequency of oscillation,
• power of oscillation within a particular frequency band,
• area power of oscillation and
• rhythmicity.
Power spectra of network activity, which quantitatively defines the frequency components
of oscillatory activity, were used to assess these oscillatory properties. Power spectra were
derived from 60-second epochs of data, whereby a Fast-Fourier Transform algorithm
breaks down the oscillation into its constituent sinusoidal waveform components and
calculates the power of each waveform. Data is subsequently plotted as a sum of squares
of the voltage at a specific frequency, over a range of frequencies (0.3-10Hz).
2.8.1 Analysis of Network Oscillations
Most data presented in Chapters 4 and 5 of this thesis is in the form of individual power
spectra. Mean peak frequency and amplitude of oscillation were calculated from pooled
data. A systematic analysis of changes in oscillatory activity is undertaken by measuring
the power of the oscillations corresponding to a relevant range of frequencies, such as
activity in the delta range. The oscillatory power was calculated as the area under the
spectra between two specific frequency boundaries. Power in the delta range was calcu-
lated between 0.5 and 5Hz.
The rhythmicity of an oscillation was calculated via autocorrelation analysis of a 1 second
epoch of extracellular data. An autocorrelation is a measure of how a signal is correlated
with itself. The resultant graph generally looks similar to a sinusoidal damping curve,
with the strength of the signal being plotted against time. The rhythmicity can be calcu-
lated from the autocorrelation by measuring the amplitude of the first side peak on the
Y axis. The mean peak frequency can also be determined due to the inverse relationship
between time and frequency. Whereas cross-correlation analysis calculates the similarity
between two 1 second epoch recordings. If both signals are synchronised, the resultant
graph is sinusoidal. Cross correlation was used to measure the synchrony between the
oscillatory activity at two recording sites and used to determine the phase-lag between
the two sites. The position of the central peak on the Y axis at time 0 determines the
synchrony between the two sites whilst the side peak on the X axis is a measure of the
phase lag.
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Within the confines of this thesis, an epileptiform form is characterised as an anoma-
lous event when compared with the oscillatory activity preceding and following it. When
epileptiform activity was detected during a 60 second epoch of extracellular data, each
individual occurrence was categorised as either a wave discharge (WD) or a spike wave
complex (SWC). A wave discharge had to have an amplitude of >200µV peak-to-peak,
a smooth trace with no spikes interrupting the wave and easily distinguishable from the
general LFP activity. The only difference between a wave discharge and a spike wave
complex was that, a SWC needed to have a spike present during the wave, the position
within the wave was inconsequential. The number of WDs and SWCs was recorded for
each 60 second epoch of data. This data could then be used to calculate the incident rate
of each epileptiform activity category, the total number of occurrences and the effect of
drug concentration on epileptiform activity within the region recorded from.
Spectrograms were produced to understand the frequencies embedded within the epilep-
tiform activity, this would also allow for a categorical difference to be observed between
the two epileptiform categories. Using Matlab (Mathworks), an epoch containing epilep-
tiform activity, generally 1 second in length, was extracted from a 60 second recording. It
was then filtered using a butterworth, highpass filter using the Matlab SOSfilt function
(Fs=5kHz, Fstop=4Hz, Fpass=6Hz, Astop=20dB, Apass=1dB). This filtered data was
then processed using the Matlab spec function to produce a spectrogram with 8192 bins.
The maximum and minimum limits for the colourmap for the spectrogram were set to
0.05 and 0.01 respectively. Due to the frequencies of interest in this reasearch, the y axis
was always set to 100Hz.
2.8.2 Analysis of Intracellular Activity
Sharp electrode recordings of cells which had a resting membrane potential negatively
greater than -50mV and action potentials which were reaching over 0mV were recorded.
Electrophysiological characterisation of these cells was achieved using a 0.2nA depolar-
ising or a 0.3nA hyperpolarising current injection step with a duration of approximately
200ms [McCormick et al., 1985]. Figure 2.3 shows examples of the intrinsic character-
istics of the cell subtypes studied: Regular spiking (RS) neurons and intrinsic bursting
(IB) neurons. Layer V RS cells were defined from the position of impalement in the slice
(Layer V) and the slow, accommodating action potentials with slow after hyperpolarisa-
tions (AHPs) (Figure 2.3A). The same method was utilised for RS cells in layers II and
III (Figure 2.3B). IB cells in Layer V displayed a very different response to the depolar-
ising current injection. Single bursts of activity were seen consisting of multiple APs, in
Electrophysiological Methodology 54
many cases these were superimposed on a slow depolarising envelope followed by very
slow afterhyperpolarisation (Figure 2.3C). Excitatory postsynaptic potentials (EPSPs)
were gained by hyperpolarising cells to the point where action potentials no longer fired,
typically -75mV with a DC current injection. Inhibitory postsynaptic potentials (IPSPs)
were gained by increasing the membrane potential of the cell to -30mV by injecting a
positive DC current.
2.8.3 Analysis of Utah Data
Each of the 96 active channels was individually inspected for unit activity using Central
software (Blackrock Microsystems Inc. USA). If units were found to be present, these
were labeled using different coloured ‘windows’. Concurrently, characterisation of these
units was attempted, whereby units were initially characterised by their location in the
slice, i.e. within the Superficial Layers (Layer I-III) or the Deep layers (Layer IV-VI).
This was then developed by noting if the spike rate was regular or bursting, as this infor-
mation would lead to classifying units as Superficial Regular Spiking (SRS) cells, Deep
Regular Spiking (DRS) cells or IB cells. This process was applied for each slice and for
each drug concentration.
Unit data was exported to Neuroexplorer where further analysis was applied (spike syn-
chrony analysis (time distance to the nearest spike between pairs of units), spike-spike
correlations and spike-field correlations). The numerical outputs of this analysis was ex-
ported to Matlab for thresholding and pictorial representation with reference to electrode
positions in the slice.
For spike-spike correlations, cross-correlations were performed between each pair of units
and connectivity was quantified by extracting the y-axis value of where the central peak
intercepted the Y-axis. For spike-field correlations, correlations with continuous variables
were preformed between the unit spike rate histograms and the LFPs for each unit and
LFP combination. The correlations was similarly quantified, by extracting the intercept-
ing point of the central peak on the Y-axis.
With regards to LFP data recorded via the utah array, maps of the spatial distribution
of the activity were produced using MatLab, where they were mapped with reference to
electrode positions in the specific Utah grid used. This was the interpolated and illus-
trated in a two dimensional ‘surf’ plot with a ‘jet’ colourmap.
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2.9 Statistical Analysis of Data
Statistics were calculated on filtered data using SigmaPlot 11 software (Systat Software
Inc., San Jose, CA, USA). Data was primarily analysed to determine whether the data
was normally distributed. Normally distributed data was presented as mean ± standard
error of the mean (S.E.M.). Paired t-tests were also used on the normally distributed
data to measure any differences between the mean of before and after a manipulation
from the same slice. However, if the data was not from the same slice, an unpaired
t-test was used. A One-way Analysis of Variance (ANOVA) test calculates the difference
between the means of two or more data sets, and was used to help determine whether any
significant changes were seen in the oscillatory response to drug/concentration changes.
Alternatively, if the data was not normally distributed it was expressed as a median
value with it’s interquartile range (displayed as x → y). The Mann-Whitney Rank Sum
Test provided an alternative to the t-test when handling not normally distributed data,
whereby differences in the medians of the two sets of data were compared. Results were
deemed statistically significant if P<0.05.
Chapter3
Quantification and modelling of spike and
wave discharges
3.1 Introduction
This brief chapter will consider in greater detail the nature of seizure discharges associated
with sleep. The aim is provide a clinical reference point to be able to understand the
success of the models used in later chapters and to see what can be learnt relating to
putative epileptogenic mechanisms.
3.1.1 Detailed features of spike and wave discharges use for
detection
Syndromes in which spike and wave discharges are associated with sleep are numerous
as previously detailed in chapter 1. Interestingly, despite the obvious nature of these
discharges when examining EEG traces ‘by-eye’, it has proven difficult to automate this
process. This may in part be due to the variability between patients and also the variabil-
ity in the morphology of the discharges associated with sleep (e.g. simple centrotemporal
spikes, spike and wave discharges, polyspike and wave discharges and continous spike and
wave discharges (CSWS)). This section will concentrate on wave discharges (WD) as a
derangement of normal delta rhythms, whilst spike and wave discharges will be consid-
ered as themselves as they account for the main form of epileptic activity seen during
experiments in this thesis.
The majority of methods that are used for detecting sleep-associated and related ab-
sence seizures rely on the two keys features of the discharges - the slow wave and the
kinetically faster spike. These are reasonably preserved whether they occur as discrete,
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single events or in runs (multiple consecutive events). Clincial data shows epochs of large
amplitude (0.1-1mV) spike and wave discharges lasting from approximately 1 second (the
duration of a single event), to many minutes [Van Hese et al., 2009]. These components
can be separated irrespective of duration and amplitude using spectral analysis, of which
there are several variations. Van Hese (2009) used a modified FFT-based algorithm to
fairly successfully detect runs of spike and wave complexes. More mathematically sophis-
ticated spectrum-based approaches produce similar results. For instance, spectra derived
using complex Morlet wavelets is also able to robustly detect runs of spike and wave
discharges [Xanthopoulos et al., 2009]. However, while useful for CSWS-like, long last-
ing events, these spectrally-based methods do not perform well when looking at single,
discrete events.
An alternative to this spectral based approach to detecting sleep-associated seizure-like
events, is to use component analysis. Principal component analysis by singular value de-
composition has been shown to be particularly useful at removing or enhancing transient
events that drastically vary from the mean activity (i.e. artefact removal or spike detec-
tion) [Lagerlund et al., 1997]. Simply, the process breaks the overall EEG signal into it’s
separate components and deals with these separated parts as individual and independent
timeseries. The analyst can then recombine a series of components to capture as much
of the signal of interest, and as little of the remaining, unwanted activity. The absolute
values of each relevant component can then also be combined to create a numerical in-
dicator for event detection. Variations on this theme are known to have yielded good
detection results and reinforces the theory that the spike and wave components of the
spike and wave complex are indeed separate entities [McKeown et al., 1999]. McKeown
et al (1999), took data from 5 patients with superficially variable seizure-like events.
Using independent component analysis, they found at least two distinct components for
the spike or the wave, each with a spatially different localisation. These components
were also completely separable from the rest of the signal that described the background,
non-seizure related activity.
These different approaches all strongly suggest that the mechanism underlying the spike,
and that underlying the wave, have different origins in the brain.
3.1.2 Clinical features suggesting possible mechanisms.
Possible mechanisms related to the construction of an experimental model of sleep-
associated seizure-like activity can be better understood through the application of two
separate areas of clinical data: Firstly, the pharmacological spectrum of successful treat-
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ments. Secondly, the relationship between spike and wave discharges and other brain
rhythms with known underlying mechanisms.
Sleep associated epilepsies most often present during childhood. Many conventional anti-
epileptic drugs do not have the same effect in children as they do in adults, making the
approach of the clinician difficult. However, a number of approaches have been shown to
have at least partial success, both in alleviating seizures and improving the cognitive per-
formance of the patient. It has been suggested by clinicians that the primary pathology
may be linked to the immune system due to the significant improvement in some Landau
Kleffner patients with CSWS following immunoglobulin administration. This was even
seen in patients who had not responded well to prior attempts with other therapies [Arts
et al., 2009]. However, improvement was not always seen, and any connection to immune
status remains a mystery. As seen in most epilepsies, those associated with sleep also
respond fairly successfully to drugs that boost synaptic inhibition (e.g. see [Veggiotti
et al., 2012]). The efficacy of benzodiazapines (clobazam 1mg/kg/day or clonazepam
0.1mg/kg/day) has been established, but they do not work in all patients and can have
unwanted cognitive side effects (being profoundly sedative and hypnotic agents). In ad-
dition, some classical antiepileptic agents that boost inhibition (e.g. carbamazepine and
phenobarbital) actually make the seizures worse, casting doubt on a role for GABAergic
system deficits in epileptogenesis during sleep. Ethosuximide, a blocker of T-type cal-
cium channels [Broicher et al., 2007] has been shown to be effective in some spike and
wave associated epilepsies, but not specifically those related to sleep [Yasuhara et al.,
1991].
Of the most recent antiepileptic drugs, Levetiracetam has proved particularly effective.
It has been shown to decrease spike and wave complexes rapidly and reliably [Cavitt
and Privitera, 2004]. Interestingly, the drug is unique in that it modulates synaptic vesi-
cle proteins that results in a use-dependent reduction in both excitatory and inhibitory
neurotransmitter release [Gillard et al., 2006]. Work by McTague and Cross (2013), has
shown that changes in pH provided by the kerogenic diet also appear to be effective,
although the reasons for this are currently unknown.
In terms of the relationship between spike and wave complexes and other EEG rhythms,
the connection to the delta rhythm is explicit in sleep-associated epilepsies. This would
suggest that some aspect of the normal generator mechanisms of the delta rhythm
may also underlie the spike and wave complex. Interestingly, observations made dur-
ing seizure-like events during wakefulness would also suggest this. Delta and slow wave
oscillations still dominate the spectrum during wakefulness although they are far smaller
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in magnitude. Nevertheless, it has been proposed that derangement of delta rhythms,
specifically slowing and increasing in variability period-on-period (polymorphic delta),
are a good pre-ictal indicator for spike and wave-like discharges [Tao et al., 2011]. This
correlation between delta slowing and spike and wave complexes is also seen in tuber-
ous sclerosis. In this case, both measures are affected by cortical glucose suggesting
a metabolic basis of this type of epilepsy [Nishida et al., 2008]. The slowing of sleep-
associated rhythms has been shown experimentally to be related to a decrease in glucose
concentration [Cunningham et al., 2006]. Cunningham et al (2006) demonstrated that
slow wave oscillations, and their frequency, were tightly related to the activity of an ATP-
sensitive potassium channel. Reducing glucose (the‘fuel’ for the brain), reduced energy
levels in neurons (in terms of ATP concentration), thus causing the potassium channels to
open. This is turn resulted in a switch from high frequency activity in the EEG to hyper
polarised neurons prone to burst discharges favouring much slower frequencies of activity.
This latter work was performed in animal model in vitro, where control and access to
specific mechanisms is far greater than in the clinical situation. The use of animal models
to sleep-associated epileptiform activity will be introduced in more detail in chapter 4.
3.1.3 Aims
The aim of this chapter was to provide clinical data to directly compare with results from
the experimental model detailed in chapters 4-6.
3.2 Methods
Clinical recordings were taken from an inpatient at the Royal Victoria Infirmary (New-
castle upon Tyne). The patient was an 11 year old female with a history of learning
impairment from approximately age 4. The patient presented with symptoms of pre-
dominantly sleep-associated generalised seizures which has gradually worsened over the
year before recordings used here were taken.
Extracranial EEG measurements were taken suing the standard 10-20 electrode place-
ment (see figure 3.1B). Data was collected and digitised using a SynAmps-2 Neuvo long
term monitoring system (Compumedics Ltd). Clinical observation used a double-banana
montage with data down sampled to 256Hz. Raw, individual channel data was transferred
to MatLab using the Biosig suite of programmes (Institute of Science and Technology,
Austria), where the data was earth-subtracted and band-stop filtered to remove mains
noise (FIR filter, 49.5-50.5Hz, -50dB).
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Most automated spike and wave detection routines use the spectral signature of the
EEG data (section 3.1.1). Here, we constructed a measure of spike and wave complexes
(SWC) by first deriving spectrograms of the filtered data from each channel. Data was
Hanning windowed over 1 second epochs, moving along the dataset with as 39ms (10 data
point) time-step. The SWC ‘magnitude’ measure was quantified as the mean power (in
mV2) of the underlying, on-going wave discharge over 10s (see figure 3.2A) multiplied by
the power in the band encompassing the spike discharges (in this patient’s case, 4-9Hz).
This simple analysis allowed separation of SWCs from any changes in underlying delta
power and frequency. Spatial maps of SWC magnitude were constructed by arranging
each EEG channels ‘magnitude’ on a 2D grid (see figure 3.2 with respect to the montage
placement seen in figure 3.1).
3.3 Results
EEG recordings obtained from the Neurophysiology department revealed a pattern of
activity where wakefulness was associated with fairly normal EEG rhythms. However,
in one epoch (see figure 3.1A) the patient went from relaxed wakefulness to sleep. The
onset of sleep (from visual inspection of videotelemetry) was accompanied by the onset of
a large-amplitude, protracted (>10 minutes) non-convulsive, electrographic seizure. Su-
perficial analysis of this activity revealed a typical CSWS-type occurrence of repetitive
spike and wave complexes (figure 3.1C). Both spike and wave amplitudes varied consid-
erably across different electrodes, with peak amplitudes being seen on electrodes C3, P3
and T5 (mean maximal amplitude 248±25µV, n=100 events , P3). Marked inversions of
the waveform were seen between C3 and more frontal electrodes (e.g. F3) and to a lesser
extent across the midline. The ratio between spike and wave occurrence and amplitude
appeared to vary across the montage. While waves were seen strongest in electrodes in
the left rear quadrant, some position showed very little wave activity but near continu-
ous, low amplitude spikes at approximately 3-7Hz (e.g. Cz and T4). In contrast, on no
channels were waves seen without accompanying spikes.
GIven the spectrum-based approaches to spike and wave complex detection, the data was
subjected to simple spectrographic analysis (figure 3.2A). This approach clearly demon-
strated the relationship between delta frequency activity and the spiking. The near
continuous spike and wave complexes yielded a strong spectral line peaking at 1.8±0.2Hz
(a slow delta rhythm, see section 3.1), although the magnitude of the peak was vari-
able. In this patient, spikes manifest as transient increases in spectral power peaking
between 4 and 10Hz, with a mean peak frequency of 6.5±0.8Hz. Combining the mean
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powers in these two bands yielded a spatial map of spike and wave complex magnitude
(figure 3.2B). A clear peak in this measure of spike and wave activity was observed along
the left temporoparietal axis. This peak was stable during the seizure. The dominance
of delta power in this method of quantification yielded low powers in electrodes where
the wave component of the spike and wave discharge was of low amplitude or absent (i.e.
particularly Cz and T4).
The lateralisation of the spike and wave complexes were examined further by generating
spatial maps of the raw, filtered electrode voltages (figure 3.2C). The initial wave positiv-
ity was seen on electrodes which loosely correlated with those that were previously giving
peak spike and wave magnitudes from above quantification method. However, peak ini-
tial positivity was shifted more towards the back of the brain, peaking in electrodes T5,
P3 and O1. Interestingly, the peak negativity of each discharge in these electrodes was
associated with peak positivity in corresponding contralateral electrode positions, with
some positivity also seen in the right frontal area. At the termination of the spike compo-
nent of the spike and wave discharge, a remarkable midline symmetry was seen. Positive
peaks were seen along the entire midline from FPz to Pz and across both temporopari-
etal axes. This difference in spatial localisation of signal positivity appeared to correlate
with a temporal shift in the spike relative to the wave component of each spike and
wave discharge across the midline (e.g. compare P3 vs P4 and T5 vs T6 in figure 3.2B).
While figure 3.2 shows a single example, the illustrated pattern of spatiotemporal voltage
changed was remarkably stereotypes across the 100 spike and wave complexes analysed.
3.4 Discussion
The data presented and superficially analysed in this chapter provides the core features
of spike and wave discharges that need to be present for an experimental model of sleep-
related spike and wave discharges to be valid. These are:
1. A clear relationship with delta frequency activity: The wave component of each
spike and wave discharge should correspond to a large, slow period of delta activity.
2. The spatial localisation of the discharges should correspond with regions generating
the largest delta power: In humans this has been shown to be the parietal and
frontal areas [Ioannides et al., 2009]. While some studies show that SWCs are
of frontal origin during clinical observation and some animal models [Medvedev
et al., 1996, Kubota et al., 1997], the patient examined here showed clear parietal
dominance. This fits with the general spectrum of epileptiform abnormalities from
BECTS through to CSWS and is therefore, a more attractive region on which to
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Figure 3.1: Example spike and wave seizure discharge. A. A 10 minute recording
taken from electrode P3 as the patient progressed from relaxed wakefulness to sleep.
Increase in peak-peak amplitude from onset corresponds to the occurrence of near-
continuous spike and wave complexes. B. Diagram illustrating the placement of the
electrodes used, positioned in the standard 10-20 format. C. Expanded timescale traces
from each electrode depicted in figure B after filtering (see 3.2). Note the dominance of
the spike and wave complexes on electrode in the lower right quadrant.
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Figure 3.2: Characterisation of clinical spike and wave discharges. A. Example
2.5s epoch of data taken from electrode C3. Below is the spectrogram illustrating the on-
going delta activity interspersed with 4-9Hz (theta frequency range) spectral signature
of each spik . Colourmap scale is in mV2. B. Magnitude of spike and wave complexes
(SWC) over 10s of activity (see 3.2), plotted over the electrode grid. Note the clear
localisation of maximal activity in the right temporo-parietal axis in this patient. C.
Spatial maps of raw electrode voltage during a single SWC. Note the ‘flip-flop’ of peak
positive potential (red in the colourmap) during the spike component of the SWC.
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base a model aims at uncovering general principles.
3. The spike component and the wave component should be clearly distinct entities.
Spatial separation across EEG electrodes was clear in the patient data presented
in this chapter. With this resolution, it is not clear whether this represents a
large anatomical difference in the presence of underlying mechanisms, or a ‘field
orientation’ issue where both components come from different cortical laminae.
This will be addressed in chapter 6.
4. The association with the onset of sleep should be present in in vitro models through
the relationship to known neuromodulator state differences between sleep and wake-
fulness. This point will be dealt with in more detail in the next chapter.
Chapter4
Generation of epileptiform pathology from
delta frequency activity
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4.1 Introduction
4.1.1 Animal models of spike and wave discharges and their
association with sleep
Two models of spike and wave related epilepsy dominate the literature: The Genetic
absence epilepsy rat from Strasbourg (GAERS), and the Wistar albino Glaxo rat from
Rijswilk (WAG/Rij). Both are inbred strains that spontaneously develop non-epileptic
spike and wave seizures during development that persist robustly throughout adult-
hood [Marescaux et al., 1992]. In the case of GAERS rats, their seizure-like activ-
ity shares any features with human absence epilepsies indulging occasional generalised
seizures interspersed with many bilateral spike and wave complexes (SWC), particu-
larly along the frontoparietal attention axis [Danober et al., 1998]. The morphology and
spatial localisation of the spike and wave complexes suggests a good model for sleep as-
sociated syndromes showing CSWS. However, in the GAERS rats abnormal activity is
most prominent during relaxed wakefulness, with only sporadic occurrences during sleep.
This casts doubt on the commonality of an underlying mechanism but some core features
may be shared enough to warrant consideration here.
The second genetic inbred model, the WAG/Rij strain shows more complex seizure-like
activity. At least two distinct types of spike and wave discharge are seen, one having obvi-
ous behavioural correlates seen during sleep and one without behavioural correlates seen
during waking [Van Luijtelaar and Coenen, 1988]. The circadian pattern of these SWCs
suggests a good relationship between the sleep-associated discharges and those associated
with CSWS in humans [Van Luijtelaar and Coenen, 1988]. Given this, it is interesting
to note that, like human sleep-associated seizures, WAG/Rij type one discharges were
correlated with enhanced and slowed delta power in the cortex [van Luijtelaar et al.,
2011]. Several other researchers have also noted a relationship between SWCs and sleep
associated rhythms in these animal models [Pinault et al., 2001]. A common feature of
these studies is the evidence for involvement of thalamus, in particular strong thalamo-
cortical projections [Lu¨ttjohann et al., 2013,Avoli, 1983]. However, these latter authors
demonstrated that increases in spectral power, particularly in the lower frequency (delta)
range, preceded SWCs more overtly in the somatosensory cortex. This region of the brain
is analogous in part to human parietal regions also shown to demonstrate the strongest
delta power and SWCs (see above).
As well as the two inbred strain models described above, SWCs are also seen in ani-
mal models of stroke. It is well recognised clinically that seizure-incidence increases after
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central ischemic episodes [Beghi et al., 2011] and this can be modelled in rats with vary-
ing degrees of middle and anterior cerebral artery occlusion [Srejic et al., 2013]. These
authors noted a rapid (within 1 hour) increase in the incidence of theta and gamma
rhythm generation in the affected cortical areas leading to classic SWCs in about half of
all the rats tested. The higher frequency rhythms (up to 120Hz) were also seen to occur
transiently at the transition from wave to spike in the SWC, providing another marker
which an in vitro model should include.
Given these models, and their caveats, what can we learn about putative primary mech-
anisms for spike and wave complex related seizure genesis?
4.1.2 Putative mechanisms of spike and wave complexes in an-
imal models
Pharmacological manipulation is far more easily, and ethically, performed in animal mod-
els and therefore it is perhaps not surprising that the experimental platforms described
in the previous section have yielded a substantial amount of data pointing to the mech-
anisms underlying SWCs and related seizure-like events.
In terms of synaptic inhibition, the clinical data paints a rather confused picture (see
section 3.1). Antiepileptic drugs targeting GABAA receptors have mixed effects on sleep-
associated epilepsies. In contrast, both clinical and animal studies have suggested that
GABAA receptors play a role [Ostojic´ et al., 2013]. This form of synaptic inhibition is
metabolism-sensitive and it known to participate in the type of slow wave rhythms that
can transform into SWCs (e.g see [Craig et al., 2013]) so it is not clear whether this form
of inhibition is deranged in sleep epilepsies or whether it simply needs to be present to
trigger the seizures indirectly.
There is evidence that synaptic excitation may also play a role. NMDA receptors which
control the excitability of deep layer (layer V and VI) cortical neurons appears to be
hyperactive in some forms of absence epilepsy associated with SWCs [D’Antuono et al.,
2006]. It is unclear from this study whether this reflects an increase in intrinsic excitabil-
ity of deep layer neurons, being strongly interconnected by NMDA receptor-containing
synapses, or whether the increase seen is directly responsible for the hyper-excitability.
The situation is further complicated by the observation that dizoclipine (MK-801, a non-
competitive NMDA receptor antagonist) when administered to rats produces SWCs de
novo [Feinberg et al., 1995]. The large pyramidal cells in the deep layers of the cortex
express a large, low voltage-activated calcium conductance (T-conductance) which pro-
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motes intense but brief burst discharges in dendrites. It has been proposed that excessive
excitation of this conductance may underlie many of the slow wave abnormalities and
perhaps also SWCs in some epilepsies [Cheong and Shin, 2013]. The T-conductance is
reduced by ethosuximide, which may provide a mechanism for the efficacy of this drug
in spike and wave epilepsies clinically (see chapter 3.1).
Further evidence for a mechanistic role for glutamatergic excitatory synaptic transmis-
sion comes from studies looking at metabotropic glutamate receptors in seizure-prone in-
bred strains. Interestingly, increasing the activity via metabotropic glutamate receptors
that enhance the postsynaptic excitation (Group 1, mGluR1 & 5) can actually decrease
SWCs in WAG/Rij rats [D’Amore et al., 2013]. In line with this, increasing activity of
metabotropic receptors that in turn decrease glutamate release presynaptically (therefore
reducing postsynaptic excitation) have the opposite effect. Group 3 mGluRs enhance
SWCs [Ngomba et al., 2008]. These receptors are known to inhibit the cyclic AMP
cascade, hence they may potentiate seizures by altering adenosine phosphate-sensitive
potassium channels [Cunningham et al., 2006] (see section 3.1).
Seizures that manifest, particularly during sleep should be sensitive to neuromodulatory
cues that also change during the sleep/wake cycle. Noradrenaline, dopamine, serotonin
and acetylcholine levels all change markedly during wakefulness and different stages of
sleep, as previously described in section 1.2.1. It is perhaps not surprising then, that
the incidence of SWCs has been shown to be related to the level of these chemicals in
the brain [Bercovici et al., 2009]. The relationship between dopamine receptor function
and SWCs is particularly interesting. Two distinct types of SWC associate differentially
with wake and sleep states (see section 3.1). Dopaminergic agents also control these two
different types of SWC by different means, such that events seen during sleep were in-
creased by lower dopamine receptor function (as seen during deep sleep) while those seen
during wakefulness (when dopamine levels are high), were attenuated [Midzianovskaia
et al., 2001]. Using the same rat model, an experimental study by Sitnikova et al (2005)
reported that lowering postsynaptic noradrenergic activity, which is normally seen during
deep sleep, also increases the number of SWCs seen.
The relationship between SWCs and the cholinergic system is particularly intriguing.
A range of drugs that boost cholinergic transmission in general (e.g. physostigmine)
reduced the incidence of SWCs in a dose dependent manner in vivo [Danober et al.,
1993]. Similarly, these authors showed that selective muscarinic receptor agonists also
reduced SWCs. However, the role of muscarinic receptors in spike and wave generation is
not straightforward. Application of the muscarinic receptor antagonist, scopolamine had
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mixed effects. At low concentrations, SWCs were increased, but at high concentrations
they were suppressed. Danober et al (1993), also showed that the acute application of
the broad spectrum muscarinic receptor agonist, pilocarpine suppressed SWCs. However,
following the administration of pilocarpine, a chronic epileptic syndrome develops over
many months which is characterised by intense SWCs which are particularly associated
with the sleep state [Ferreira et al., 1999].
The role of nicotinic receptors in seizure generation is similarly complex. In the inbred
strain models of SWCs nicotine itself suppresses epileptiform activity [Danober et al.,
1993]. However, these authors also demonstrated that the nicotinic receptor antagonist,
mecamylamine had no effect. This may be due to the subunit selectivity of this drug at
nicotinic receptors and this will be considered in detail in chapter 5.
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is associated with high
penetrance to several nAChR mutations, particularly α4 and β2 subunits. An ”n of
one” clinical study by Willoughby et al (2003) where the single female patient with
pharmaco-resistant ADNFLE participated in an open and double blind trial of nicotine
patch application, reported a significant decrease in the number of seizures in the pres-
ence of the nicotine patch when compared to the control. The average number of seizures
a day decreased from 1.65±2.36 to 0.01±0.00 (P<0.0001) when the nicotine patch was
applied. A later clinical trial by Brodtkorb and Picard (2006) in which the epilepsy char-
acteristics and nicotine habits of two families with two different α4 mutations (776ins3
(insertion mutation) and S248F (missense mutation)), also reported a significant decrease
in seizure occurrence when nicotine was administered (P=0.024). In vitro studies have
shown that these mutant nAChRs have increased sensitivity to acetylcholine, resulting
in a gain of function [Moulard et al., 2001]. Nicotine is known to desensitize nAChRs,
therefore it was hypothesised that this increased sensitivity could be combated by the ad-
ministration of nicotine [Brodtkorb and Picard, 2006]. A molecular pharmacology study
by Son et al (2009) reported that ADNFLE is related to the stoichiometry of the α4β2
nAChRs, where (α4)3(β2)2 has higher sensitivity than (α4)2(β2)3. The authors results
corroborated the previously mentioned theory with evidence that nicotine can revert the
subunit stoichiometry to similar ratios measured in wild type mice i.e. seizure/epilepsy
free state. Hence supporting the hypothesis that nicotine may decrease seizure frequency
in ADNFLE patients. Very little literature is available relating other idiopathic epilepsies
to nicotine. This may be due to the typical patients with nocturnal idiopathic epilepsies
being children and generally not being old enough to smoke, however in 2011 it was
estimated that 5% of children aged 11-15 years smoked at least one cigarette a week [Gill
et al., 2012].
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Nicotine however, is also known to induce seizures at higher doses. The mechanism
underlying the convulsive effects of nicotine are relatively unknown, however several
studies conducted on inbred strains of mice have indicated that several nAChRs may be
involved [Bastlund et al., 2005, Franceschini et al., 2002, Salas et al., 2004, Stitzel et al.,
2000, Broide et al., 2002]. Franceschini et al (2002) have reported that the α7 nAChR
is thought not to be necessary for the mechanisms underlying nicotine-induced seizures,
as the dose dependant curve was similar across different strains of α7 knockout mice.
Whereas work by Salas et al (2004) has shown that β4 and α3 nAChR subunits are medi-
ators of nicotine-induced seizures and hypolocomotion, as both aAChR subunit knockout
mouse models displayed decreased sensitivity to acute nicotine. In addition, Stitzel et
al (2000) have shown that by studying restriction fragment length polymorphisms in in-
bred lines, both the α4 and α6 nAChR subunits are linked with nicotine-induced seizure
sensitivity.
4.1.3 Aims and Objectives
From the arguments above it was hypothesised that disruption of cholinergic neuromod-
ulation should be necessary and sufficient to generate epileptiform activity from delta
rhythms similar to that seen in patients during deep sleep. However, in the absence of an
intact thalamocortical system in the slice, the aim was to see whether the local circuitry
in neocortex alone was sufficient to support such pathology.
4.2 Methods
Adult male Wistar rats were utilised in the following in vitro experiments. 450µM slices
were prepared and maintained as outlined in the methods chapter 2.2- 2.4. Analysis and
statistical techniques used are detailed in chapters 2.8 and 2.9. All experiments recorded
in this chapter utilised extracellular field recordings using glass electrodes. Oscillatory
activity in the delta frequency range was initially induced by application of carbachol
[4µM] and SCH23390 [7µM], a D1-like receptor antagonist.
The area power of oscillations were used as the primary indication of the strength of
oscillatory activity, with the peak amplitude of the power spectra used as a secondary
method of intensity. The area power of delta oscillations was taken between 0.5 and 5Hz.
The frequency of activity was measured from the peak of the power spectra and hence
represents the modal frequency of oscillatory activity over a 60 second epoch. As detailed
in section 2.8.1, for an epileptiform event to be classified as a wave discharge (WD), it
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must have a peak-to-peak amplitude of >200µV, be a smooth trace with no spikes in-
terrupting the wave and easily distinguishable from the general LFP activity. Whereas
for an epileptiform event to be classified as a spike wave complex, the wave portion must
also have a peak-to-peak amplitude of >200µV, a positive spike which briefly interrupts
the ‘flow’ of the wave before returning to complete the wave and be easily distinguishable
from the general LFP activity.
4.3 Results
4.3.1 Laminar profile of induced delta rhythms in the rodent
somatosensory cortex
In view of the work conducted by Carracedo (2010), carbachol [4µM] and SCH23390
[7µM] were bath applied to induce delta frequency oscillations. To confirm that the
optimum oscillatory response in the somatosensory region was within layer V, as sug-
gested by Carracedo (2010), laminar profiles were recorded from the six layers of the
cortical column, as depicted in figure 4.1B. Oscillatory activity was observed within all
layers, although principally between layers IV and VI. A significant variation in delta
band power with reference to cortical layer was observed (P<0.001, n=7, One Way Re-
peated Measures ANOVA). This variation in mean power was greatest between layers I
and IV (P=0.02, n=7, paired t-test) where the mean delta band power in layer I was
0.11±0.02µV2 in comparison to 0.36±0.06µV2, the delta power in layer IV. The variation
in delta power between layer I and layer V was not considered to be statistically significant
however this is likely to be due to the variation within the layer V dataset. The frequency
of the delta oscillations within the cortical column did not significantly fluctuate, with the
mean peak frequency of the delta oscillations in layer V of the somatosensory cortex being
1.5±0.18Hz (P>0.05, n=7, One Way Repeated Measures ANOVA, Figure 4.1Ci). In view
of these results, along with Carracedo’s (2010) findings, for the purpose of longitudinal
profiles, and the pharmacological manipulations described in later chapters, extracellular
field electrodes were positioned in Layer IV/V for all delta frequency manipulations.
4.3.2 Acute bath application of non-selective nicotinic acetyl-
choline receptor antagonist, d-tubocurarine causes a dose
dependent increase in delta frequency activity in the so-
matosensory cortex
Delta frequency oscillations were induced in somatosensory cortex containing coronal
rat slices by bath application of carbachol [4µM] and SCH23390 [7µM], as used in the
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Figure 4.1: Laminar profiles of delta activity in a coronal section of somatosen-
sory cortex A. A laminar profile of power spectra from 60s epochs of extracellular
activity from Carbachol and SCH23390 induced delta oscillations in the Somatosensory
region.B. A diagram of a coronal slice of the somatosensory region used in experiments
and location of recording electrodes. C. Mean data comparing (i) the frequency and (ii)
power of Carbachol and SCH23390 induced oscillations (n=7).
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previous laminar study. In a previous study by Carracedo (2010), the application of
d-tubocurarine (DTC) [10µM], a competitive, broad spectrum nAChR antagonist was
associated with the induction of epileptiform activity in the slices, as it built upon the
effect carbachol had on both the muscarinic and nicotinic receptor subtype, due to it’s
non-selective cholinergic agonistic properties. This epileptiform activity is very similar
to the EEG and examples detailed in chapter 3. To ascertain the level of inducement
needed for epileptiform activity to occur, DTC concentration response experiments [2 -
10µM] were undertaken.
During in vitro experimental conditions, the bath application of DTC resulted in no
statistically significant change in mean delta frequency band power (P>0.05, n=17, One
Way Repeated Measures ANOVA, figure 4.2Di). After 40 minutes of DTC [10µM] ap-
plication, the mean power was 3.67±1.35µV2 compared to the mean power during the
control state, 1.28±0.38µV2. Figure 4.2Dii displays a steady increase in mean delta band
power however, due to the size of the error bars, it can be assumed that this result was not
statistically significant due to the variation in the dataset. Figures 4.2A and B, display
an example of how the delta band power is known to increase with DTC concentration.
The frequency of the delta rhythm saw a significant effect of DTC concentration (P<0.001,
n=17, One Way Repeated Measures ANOVA, figure 4.2Dii). The ANOVA reported that
all concentrations of DTC saw a significant effect when compared to the control state,
however there was little change between the mean peak frequency of [5µM] and [10µM]
concentrations, as can be seen in figure 4.2Di. Within 40 minutes of DTC [5µM] applica-
tion, the mean peak frequency of the delta band was reduced from 1.74±0.13Hz during
the control condition to 1.0±0.09Hz (P<0.001, n=17, paired t-test).
Autocorrelation analysis was conducted in order to assess the effects of the drug on
the rhythmicity of the activity in the slice. Prior to DTC application, auto-correlation
analysis of delta oscillations resulted in a graph that was sinusoidal in form indicating
that the activity was intrinsically rhythmic. The autocorrelation data was normalised,
thus the height of the central peak was always 1 with reference to the y-axis. Auto-
correlation analysis revealed that no statistically significant effect of concentration was
observed for the rhythmicity of the delta frequency oscillations (P>0.05, n=17, One Way
Repeated Measures ANOVA, Figure 4.2Diii). The mean ratio of the first peak to the
central peak during the control condition was 0.38±0.05 whilst the mean ratio during the
final concentration [10µM] was 0.35±0.07. Therefore, it can be surmised that although
DTC [10µM] concentration saw an increase in SWCs, the recorded data between these
complexes saw little change in delta rhythm.
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Laminar profile of delta frequency induced oscillations with acute application
of non-selective nicotinic acetylcholine receptor antagonist, d-tubocurarine.
In Section 4.1, it was determined that Somatosensory cortex Layers IV and V were the
most robust for delta frequency oscillations when using the delta inducing drugs, carba-
chol [4µM] and SCH23390 [7µM]. To understand the effect of DTC across the laminae on
delta frequency oscillations, a further laminar profile experiment was conducted, in which
the effect of DTC [5µM] application was compared with the laminar profile of the control
state. As previously used, 60 second epochs of data were recorded for each of the six
layers of a cortical column, as depicted in figure 4.3B. Statistical analysis reported that
there was a significant effect of drug on mean power of the delta band (P=0.0003, n=7,
Two Way Repeated Measures ANOVA), as was expected from the results of the previ-
ous subsection 4.3.2. The least square mean values as a comparison of drug only were
0.21±0.13µV2 and 1.02±0.12µV2 respectively. The difference in the mean delta power
values for the different cortical layers is greater than would be expected by chance after
allowing for effect of differences in drug (P=0.004, n=7, Two Way Repeated Measures
ANOVA). The difference of the least square mean values for the effect of drug and cor-
tical layer were particularly different for layers IV and V (as expected) which went from
0.36±0.21µV2 and 0.25±0.21µV2 respectively during the control state, to 1.91±0.21µV2
and 1.37±0.21µV2 following [5µM] DTC application. When compared to layer II, a
significant difference was seen between these Layers (P=0.001, n=7, Holm-Sidak Pair-
wise Comparison). During the control state the mean delta band power in layer II was
0.09±0.21µV2 and 0.52±0.21µV2 after DTC application. Figure 4.3A portrays this ef-
fect of drug and cortical layer very nicely. There is, however, no significant interaction
between drug and cortical layer relating to mean delta band power(P>0.05, n=7, Two
Way Repeated Measures ANOVA).
The frequency of the delta rhythm saw a significant effect of drug (P=0.001, n=7, Two
Way Repeated Measures ANOVA), as was expected from the results of the previous sub-
section 4.3.2. With no account for layer, the least square mean peak frequency during
the control state was 1.46±0.05Hz in comparison to 0.94±0.05Hz following DTC [5µM]
application. Unlike the result for mean delta band power, there was a significant interac-
tion between drug and cortical layer i.e. the magnitude of the effect the drug had on the
frequency depended on which cortical layer the electrode was recording from at that point
(P=0.03, n=7, Two Way Repeated Measures ANOVA). Pairwise Multiple Comparison
statistical methods reported that there was no significant effect of layer within drug, i.e.
There was little variation in frequency between layers during a single drug concentration
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Figure 4.2: A. 5 second epoch of extracellular activity from layer V of the somatosensory
cortex after application of delta inducing drugs and increasing d-tubocurarine concen-
tration. B. Power spectra produced from 8 second epochs of data in the absence of
epileptiform activity. C. Autocorrelation from an 8 second epoch of activity in the ab-
sence of epileptiform activity. D. Concentration response curves of mean frequency, mean
power and mean rhythmicity ratio of activity (n=17) during DTC applications.
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(P>0.05, n=7, Holm-Sidak Pairwise Comparison). However, within layers II to V indi-
vidually, there was a significant effect of drug on mean delta frequency (P<0.02, n=7,
Holm-Sidak Pairwise Comparison, figure 4.3Ci) ). For example, in Layer V during the
control condition the mean peak frequency was 1.51±0.18Hz compared to 0.77±0.09Hz
after 40 minutes of DTC [5µM] bath application (P=0.002, n=7, paired t-test).
Cross-correlation analysis of delta frequency induced oscillations with acute
application of non-selective nicotinic acetylcholine receptor antagonist, d-
tubocurarine.
Cross-correlation analysis was used to determine the degree of phase lag and synchrony of
the delta rhythm across the laminae of the cortical column. For this purpose, 60 second
epochs of extracellular data were obtained simultaneously from two different locations
for a comparison. A reference electrode was placed in deep layer V whilst a second
roaming electrode was used to record from each of the other layers in turn, as depicted
in figure 4.4B. From this analysis, it was discernible that the delta activity in each of the
layers during the control state led that of Layer V, with the exception of Layer I, in which
the activity seemed to lag behind it, as can be seen from the black line in Figure 4.4C.
Layer I is also the only layer in which the delta rhythm appears to be 180 degrees out
of phase with the reference electrode in Layer V, unlike the other layers, as shown in
Figure 4.4A. The bath application of DTC [5µM] caused the deeper layers to slightly lag
behind the reference electrode in Layer V (red line in figure 4.4C), however this is not
easily discernible for figure 4.4A. However, Layer I remained approximately 180 degrees
out of phase with the reference electrode in Layer V.
4.3.3 Epileptiform activity
In the previous subsections of this chapter, the main focus has solely been the delta
rhythm and how DTC affects it. However, this is not the only activity that has been
seen during these experiments. The other kind of activity that has been observed is
epileptiform activity, which is detailed in depth in Section 1.7.1.
Of the twenty-eight experiments conducted, Wave Discharges (WDs) were present during
12 experiments resulting in a WD incidence rate of 0.43 per experiment. During these
twelve experiments, the number of WDs detected during a 60 second epoch ranged from
2 to 8 following DTC [5µM] application and ranged from 1 to 3 WDs per 60 second
epoch following DTC [10µM] application. In total, 45 WDs were detected during the
recorded 60 sec on epochs from the twenty-eight experiments with the majority being
Generation of epileptiform pathology from delta frequency activity 78
0.1 1 10 0 
6 0.1 1 10 0 
6 0.1 1 10 0 
6 
0.1 1 10 0 
6 
1 
2 
3 
4 
5 
6 
0 1 2 3 
C
or
tic
al
 L
ay
er
 
Frequency (Hz) 
1 
2 
3 
4 
5 
6 
0 1 2 3 
C
or
tic
al
 L
ay
er
 
Power (uV2 / Hz) 
I 
A B 
C 
C
or
ti
ca
l 
 L
ay
er
 
II 
III 
IV 
V 
VI 
Po
w
er
 (1
0-
4 
V
2 /H
z)
 
Frequency (Hz) 
(i) 
I 
II 
III 
IV 
V 
VI 
(ii) 
I 
II 
III 
IV 
V 
VI 
0.1 1 10 0 
6 
0.1 1 10 0 
6 
Figure 4.3: D-tubocurarine increases the mean area power of delta activity
whilst decreasing modal frequency A. A laminar profile of power spectra from 60s
epochs of extracellular activity from Carbachol and SCH23390 induced delta oscillations
(black trace) and DTC [5µM] induced delta oscillations (red trace) in the Somatosensory
region. B. A diagram of a coronal slice of the somatosensory region used in experiments
and location of recording electrodes. C. Mean data comparing (i) the frequency and (ii)
power of control state oscillations (black trace) and DTC induced oscillations (red trace)
(n=4).
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Figure 4.4: Correlation analysis of delta activity throughout the laminae of a
single cortical column in the somatosensory cortex A. Cross-Correlations from
a 60 second epoch of extracellular activity induced by Carbachol [4µM] and SCH23390
[7µM] (black trace) and d-tubocurarine (red trace) from different layers within a cortical
column of somatosensory cortex (n=4). The reference electrode was positioned in layer
VI, with a roaming electrode recording from layers I, II, III, IV, V and VI. B. A diagram of
a coronal slice of the somatosensory region indicating positions of extracellular electrodes
during the laminar profiles. C. A graph showing the mean phase angle of Carbachol and
SCH23390 induced oscillations (black trace) and d-tubocurarine induced oscillations (red
trace) in each layer of the somatosensory cortex (n=4).
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detected during [5µM] application. Figure 4.5.1 shows a 1 second example of a WD
during [5µM] DTC, extracted from a 60 second epoch. Below is the corresponding spec-
trogram (figure 4.5.1c). The number of WDs tends to peak during [5µM] concentration
as can be seen from figure 4.5.3, however this effect is not considered to be statistically
significant (P>0.05, n=20, One Way Repeated Measures ANOVA). The morphology of
the wave discharge is generally very similar to a typical delta wave however the trough
is much deeper, i.e. the majority of the WDs detected had an amplitude of greater than
250µV and interjected the typically delta rhythm. The WDs also generally lasted more
than 500ms before the trace returned to it’s initial position. The example WD shown in
figure 4.5.1a, is embedded with frequencies less than 20Hz (delta, theta, alpha frequen-
cies, figure 4.5.1b) for it’s majority (figure 4.5.1c). However, the bottom of the trough
co-insides with a short burst of gamma activity.
Spike Wave Complexes (SWCs) were present during nine of the twenty-eight experiments,
resulting in an incidence rate of 0.32 SWCs per experiment. In total, 92 SWCs were de-
tected during the recorded 60 second epochs from the nine successful experiments with
the majority being detected during [10µM] application. Figure 4.5.2 shows a 1 second
example of a SWC during [10µM] DTC extracted from a 60 second epoch. Below is the
corresponding spectrogram (figure 4.5.2). The number of SWCs saw a significant effect
of concentration (P=0.03, n=20, One Way Repeated Measures ANOVA, Figure 4.5.3).
The median occurrence of SWCs during the control state was zero compared to 0 (0 →
5) SWCs per 60 second epoch after 40 minutes of DTC [10µM] application (P=0.004,
n=28, paired t-test). The morphology of the SWC is very different to the WD, however
it is fairly similar to the spike and wave events detailed in Chapter 3. As with the WD,
there are several different frequencies embedded in the SWC, however during and just
following the spike there is a burst of activity in all frequency ranges below 100Hz. Also
following the spike, the less than 20Hz frequencies are much more intense than during
the WD as shown in figure 4.5.2c.
During a single experiment, electrodes were placed in both superficial (Layer I or II) and
deep (Layer V) regions of a cortical column in the somatosensory region. The premise
behind this experiment was to understand the corresponding effect seen in the superficial
layers during the previously described epileptiform activity observed in the deep layers
during DTC application. Figure 4.6 shows 5 second epochs of paired data during the
control state and the different DTC concentrations used (10µM and 20µM). Throughout
the different concentrations, the epileptiforms in the deep layers are very similar to those
seen previously, as can be expected. During the control state, the superficial epoch is
approximately 180 degrees out of phase with the deep epoch, which was also expected
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Figure 4.5: Characteristics of epileptiform activity during d-tubocurarine ap-
plication. 1a). 1 second trace of a typical wave discharge extracted from 60 second
epoch after 5µM application. b). Embedded frequencies extracted via the application
of a high pass filter. c). Spectrogram corresponding to the trace shown above in a).
2a). 1 second trace of typical spike wave complex extracted from 60 second epoch after
10µM application. b). Embedded frequencies extracted via the application of a high
pass filter. c). Spectrogram corresponding to the trace shown above in a). 3. Bar
chart showing the mean occurrence of WDs and SWCs during a 60 second epoch with
increasing concentration.
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having seen the same phenomenon during the laminar profiles in Section 4.1. However,
the delta rhythm seen in the superficial layers has a more sawtoothed appearance com-
pared to the delta rhythm in the deep layers.
In figure 4.6, the corresponding spectrograms are adjacent to the recorded epochs. The
spectrograms for all the superficial layers across all concentrations, visually, have a greater
amount of sub-20Hz activity in comparison to the deep layers. The superficial layers also
tend to retain their delta frequency oscillations more so than their deep layer counter-
parts, particularly following the bath application of [10µM] DTC. During [10µM] DTC
application, the traces are still 180 degrees out of phase with each other however the
magnitude of the epileptiform in the deep layer does not seem to be fully reflected in the
superficial layer. Nevertheless, high frequency activity is detected in both regions simul-
taneously, as shown in the corresponding spectrogram. The magnitude of the deep layer
epileptiform is matched following the bath application of [20µM] DTC, as seen in fig-
ure 4.6. The spike wave seen in the superficial layers is very similar to the EEG recordings
detailed in Chapter 3, figure 3.1. The corresponding spectrograms show high frequency
activity during the epileptiform activity, particularly in the deep layer. In contrast, very
little low frequency activity is detected in the deep layers, unlike the superficial layers
which seems to retain in low frequency activity however not to the extent seen during
the previous concentrations.
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4.4 Discussion
The results reported in this chapter provide evidence that shows that epileptiform be-
haviour characteristic of that seen in EEG recordings during slow wave sleep in children
with nocturnal epilepsies can be generated in the isolated brain slice preparation.
From the laminar profile analysis, delta rhythm activity was prominent throughout the
cortical column although the power of the oscillation varied with location. As was ex-
pected, the power of the oscillations in deep layers, particularly layer V were greater
than that in the superficial layers which corresponds to the results presented by Car-
racedo (2010). Also previously reported by Carracedo (2010), was the lag of layer V
delta activity behind the activity in the other cortical layers (bar layer I) inferring layer
V was the origin of the rhythm. Layer I is known to contain the apical dendrites of
neurones in layer V, which may explain the inverse phase relationship between the two
layers. The application of DTC resulted in the lag in layer V becoming more pronounced.
4.4.1 Paroxysm activity in the isolated cortex
Results from this chapter support work by Lu¨ttjohann et al (2013) and Avoli (1983)
showing that SWCs can be observed in the somatosensory region of rat brain. Although
no statistically significant increase in delta rhythm spectral power was observed preceding
SWCs, visually there was a general increase in power spectra with concentration before
SWCs occurred which has also been observed in the somatosensory cortex of WAG/Rij
rats by the authors. This is of particular interest as the common feature between the
studies by these authors is the involvement of the thalamus, which the isolated section
of neocortex used within this thesis is independent of as well as other brain regions
associated with sleep. A review by Blumenfeld (2005) presented many studies that
demonstrated the need for the thalamus and cortex to be present for SWCs to occur.
Conversely, he also presented several studies that argued that the thalamus does not
need to be present to induce SWCs. The author further goes on to state, ‘demonstrating
that some forms of SWCs can arise from isolated cortex does not mean that all spike-
wave discharges arise from cortex independently of the thalamus’ [Blumenfeld, 2005].
Unlike the studies detailed in the authors review, the SWCs seen in this chapter are
not continuous. On average, 1 SWC occurred every 15 seconds after the application of
DTC [10µM], with the SWC lasting approximately 500ms in total. Is the reason behind
these non-continuous SWCs due to the lack of true thalamo-cortical projections and the
pharmacological delta frequency oscillation model being inadequate to permit continuous
SWCs as seen in in vivo models? Work by Vergnes et al (1987) and Pelligrini et al (1979)
describes the neocortex alone is less capable of sustaining paroxysm activity, therefore
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suggesting that this may be the case. For the purpose of this research, the mere presence
of SWCs is sufficient, however to understand if the findings are true, a future in vivo
comparison study would be of interest.
4.4.2 Possible relationship between Wave Discharges and Spike-
Wave Complexes
In section 2.8.1 in the main Methods chapters, wave discharges (WDs) are defined as
a clearly distinguishable waveform from that of the general LFP activity, with an am-
plitude >200µV peak-to-peak and no spike interrupting the smooth wave. As stated,
the only difference between a WD and a spike-wave complex (SWC) is the presence of a
spike within the wave, the position of said spike within the wave is inconsequential to this
research. The majority of the literature related to epileptiform activity only discusses
SWCs, is this because SWCs are easily distinguishable to the ambient rhythm in com-
parison to the WD? The WD generally looks like an enhanced period of delta rhythm
activity, although these are individual events and do not seem to effect the rhythmicity
of the delta rhythm, instead they seem to interject it at random intervals. Therefore
suggesting that these events are separate from the delta rhythm. With reference to this
provisional research, the understanding is that the wave discharge is observed before the
occurrence of SWCs. Whether the WD is a precursor to the SWC is unknown at present,
however as the occurrence of SWCs increases, the number of WDs decreases therefore im-
plying that this may indeed be the case. It may be possible that WDs are the beginning
of SWCs before an unknown capacity is reached where the WDs morph into complete
SWCs.
4.4.3 High frequency components of paroxysmal activity
Higher frequency activity, mainly gamma frequency oscillations were observed to coin-
cide with the spike in the SWCs which were detected using spectrograms. This high
frequency activity was followed by a high intensity of low frequency activity (<20Hz).
This characteristic is typical of spike wave paroxysmal activity [Blumenfeld, 2005] and is
also very similar to that seen in animal models of stroke. In cortex, gamma oscillations
are thought to be related to the emergence of localised activity in a small region [Steri-
ade and Amzica, 1996]. Recent studies have reported that low band gamma (30-60Hz) is
localised to the deep layers, predominantly layer V, whereas the high band gamma (80-
200Hz) is localised more superficially to layer II and generated by synaptic excitation and
inhibition in layer III [Srejic et al., 2013]. Both of these gamma bands are thought to
be mediated by GABA receptors, however there is some evidence that the high gamma
oscillations are mediated by gap junctions instead [Whittington et al., 2000]. DTC is a
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known GABAA antagonist and the disruption of GABA transmission is thought to induce
seizures [Treiman, 2001]. In the feline generalised penicillin epilepsy model, a large dose
of penicillin, a weak GABAA antagonist, induces 3-4Hz generalised SWCs and episodes
of unresponsiveness which resemble human absence seizures [Avoli and Gloor, 1982].
This may mean that DTC is acting on the GABAA receptors instead of the nAChRs
or the 5HT3 receptors, however at this point it is unclear. Future research is needed to
understand the receptor subunits responsible for SWC inducement.
4.4.4 Low frequency components of paroxysmal activity
Intensity of alpha and beta frequencies oscillations present in all superficial recordings
is greater than the deep layers across all concentrations states, except during an SWC
where the intensities match. As stated in Section 1.5.2, alpha activity can be superim-
posed on delta rhythms during SWS and tends to be present when a person complains
of non-restorative sleep and is generally observed in those with sleeping disorders [Jaim-
chariyatam et al., 2011]. This therefore could imply that as the alpha and beta frequency
activity is present before the application of DTC, that the delta model used is itself a
precursor to epileptiform activity in the superficial layers.
4.4.5 Relationship to nicotinic mechanisms of seizure reduction
Nicotine is thought to help decrease seizure frequency in ADNFLE patients as described
in section 4.1. The SWC model derived in this chapter antagonises several different
families of receptors to induce seizure-like activity, which clinically, nicotine would agonise
to reduce the prevalence of seizures. Nicotine is known to effect specific subunits (α4 and
β2) whereas DTC is a broad spectrum antagonist which blocks all nAChRs as well as the
aforementioned 5-HT3 and GABAA receptors. Therefore it is currently unknown if the
nicotinic mechanisms involved in reducing seizures are related to those in this research
which induce the epileptiform activity, or if other subunits play a role. As previously
stated, further research is needed to understand the role the separate receptor subunits
play in paroxysm evocation.
4.4.6 Current mediated paroxysm activity
The hyperpolarization-activated cation current, Ih, is known to play an important role
in delta frequency activity, as the blockade of the current can result in the cessation
of the delta rhythm [Hughes et al., 1998]. The delta rhythm model used in this the-
sis is known to respond in a similar way [Carracedo, 2010]. Studies by Schwindt et al
(1988) and Spain et al (1987) have demonstrated that Ih cortical currents contribute
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to spike repolarisation, spike frequency adaptation and afterhyperpolarisation magni-
tude and duration. Whilst alterations in Ih current are associated with SWCs in HCN2
knockout mice and stargazer mice [Di Pasquale et al., 1997], where reduced Ih is thought
to enhance cortical excitability by increasing dendritic impedance. The Ih current can
be modulated by 5-HT resulting in the inducement of a positive shift of up to 10mV in
its half-maximal activation, which is of interest due to the antagonistic nature of DTC
on 5-HT3 receptors. The application of serotonin is known to increase the amplitude of
Ih current, therefore it is possible that DTC would decrease the amplitude. During the
DTC [10µM] application, the delta rhythm was shown to still be present in-between the
SWCs (figure 4.2), however as shown in figure 4.6, although the delta rhythm is much
less prominent, it has not ceased. These observations imply that with an increase in
DTC, Ih may be decreased, however not sufficiently enough to result in the cessation of
the delta rhythm. This possible decrease in Ih may also be involved in the inducement
of SWCs through the enhancement of cortical excitability.
Ethosuximide, an anti convulsant drug, is known to block SWC firing in GAERS rats in
the somatosensory cortex [Manning et al., 2004]. Interestingly, it is also used to reduce
persistent sodium current in thalamic and cortical neurons [Leresche et al., 1998]. An
increase in sodium current may therefore be associated with neuronal bursting, hyper
excitability and subsequently, the generation of SWCs. This may be the molecular basis
of SWCs in WAG/Rij rats, which are reported to have increased expression of voltage-
gated sodium channels NaV 1.1 and NaV 1.6 compared with non-epileptic controls [Klein
et al., 2004]. However, DTC antagonises ligand gated ion channels, therefore stopping
the inflow of sodium ions. Hence, it can be concluded that although sodium currents are
thought to be responsible for SWCs in some animal models of epilepsy, it may not be
the molecular basis of the SWCs detailed in this thesis.
4.4.7 Summary
This chapter has described the processes involved in the optimisation of an in vitro spike
wave complex in slow wave sleep model in the rat somatosensory cortex. With its con-
clusion, a reasonably reliable model of the epileptiform activity prevalent in childhood
nocturnal epilepsies has been established. To reiterate, the conditions that were found
to be most favourable for the production of epileptiform activity consist of the initial
application carbachol [4µM] and SCH23390 [7µM] to induce the delta rhythm in 450µm
sections of the somatosensory cortex cut in the coronal plane. Upon delta rhythm sta-
bilisation, the application of DTC [10µM] would induce epileptiform activity similar to
that seen in clinical EEG studies.
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The development of this in vitro epileptiform activity model provides an introduction
to a relatively novel area of study, hence providing significant opportunities for further
investigation. The experiments in the subsequent chapters of this thesis will provide an
in depth study of the rhythm, the mechanisms underlying its generation and it’s spa-
tial distribution through the cortical layers of the somatosensory cortex. Chapter 5 will
explore the basic pharmacological properties of the epileptiform activity with the aim
of identifying the key receptor subunits responsible for the generation of the SWCs and
WDs.
Chapter5
Pharmacological generation of epileptiform
activity during cortical delta rhythm
89
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5.1 Introduction
The previous chapter of this thesis described the discovery, optimisation and basic char-
acterisation of the impact of the non-specific competitive nicotinic acetylcholine receptor
antagonist, d-tubocurarine on a cortical delta model in the somatosensory cortex of the
rat in vitro. This was elicited by mimicking the neuromodulatory processes associated
with non-REM sleep. The basic electrophysiological properties of the delta rhythm and
epileptiform activity were used to describe the effect of d-tubocurarine (DTC). The results
of these experiments have strongly indicated that nAChRs are involved in the epilepti-
form activity relating to childhood nocturnal epilepsies. However, there are many nAChR
subunits which DTC may be blocking, hence inducing the epileptiform activity. DTC
is also known to be a potent 5-HT receptor antagonist [Gerschenfeld and Paupardin-
Tritsch, 1974, Wonnacott and Barik, 2007], acting on the 5-HT3 receptor subunit pre-
dominantly [Peters et al., 1990] particularly at concentrations between 1 and 10µM.
Higher concentrations of DTC also block GABAA receptor mediated currents [Wotring
and Yoon, 1995]. Therefore, it is currently unclear, the antagonism of which particular
neuromodulator/s elicits the spike and wave epileptiform activity. The following sec-
tions briefly introduce what is currently known about the neuromodulator subunits DTC
effects and how they are currently thought to link to childhood nocturnal epilepsies.
5.1.1 Nicotinic Acetylcholine Receptor Subunits
Acetylcholine (ACh) and it’s receptor subtypes have previously been discussed in depth
in section 1.2.1, however their response to d-tubocurarine has not, which will be remedied
in this introduction.
Previous studies have reported that at low concentrations DTC has been shown to be a
competitive antagonist, meaning that it can bind to any nAChR but will not activate the
receptor. The antagonist will compete for binding sites with agonists, such as nicotine
and acetylcholine, and at sufficient concentrations will displace the agonist [Pedersen
and Cohen, 1990]. With a competitive antagonist, higher concentrations of the endoge-
nous agonist, in this case acetycholine, can displace DTC and restore receptor function.
However, at higher concentrations (like the ones used in the previous chapter) DTC is
considered to be non-competitive. Therefore, the concentration of the agonist can be
disregarded as, no matter the agonist concentrations, the antagonist cannot be removed
from the receptor and therefore cannot restore function [Colquhoun et al., 1979]. DTC
cannot normally cross the blood brain barrier. It is generally considered a neuromuscu-
lar relaxant with regards to nAChRs. However, it is also known to antagonise neuronal
nAChRs in in vitro studies in chicks, specifically α4 and non-α7 subunits [Bertrand et al.,
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1990]. Due to it’s non-specific competitive nature, DTC is thought to block most AChR
subunits, therefore understanding what role each subunit plays in the evocation of epilep-
tiform activity seen in the present studies is necessary.
In 1959, a paper written by Nisbet reported the treatment of status epileptics with
D-tubocurarine, in this case however, DTC was administered as a muscle relaxant dur-
ing seizures. Several studies have explored intraventricular injections of DTC which
have been monitored using EEG to understand their effect on hippocampal activity
(e.g. [Carmichael et al., 1964, Feldberg and Fleischhauer, 1963]). In contrast to the re-
sults from the Nisbet (1959) study, results demonstrated that high doses of DTC elicited
epileptic spike and wave complexes which were linked to the theta rhythm [Dajas et al.,
1983]. As stated previously DTC cannot easily pass through the blood brain barrier,
therefore in the body it acts as an anti-epileptic agent, whilst when directly introduced
to the brain, it has an epileptogenic effect.
Several nAChRs have been linked to childhood idiopathic epilepsies. The α7 subunit
is linked to BECTS [Neubauer et al., 1998], mutations in γ3 subunits have been linked
to CAE [Everett et al., 2007] and α3−5, α7, β2 and β4 subunits have all been linked to
rare genetic mutations in ADNFLE [Marini and Guerrini, 2007,Siddiqui et al., 2007,De-
Fusco et al., 2000], of which all three conditions display epileptiform abnormalities during
slow-wave sleep. As previously detailed in Chapter 1.7.2, patients with these idiopathic
epilepsies have difficulty with executive tasks, i.e maintaining attention, visuo-spatial
skills and working memory. The nAChR subunit antagonists used within this chapter
have been chosen to selectively block these receptors, to help understand the mechanisms
responsible for paroxysmal event generation.
The nAChR subunit antagonistic agents that will be utilised within this research have
been chosen to allow for a greater understanding of which receptor subunits, if any, are
responsible for the generation of epileptiform activity. Pancuronium dibromide was cho-
sen due to its skeletal muscle relaxant properties which would relate to the Nisbet study
mentioned previously. DHβE has been shown to disrupt cognitive performance when in-
jected directly into the rodent brain [Felix and Levin, 1997]. This study also reported a
similar result when MLA, a potent α7 antagonist was similarly administered. Due to the
agents ability to interact with both α4β2 and α6β2 receptors at concentrations >40nM, a
more selective agent (MG624) was used in this study. As stated above, α3−5 and β4 sub-
units have also been linked to idiopathic epilepsies, therefore agents that specifically act
upon these subunits were required for this study (α-conotoxins PnlA (α3β2) and AuIB
(α3β2)).
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5.1.2 Serotonin
5-hydroxytryptamine (5-HT) or serotonin and it’s subtypes have been discussed in depth
in section 1.2.1 however, similarly to nAChRs above, their response to DTC has not
which will be remedied in this introduction.
Over the past 15 years it has become well established that DTC is a potent antagonist
of the 5-HT3 receptor [Yan et al., 1998, Yan and White, 2002, Hope et al., 1999, Peters
et al., 1990, Eisele et al., 1993] as well as a potent antagonist of nAChRs (as previously
discussed). As stated in section 1.2.1, when the 5-HT3 subtype receptor is antagonised,
an increase in slow wave sleep (SWS) and/or rapid eye movement (REM) sleep is ob-
served [Ponzoni et al., 1995]. DTC has similarly been documented to induce amplification
of SWS EEG recordings and to desynchronise activity during REM sleep [Haranth and
Venkatakrishna-Bhatt, 1977]. This would imply that the mechanisms behind the in-
creased delta rhythms observed during slow wave sleep due to the antagonism of the
5HT3 receptor subunit are similar to those during DTC administration. It can therefore
be hypothesised that a selective 5HT3 antagonist, such as MDL 7777 will elicit a similar
response to that seen in the previous chapter, following the administration of DTC.
Through studies in both animal and human models of epilepsy, serotonin is generally
known to play a role in epileptic mechanisms. In 1989, Dailey et al reported a de-
crease in the concentration of serotonin in the cortex of the genetically epilepsy-prone
rat (GEPR) model of generalised epilepsy. While in 1996, Statnick et al further reported
a decrease in Vmax for [
3H] serotonin, a synaptosomal 5-HT uptake and tryptophan hy-
droxylase activity. Pharmacological studies on these animals as well as the maximal
electroshock model and several others have shown that the administration of drugs that
improve 5-HT transmission inhibit seizures [Statnick et al., 1996]. Whilst, susceptibility
to seizures is increased with a reduction in neural 5-HT concentration both in animal
models and humans [Lazarova et al., 1983, Wenger et al., 1973]. The antagonism of the
5-HT3 subtype receptor has specifically been shown to lower the clonic seizure threshold
of pentylenetetrazole induced seizures in mice [Gholipour et al., 2007]. Therefore, it is
possible that the application of 5-HT3 antagonist MDL 7777 will increase the possibility
of epileptiform activity in vitro.
5.1.3 GABA
γ-aminobutyric acid (GABA) is considered to be the major inhibitory neurotransmitter
in the central nervous system. There are three classes of GABA receptors: GABAA,
GABAB and GABAC . GABAA receptors are ligand-gated chloride ionotropic receptors
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which are the principal receptors in GABAergic synaptic transmission [Li and Xu, 2008].
GABAB receptors are G protein coupled receptors and are less prevalent in the CNS
than GABAA receptors. GABAC receptors are also ligand-gated chloride ionotropic re-
ceptors, however unlike GABAA receptors, they only exist in the visual pathway [Li and
Xu, 2008]. Research undertaken during this thesis is only interested in GABAA recep-
tors due to the antagonistic effect DTC has on GABAA receptors [Wotring and Yoon,
1995]. Whole-cell patch-clamp experiments by Siebler et al (1988) demonstrated the de-
crease in GABA currents following micro molar concentrations of curare (also known as
d-tubocurarine). As stated previously DTC, is known to be a non-selective competitive
nAChR antagonist, however due to the similarities between the nACh and GABAA re-
ceptors, both members of a pentameric ligand gated family of channels, it would suggest
they share common features and react similarly to DTC [Wotring and Yoon, 1995]. In
some regions, the homology between nAChRs and GABAA receptors is 60%, both recep-
tors contain a β subunit extracellular loop and a similar α helical protrusion into the pore
which may act as a gate [Schofield et al., 1987]. Several articles have suggested that the
GABAA receptor in the brain most likely consists of α1, β2 and γ2 subunits [Laurie et al.,
1992, Benke et al., 1994, Rabow et al., 1995, McKernan and Whiting, 1996]. Wotring et
al (1995) believed that a single DTC molecule was able to block both GABA binding sites.
Kafka et al (1986) observed that GABA transmission increases during sleep when com-
pared to the level observed during wakefulness. GABA transmission, which is mediated
by the GABAA receptor subtype due to the abundance in the CNS, has been implicated
in learning and memory processes. Interference of GABA mediated transmission has
been shown to have a negative effect on learning and memory. As GABAergic activity
is increased during sleep, this disruption may have a negative effect on sleep dependant
memory processes. In 2010, Shen et al conducted a study into the role of α4βδ GABAA
in shaping learning deficits during puberty in female mice. They found that, in female
wild type mice, inhibition mediated by the GABAA receptor subtype resulted in deficits
in learning during puberty and a decrease in ability to perform long term potentiation
(LTP) - dependant memory tasks, whereas these deficits were not observed in prepuber-
tal and pubertal δ-/- KO mice. This effect was thought to be as a result of a decrease in
N -methyl-D-aspartate (NMDA) receptor activation and subsequently a decrease of LTP.
In a review of GABAergic mechanisms in Epilepsy, Treiman (2001) describes epileptic
seizures as paroxysmal hyper synchronous transient events that are the result of either
too much excitation or too little inhibition in the particular region of the brain where the
abnormal activity is initiated. As previously stated, GABA is recognised as the princi-
pal inhibitory neurotransmitter hence it is likely that the antagonism of GABA induces
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seizures whilst the agonism of GABA suppresses them [Treiman, 2001].
5.1.4 Aims and Objectives
The previous section provides a brief introduction to to earlier work and knowledge
accumulated in which DTC has been shown to antagonise three specific types of receptors:
nicotinic Acetylcholine, 5-HT3 and GABAA. The aims of this chapter are to:
• To understand which specific receptor subunits respond similarly to DTC applica-
tion through pharmacological manipulation via receptor specific antagonists.
• To mimic oscillatory activity induced by DTC using pharmacological agents to
investigate the mechanisms underlying DTC-induced epileptiform activity.
• To understand the variation in epileptiform activity and how it differs during the
antagonism of different receptor subunits.
5.2 Methods
Methods were the same as those detailed in chapter 4. Delta activity was induced through
the co-application of carbachol [4µM] and SCH23390 [7µM] and was allowed to develop
and stabilise over a 2 hour period. All pharmacological compounds were bath applied
to slices and allowed to act for 40 minutes, in order to allow for any effects to stabilise.
Data from pharmacology experiments detailed within this chapter were obtained through
extracellular field recordings. The power of the activity in the delta frequency band (0.5-
5Hz) was compared before and after pharmacological manipulation and was taken as the
primary indicator of the strength of the oscillation. All statistics will be written to two
decimal places unless the number is less than 0.005 where it will be written as three
decimal places.
During data analysis, if spike and wave complexes (SWCs) were present in the 60 sec-
ond epochs, three separate epochs of either 8 or 3 seconds durations, dependent upon
the frequency of the SWCs, per concentration were used during the frequency and power
analysis to ascertain the pharmacological effect of the drug, solely upon the delta rhythm.
The mean values were calculated for each 60 second epoch of data, which were then used
to calculate the overall mean, standard deviation and standard error of the mean (SEM)
values per concentration as shown in the concentration response graphs of each drug.
Rhythmicity was also measured using the same 8 or 3 second epochs. Once the data had
been extracted from the autocorrelation graphs, the same method was used to calculate
the overall mean, standard deviation and SEM values as frequency and power. Single 8
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or 3 second epochs were used to produce the frequency spectrums and autocorrelations
seen in each figure in this chapter. To better understand the high frequency activity
embedded within the delta oscillations, 1 second epochs were extracted from 60 second
recordings during which epileptiform activity was present.
5.3 Results
5.3.1 The effect of the bath application of nicotinic acetylcholine
α7 subunit selective antagonist MG624 to delta frequency
oscillations
Delta frequency oscillations were induced in somatosensory cortex containing coronal
rat slices by the bath application of carbachol [4µM] and SCH23390 [7µM], as used in
Chapter 4. To discover if disrupted signalling through nicotinic receptors containing the
nAChR α7 subunit was a component of the mechanism behind spike and wave complexes
(SWCs) induced by general nicotinic antagonist (Chapter 4), MG624 concentration re-
sponse experiments [1 - 10µM] were undertaken. Due to the results from Chapter 4,
recordings were only taken from layer V of the somatosensory cortex as this layer was
found to have both the most stable, large amplitude control delta oscillation and the
largest observable effect of d-tubocurarine (DTC).
During in vitro experimental conditions, the bath application of the neuronal α7 subunit
containing nAChR subtype selective antagonist MG624 resulted in a significant decrease
in power of the delta band from a median value of 0.30µV2 (0.08µV2 → 0.58µV2) to
0.04µV2 (0.03µV2 → 0.05µV2) after 40 minutes of MG624 [10µM] application (P=0.004,
n=4, Friedman Repeated Measures Analysis of Variance on Ranks). This significant ef-
fect can be observed in figure 5.1D. There is an obvious decrease shown in figure 5.1D
during the bath application of MG624 [2 and 5µM], however due to the variation in the
dataset, the effect observed during these concentrations was not statistically significant
(P>0.05, n=12, One Way Repeated Measures ANOVA).
The delta rhythm proved to be insensitive to a blockade of α7 subunit containing nAChRs
and the mean peak frequency remained fairly constant throughout the experiment (1.36
± 0.1Hz during control versus 1.14±0.15Hz after MG624 [10µM], P>0.05, n=12, One
Way Repeated Measures ANOVA).
Autocorrelation analysis was conducted in order to assess the effects of the drug on
the rhythmicity of the activity in the slice. Prior to MG624 application auto-correlation
Pharmacological generation of epileptiform activity during cortical delta rhythm 96
analysis of delta oscillations resulted in a graph that was sinusoidal in form indicating
that the activity was intrinsically rhythmic. The autocorrelation data was normalised,
thus the height of the central peak was always 1 with reference to the y-axis. Auto-
correlation analysis revealed that no statistically significant effect of concentration was
observed for rhythmicity (P>0.05, n=6, One Way Repeated Measures ANOVA). As
shown in figure 5.1D, the variation in the dataset may be the cause of the lack of statis-
tical significance. The mean ratio of the first peak to the central peak during the control
condition was 0.48±0.08 whilst the mean ratio during the final concentration [10µM] was
0.28±0.01.
Of the eleven experiments conducted, wave discharges (WDs) were present during 5 ex-
periments resulting in a WD incidence rate of 0.45 per experiment. Figure 5.2a shows
a 1 second example WD following [2µM] MG624 bath application, extracted from a 60
second epoch recording. Below it, is it’s corresponding spectrogram (figure 5.1c ). In to-
tal, 39 WDs were detected during the increasing MG624 concentrations, the majority of
which were detected during [2µM] application (figure 5.2e ). The number of WDs tends
to peak at 2µM however it is not considered to be statistically significant. Although
statistical analysis did reveal that there was a significant effect of concentration on the
number of WDs during a 60 second epoch (P=0.04, n=6, One Way Repeated Measures
ANOVA). The mean occurrence of WDs during the control state was 0.64±0.28 WDs
per 60 second epoch compared to 2.33±0.84 WDs per 60 second epoch after 40 minutes
of MG624 [2µM] application. As with the WDs detailed in Chapter 4, during the trough
there is an increased intensity of activity however in this case it is limited to frequencies
below 20Hz. There is also very little low frequency activity preceding and following the
trough, unlike during the DTC WDs.
Spike waves complexes (SWCs) were present during 2 of the five experiments, result-
ing in an SWC incidence rate of 0.18 per experiment. In total, 29 SWCs were detected
during the 60 second epochs over the varying concentrations, 5 of these were sponta-
neous. The incidence rate of SWCs increased with concentration, however this was not
found to be a statistically significant effect (P>0.05, n=6, One Way Repeated Measures
ANOVA). The mean occurrence of SWCs during the control state was 0.46±0.46 SWCs
per 60 second epoch in comparison to 3±3 SWCs per 60 second epoch following 40 min-
utes of MG624 [10µM] bath application. An example of a SWC following MG624 [10µM]
application can be seen in figure 5.2b with it’s corresponding spectrogram beneath (fig-
ure 5.2d ). The morphology of the SWC looks very different to that seen during DTC
application (refer to figure 4.5.2b ), instead of the spike being at the beginning of the
trough, it is just after the base of the trough. There is some high frequency activity
Pharmacological generation of epileptiform activity during cortical delta rhythm 97
0
0.2
0.4
0.6
0 5 10
Rh
yth
mi
cit
y 
0
0.5
1
1.5
2
0 5 10
Fr
eq
ue
nc
y (
Hz
) 
0
0.2
0.4
0.6
0.8
1
0 5 10
Po
we
r (
μV
2 /H
z) 
1 10 
0 
0.5 
1.0 
1.5 
2.0 
2.5 
1s 
100uV 
Carbachol [4μM] & SCH23390 [7μM] 
MG624 [1μM] 
MG624 [5μM] 
MG624 [10μM] 
MG624 [2uM] 
A. 
C. 
Concentration (μM) 
D. 
Po
w
er
 (1
0-
3  V
2 /H
z)
  
Frequency (Hz) 
A
ut
oc
or
re
la
tio
n 
Time (s) 
-1 0 1 -1 
0 
1 
B. 
Figure 5.1: Antagonism of nAChR subunit α7 using MG624. A. 10 second sam-
ple recording of extracellular activity from layer V of the somatosensory cortex after
application of Carbachol[4µM] and SCH23390 [7µM], followed by the application of in-
creasing concentrations of MG624. B. Power spectra produced from 8 second epochs of
data in the absence of epileptiform activity. C. Autocorrelation from an 8 second epoch
of activity in the absence of epileptiform activity, showing decreasing rhythmicity with
concentration. D. Concentration response curves of mean frequency, mean power and
mean rhythmicity ratio of activity (all n=6) during MG624 applications.
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during the SWC, however the intensity is much lower than that seen during DTC, albeit
during the SWC the intensity of the sub 20Hz frequencies increases. No pattern has been
detected with regards to epileptiform activity during a 60 second epoch i.e. occurring at
a regular frequency, however this may be due to the length of the epochs used.
5.3.2 The effect of the systematic application of nicotinic acetyl-
choline α7
? subunit selective antagonist, Pancuronium, on
delta frequency oscillations.
The bath application of the neuronal α7
? subunit containing nAChR subtype selective
antagonist, Pancuronium resulted in no statistically significant change in mean power in
the delta band as can be seen in figure 5.3D. The mean delta band power during the
control state was 0.83±0.12µV2 compared with the mean power after 40 minutes of the
application of the final concentration [10µM], 1.34±0.27µV2 (P>0.05, n=34, One Way
Repeated Measures ANOVA).
The frequency of the delta rhythm saw a significant effect of Pancuronium concentration
(P=0.004, n=34, One Way Repeated Measures ANOVA). Within 40 minutes of Pancuro-
nium [10µM] application the mean peak frequency of the delta band was reduced from
1.49±0.09Hz during the control state to 1.19±0.07Hz (P=0.002, n=34, paired t-test).
This significant decrease is not easily observable in the concentration response graph in
figure 5.3D, however this is likely due to the variance of the dataset and the small range
the frequency varied over.
Autocorrelation analysis reported a near significant decrease in rhythmicity with concen-
tration (P=0.07, n=17, One Way Repeated Measures ANOVA)(figure 5.3D. The mean
height ratio of the first peak to the central peak with reference to the y-axis was 0.32±0.05
during the control state, however as can be seen in figure 5.3C, this control signal was not
always sinusoidal in appearance. Whilst the application of pancuronium may have im-
proved the rhythmicity with regards to its sinusoidal appearance, as stated previously no
significant change in rhythmicity was detected. After 40 minutes of Pancuronium [10µM]
application, the mean height ratio of the first peak to the central peak was 0.2±0.04.
Of the fifteen experiments conducted, WDs were present during six experiments result-
ing in an incidence rate of 0.35 per experiment. In total, 76 WDs were detected during
the increasing Pancuronium concentration, the majority of which occurred following the
application of [2µM] Pancuronium (see figure 5.4e. As can be seen from figure 5.4e, there
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Figure 5.2: Characteristics of epileptiform activity during MG624 application.
a. 1 second trace of wave discharge extracted from 60 second epoch after 10µM applica-
tion. b. 1 second trace of spike wave complex extracted from 60 second epoch after 10µM
application. c. Spectrogram corresponding to the trace shown above in a). d. Spec-
trogram corresponding to the trace shown above in b). e. Bar chart showing the mean
occurrence of WDs and SWCs during a 60 second epoch with increasing concentration.
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Figure 5.3: Antagonism of nAChRs subunits α7
? using Pancuronium bromide.
A. 10 second sample recording of extracellular activity from layer V of the somatosensory
cortex after application of Carbachol[4µM] and SCH23390 [7µM], followed by the appli-
cation of increasing concentrations of Pancuronium bromide. B. Power spectra produced
from 8 second epochs of data in the absence of epileptiform activity. C. Autocorrelation
from an 8 second epoch of activity in the absence of epileptiform activity. D. Concen-
tration response curves of mean frequency, mean power and mean rhythmicity ratio of
activity (all n=8) during Pancuronium applications.
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is no obvious trend when referring to the WD incident rate and statistical analysis has
reported no significant effect of concentration (P>0.05, n=8, One Way Repeated Mea-
sures ANOVA). The mean occurrence of WDs during the control state was 0.35±0.35
WDs per 60 second epoch in comparison to 2±1.66 following 40 minutes of Pancuronium
[10µM] application. The spectrogram for the example wave discharge, see figures 5.4a
and 5.4c, contained a substantial amount of high frequency activity with the trough.
Whereas after the trough, there was a high intensity of sub 20Hz activity embedded in
the WD.
Spike wave complexes (SWCs) were only present during 3 experiments resulting in an
incidence rate of 0.17 per experiment. In total, 14 SWCs were detected during the three
experiments, 7 of which were spontaneous, i.e. occurring during the control state. The
number of SWCs varied between experiments however no significant effect of drug concen-
tration was observed (P>0.05, n=8, One Way Repeated Measures ANOVA, figure 5.4e.
The mean occurrence of SWCs during the control state was 0.41±0.41 SWCs per 60
second epoch in comparison to 0.13±0.13 following the bath application of [10µM] Pan-
curonium. The morphology of the SWC was different from the DTC SWC, however the
spectrogram contains similar features. For example, the high frequency activity occurring
during the spike as well as the increased intensity of sub 30Hz frequency activity after the
spike. However, the location of the spike in the SWC and the amplitude of the complete
SWC differ greatly from that seen during DTC application (refer to figure 4.5.2).
5.3.3 The effect of the bath application of nicotinic acetylcholine
α4 subunit selective antagonist, DHβE on delta frequency
The bath application of the α4 subunit containing nAChR subtype selective antago-
nist, Dihydro-β-erythroidine hydrobromide (DHβE) resulted in a statistically significant
change in mean power in the delta band with increasing drug concentration from the
control state to 20µM can be seen in figure 5.5D (P< 0.001, n=32, One Way Repeated
Measures ANOVA). The mean delta band power during the control state was 0.22µV2
(0.07µV2 → 0.42µV2) compared with the mean power after 40 minutes of the [10µM] ap-
plication, 0.22µV2 (0.16µV2 → 0.83µV2) (P=0.001, n=32, paired t-test). Although the
ANOVA stated that all three concentration states were significant, the number of data
points for the final concentration [20µM] (n=4) were not enough to confirm statistical
significance when a paired t-test was performed (P> 0.05, n=4, paired t-test).
The frequency of the delta rhythm saw a near significant effect of DHβE concentra-
tion (P=0.052, n=32, One Way Repeated Measures ANOVA). This lack of significance
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Figure 5.4: Characteristics of epileptiform activity during Pancuronium appli-
cation a. 1 second trace of wave discharge extracted from 60 second epoch after 10µM
application. b. 1 second trace of spike wave complex extracted from 60 second epoch
after 10µM application. c. Spectrogram corresponding to the trace shown above in a).
d. Spectrogram corresponding to the trace shown above in b). e. Bar chart show-
ing the mean occurrence of WDs and SWCs during a 60 second epoch with increasing
concentration.
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may be due to the size of and variation in the final concentration dataset (n=4) in com-
parison to the control and first concentration datasets (n=32). As shown in figure 5.5D,
a decrease in delta band frequency was observed from 1.33±0.08Hz during the control
state to 0.83±0.08Hz during the final concentration [20µM].
Autocorrelation analysis reported a statistically significant difference in rhythmicity with
concentration (P=0.023, n=17, One Way Repeated Measures ANOVA) (figure 5.5D).
The ANOVA reported a non significant different between the control state and the first
concentration, whilst the other two comparisons were considered significant. The mean
height ratio of the first peak to the central peak with reference to the y-axis was 0.28±0.05
during the control state. Following the application of [10µM] DHβE, the height ratio was
0.34±0.04 after 40 minutes. As can be seen from figure 5.5C and D, the [10µM] con-
centration generally improves the rhythmicity of the signal, however not significantly so
(P>0.05, n=17, Pairwise Comparison (Holm-Sidak)). After 40 minutes of [20µM] DHβE,
the height ratio was 0.13±0.01. As was observed previously with mean delta band power
and frequency, the size of the 20µM dataset (n=3) is not large enough to exclude to pos-
sibility that the difference between itself and the control state is due to chance (P>0.05,
n=3, paired t-test).
Of the fourteen experiments conducted, WDs were present during 5 experiments result-
ing in a WD incidence rate of 0.29 per experiment. During these five experiments, the
number of WDs detected during a 60 second epoch ranged from 1 to 10 once DHβE had
been applied, with a total of 26 being detected overall. Figure 5.6c implies that there
is an effect of concentration, however due to the size of the [20µM] dataset, there is not
enough data to determine if there is a statistically significant effect of concentration or
not. The mean occurrence of WDs during the control state was zero compared to 4.67±
2.41 following DHβE [20µM] application. The morphology of the WD in figure 5.6 is
again different from the previous WDs seen in this and the previous chapter. It is much
slower and the trough takes up a greater proportion of the 1 second epoch. There is also
very little high frequency activity occurring during the very base of the trough, however
there is the sub 20Hz activity present, as seen previously. Spike wave complexes (SWCs)
were not detected during any of the epochs recorded during the fourteen experiments,
hence an incidence rate of zero. No pattern has been detected with regards to the WD
activity i.e. occurring at a regular frequency, however this may be due to the length of
the epochs used or due to the low number of DHβE [20µM] experiments.
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Figure 5.5: Antagonism of nAChR subunit α4 β2 using DHβE. A. 10 second
sample recording of extracellular activity from layer V of the somatosensory cortex af-
ter application of Carbachol[4µM] and SCH23390 [7µM], followed by the application of
increasing concentrations of DHβE. B. Power spectra produced from 8 second epochs of
data in the absence of epileptiform activity. C. Autocorrelation from an 8 second epoch
of activity in the absence of epileptiform activity. D. Concentration response curves of
mean frequency, mean power and mean rhythmicity ratio of activity (control and 10µM
n=17, 20µM n=3) during DhβE applications.
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Figure 5.6: Characteristics of epileptiform activity during DHβE application a.
1 second trace of wave discharge extracted from 60 second epoch after 20µM application.
b. Spectrogram corresponding to the trace shown above in a). c. Bar chart show-
ing the mean occurrence of WDs and SWCs during a 60 second epoch with increasing
concentration.
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5.3.4 The effect of the systematic application of nicotinic acetyl-
choline α3 subunit selective antagonists, α-conotoxins PnlA
and AuIB on delta frequency oscillations.
The contribution of the nAChR α3 subunit to the generation of the delta rhythm and
SWDs was investigated using specific α3 subunit antagonists. These antagonists also
had the benefit of aiding the understanding of the specific roles of the nAChR β2 and β4
subunits.
α3 β2 subunit results
During in vitro experimental conditions, the bath application of the neuronal α3 β2 sub-
unit containing nAChRs subtype selective antagonist α-contoxin PnlA (hereafter referred
to as PnlA), resulted in a statistically significant decrease in the mean power of the delta
band from 2.48±0.67µV2 to 0.7±0.25µV2 after 40 minutes of PnlA [10µM] application
(P<0.001, n=11, One Way Repeated Measures ANOVA). As can be seen in figure 5.7D,
there is a significant decrease from the control state of 2.48±0.67µV2 to the second con-
centration level [2µM] PnlA of 0.94±0.36µV2(P=0.002, n=11, paired t-test). However,
after the [2µM] concentration application, the power in the delta band measured during
[5µM] and [10µM] PnlA concentrations remained stable as there is no significant change
between these three concentrations (P>0.05, n=11, Holm-Sidak Pairwise Multiple Com-
parison).
The delta rhythm proved to be insensitive to a blockade of α3 β2 subunit containing
nAChRs and the mean peak frequency remained fairly constant throughout the exper-
iments (1.02±0.12Hz during the control state versus 1.08±0.08Hz after PnlA [10µM],
P>0.05, n=11, One Way Repeated Measures ANOVA). These data are displayed in fig-
ure 5.7D.
Autocorrelation analysis revealed that no statistically significant effect of concentration
was observed for rhythmicity (P>0.05, n=8, One Way Repeated Measures ANOVA).
As can be seen from both Figure 5.7C and D respectively, the sinusoidal form remains
present throughout the concentrations indicating no decrease in rhythmicity, and little
variation in the mean height ratio of the central peak to the first peak with respect to
PnlA concentration. During the control state, the mean height ratio was 0.32±0.08 in
comparison to 0.27±0.07 40 minutes after PnlA [10µM] application.
Of the eight experiments conducted, Wave Discharges (WDs) were present at varying
concentrations in all experiments, resulting in a WD incidence rate of 1. Figure 5.8a
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Figure 5.7: Antagonism of nAChRs subunits α3 β2 using α-conotoxin PnlA. A.
10 second sample recording of extracellular activity from layer V of the somatosensory
cortex after application of Carbachol[4µM] and SCH23390 [7µM], followed by the appli-
cation of increasing concentrations of α-conotoxin PnlA. B. Power spectra produced from
8 second epochs of data in the absence of epileptiform activity. C. Autocorrelation from
an 8 second epoch of activity in the absence of epileptiform activity. D. Concentration
response curves of mean frequency, mean power and mean rhythmicity ratio of activity
(n=8) during α-conotoxin PnlA applications.
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shows a 1 second example of a WD during a [10µM] PnlA extracted from a 60 second
epoch. Below is it’s corresponding spectrogram (figure 5.8c ). In total, 151 WDs were
detected during the recorded 60 second epochs. The number of WDs tends to decrease
with concentration following an initial significant abundance of WDs following the initial
bath application of PnlA [1µM](P=0.02, n=8, One Way Repeated Measures ANOVA,
Figure 5.8e). The mean occurrence of WDs during the control state was 0.63±0.5 wave
discharges per 60 second epoch compared to the 6.13±2.19 WDs per 60 second epoch
after 40 minutes of PnlA [1µM] application (P=0.04, n=8, paired t-test). The morphol-
ogy of the WDs is quite similar to that seen during DHβE application, particularly when
looking at the width of the trough. Likewise there is very little high frequency activity
embedded in the WD. Although there does seem to be a higher concentration of low
frequency activity preceding the trough than after it.
Spike Wave Complexes were also detected at varying concentrations during four of the
eight experiments, hence resulting in a SWC incidence rate of 0.5. Figure 5.8b shows a
1 second example of a SWC during a [10µM] PnlA extracted from a 60 second epoch.
Below is it’s corresponding spectrogram (figure 5.8d ). In total, 38 SWCs were de-
tected during the increasing concentrations of PnIA. The number of SWCs was seen to
significantly increase with concentration (P=0.05, n=8, One Way Repeated Measures
ANOVA)(Figure 5.8e ). The ANOVA indicated that there may be a significant differ-
ent between the number of SWCs detected during the control state (0.13±0.13 SWCs
per 60s epoch) and the final concentration of PnlA [10µM] (2.33±1.31 SWCs per 60s
epoch) (unadjusted P=0.003, n=8, Holm-Sidak Pairwise Multiple Comparison), however
the paired t-test proved this not to be significant (P> 0.05, n=8, paired t-test). With the
data presented previously and the aid of figure 5.8e, it is reasonable to hypothesise that
as the number of WDs decrease, the number of SWCs increase. The morphology of the
PnIA SWC has some similar characteristics to those seen during DTC application. The
amplitude of the spike overshoots the amplitude of the following wave and the intensity of
the high frequency activity that coincides with the spike and it’s following low frequency
activity. However, unlike during DTC application, there is some high frequency activity
before the spike, which with DTC, occurs after the spike.
α3 β4 subunit
The bath application of the neuronal α3 β4 subunit containing nAChRs subtype selective
antagonist α-conotoxin AuIB (hereafter referred to as AuIB), resulted in no statistically
significant change in the mean power of the delta frequency band as can be seen in fig-
ure 5.9D. The mean delta band power during the control state was 0.85µV2 (0.2µV2 →
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Figure 5.8: Characteristics of epileptiform activity during α-conotoxin PnlA
application a. 1 second trace of wave discharge extracted from 60 second epoch after
10µM application. b. 1 second trace of spike wave complex extracted from 60 second
epoch after 10µM application. c. Spectrogram corresponding to the trace shown above
in a). d. Spectrogram corresponding to the trace shown above in b). e. Bar chart
showing the mean occurrence of WDs and SWCs during a 60 second epoch with increasing
concentration.
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1.22µV2) compared with the mean power after 40 minutes of the final AuIB concentra-
tion [1µM], 0.56µV2 (0.16µV2 → 0.96µV2).
The peak frequency of the delta rhythm saw a significant effect of AuIB concentration
as can be seen in figures 5.9B and D (P=0.01, n=8, Kruskal-Wallis One Way ANOVA
on Ranks). After 40 minutes of AuIB [1µM] application, the mean peak frequency of
the delta band was reduced from 1.83Hz (1.54Hz → 1.84Hz) during the control state to
0.91Hz (0.6Hz→ 1.22Hz). Although the ANOVA indicated that the relationship between
these two concentrations was significant, this was disproved by a paired t-test (P>0.05,
n=8, paired t-test).
Autocorrelation analysis was conducted in order to assess the effects of the drug on
the rhythmicity of the activity of the slice. Prior to AuIB application, autocorrelation
analysis of delta oscillations resulted in a graph that was sinusoidal in form indicating
that the activity was intrinsically rhythmic (black trace in figure 5.9C). The analysis
revealed that no statistically significant effect of AuIB concentration was observed for
rhythmicity (P>0.05, n=8, One Way Repeated Measures ANOVA). The mean height
ratio during the control condition was 0.53±0.09 in comparison to the mean height ratio
during the final AuIB concentration [1µM], 0.35±0.09. As can be seen in figure 5.9C, an
example of the autocorrelation analysis result produced, the sinusoidal form remained
intact and very closely followed the control state (black trace). Figure 5.9D also shows a
slight loss of rhythm which correlates with the example traces in figure 5.9A.
Of the eight experiments, WDs were present during two experiments resulting in an in-
cidence rate of 0.25 per experiment. However, this value is misleading as out of all the
eight experiments, only 4 WDs were detected (in comparison to the 151 WDs detected
during the eight PnlA experiments). An example 1 second trace of a WD extracted from
a 60 second epoch recording can be seen in figure 5.10a as can it’s respective spectrogram
below it (figure 5.10c). The morphology of the wave discharge is very similar to those
seen during MG624 application, with respect to amplitude, trough width and embedded
frequency intensity.
Whilst, SWCs were present during only 1 experiment resulting in an incidence rate of
0.125 per experiment. As with the number of WDs, only 1 SWC (pictured in figure 5.10b)
was detected during the eight experiments. As with the WDs, the SWC was very similar
in morphology to MG624, however there is a lack of high frequency activity which has
previously been seen during all SWCs (figure 5.10d). Epileptiform activity after appli-
cation of AuIB is barely present (figure 5.10e) in comparison to the other drugs used in
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Figure 5.9: Antagonism of nAChRs subunits α3 β4 using α-conotoxin AuIB. A.
10 second sample recording of extracellular activity from layer V of the somatosensory
cortex after application of Carbachol[4µM] and SCH23390 [7µM], followed by the ap-
plication of increasing concentrations of α-conotoxin AuIB. B. Power spectra produced
from 8 second epochs of data in the absence of epileptiform activity. C. Autocorrelation
from an 8 second epoch of activity in the absence of epileptiform activity. D. Concen-
tration response curves of mean frequency, mean power and mean rhythmicity ratio of
activity (n=8) during α-conotoxin AuIB applications.
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this chapter.
5.3.5 The effect of the systematic application of nicotinic acetyl-
choline α9α10 subunit selective antagonist, ACV1 on delta
frequency oscillations.
The bath application of the neuronal α9α10 subunit containing nAChR subtype selec-
tive antagonist, ACV1 resulted in a statistically insignificant change in delta band mean
power (P>0.05, n=15, One Way Repeated Measures ANOVA). As can be seen from
figure 5.11D, the mean power remained fairly constant with increasing ACV1 concen-
tration, although the large error bars portray a large variation in the dataset. This
variation can also be seen in figure 5.11B, which displays large delta band power dur-
ing the control state in comparison to the power during the ACV1 concentration states,
which is small by comparison. The mean power of the delta band during the control state
was 0.97±0.30µV2 in comparison to 0.80±0.36µV2 during the final ACV1 concentration
[1µM].
The mean peak frequency of the delta rhythm saw little effect of increasing ACV1 concen-
tration (P>0.05, n=15, One Way Repeated Measures ANOVA). The peak frequency re-
mained moderately stable with increasing concentration, as displayed in figure 5.11D. The
mean peak frequency during the control state was 1.48±0.09Hz compared to 1.16±0.13Hz
during the final ACV1 concentration [1µM] application.
Autocorrelation analysis reported no statistically significant change in rhythmicity with
ACV1 concentration (P>0.05, n=8, One Way Repeated Measures ANOVA) (figure 5.11D).
The mean height ratio of the first peak to the central peak with reference to the y-axis
was 0.36±0.67 during the control state. Following the application of [1µM] ACV1, the
height ratio was 0.29±0.07 after 40 minutes.
Of the eight experiments conducted, WDs were present during six experiments, resulting
in a WD incidence rate of 0.75. In total, 78 WDs were detected during the 60 second
epochs over the varying concentrations. The number of WDs tends to decrease with
concentration following an initial increase following the initial bath application of ACV1
[200nM], however it is not considered to be a statistically significant trend (P>0.05, n=8,
One Way Repeated Measure ANOVA). The mean occurrence of WDs during the control
state was 2.75±1.13 WDs per 60 second epoch compared to the 4.25±1.53 WDs per 60
second epoch after 40 minutes of ACV1 [200nM] application. The morphology of the
wave discharge following [1µM] ACV1 seems to have a greater amplitude than those seen
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Figure 5.10: Characteristics of epileptiform activity during α-conotoxin AuIB
application a. 1 second trace of wave discharge extracted from 60 second epoch after
1µM application. b. 1 second trace of spike wave complex extracted from 60 second
epoch after 1µM application. c. Spectrogram corresponding to the trace shown above
in a). d. Spectrogram corresponding to the trace shown above in b). e. Bar chart
showing the mean occurrence of WDs and SWCs during a 60 second epoch with increasing
concentration.
Pharmacological generation of epileptiform activity during cortical delta rhythm 114
-1 0 1 -1 
0 
1 
1 10 0 
1 
2 
3 Carbachol [4µM] & SCH23390 [7µM] 
ACV1 [200nM] 
ACV1 [1µM] 
ACV1 [500nM] 
A. 
Po
w
er
 (1
0-
3  V
2 /H
z)
  
Frequency (Hz) 
B. 
A
ut
oc
or
re
la
tio
n 
Time (s) 
C. 
1s 
100uV 
1s 
200uV 
0 
0.5 
1 
1.5 
2 
0 0.5 1 
Fr
eq
ue
nc
y 
(H
z)
 
0 
0.5 
1 
1.5 
0 0.5 1 
Po
w
er
 (µ
V
2 /H
z)
 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0 0.5 1 
R
hy
th
m
ic
ity
 
Concentration (µM) 
D. 
Figure 5.11: Antagonism of nAChR subunits α9 and α10 using ACV1. A. 10
second sample recording of extracellular activity from layer V of the somatosensory cortex
after application of Carbachol[4µM] and SCH23390 [7µM], followed by the application of
increasing concentrations of ACV1. B. Power spectra produced from 8 second epochs of
data in the absence of epileptiform activity. C. Autocorrelation from an 8 second epoch
of activity in the absence of epileptiform activity. D. Concentration response curves of
mean frequency, mean power and mean rhythmicity ratio of activity (n=8) during ACV1
applications.
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during previous drug applications. It also seems to have more activity embedded within
itself. This can also be seen from the spectrogram beneath, particularly the activity that
coincides with the trough of the WD, as well a the ‘normal’ sub 20Hz activity, there is
also some lower gamma activity present (25-40Hz).
Spike Wave Complexes were present during 5 of the eight experiments, resulting in a
SWC incidence rate of 0.625 per experiments. In total, 70 SWCs were detected during
the 60 second epochs over the varying concentrations, 10 of these were spontaneous.
There was no significant pattern detected with regards to the number of SWCs detected
with increasing concentration. The morphology of the SWC seen during ACV1 applica-
tion is quite similar to that seen during DTC experimentation, both in overall amplitude
and the general appearance of the spectrogram. However, the ACV1 spectrogram only
shows activity directly related to the occurrence of the SWC, in particular the high fre-
quency activity that consider with the spikes which peters off to lower frequencies as the
trace returns to normal.
5.3.6 The effect of the systematic application of 5HT3 selec-
tive receptor antagonist, MDL 72222 on delta frequency
oscillations.
The bath application of the 5HT3 subunit selective antagonist, MDL 72222 resulted in
no statistically significant change in the mean power of the delta frequency band as can
be seen in figure 5.13D (P> 0.05, n=40, One Way Repeated Measures ANOVA). The
mean delta band power during the control state was 0.85±0.1µV2 compared with the
mean power after 40 minutes of the final MDL 72222 [10µM], 1.03±0.12µV2.
The mean peak frequency of the delta rhythm saw a statistically significant effect with
increasing MDL 72222 concentration (P<0.001, n=40, One Way Repeated Measures
ANOVA). The ANOVA reported that a significant change in mean peak frequency oc-
curred between the control state and both [5µM] and [10µM], however there was no sig-
nificant change between the two concentration states, hence the most significant change
compared to the control occurred at [5µM]. The median peak frequency during the con-
trol state was 1.54Hz (1.21Hz → 1.83Hz) in comparison to 1.21Hz (0.9Hz → 1.54Hz)
during 40 minutes of MDL 72222 [5µM] application (P<0.001, n=40, paired t-test).
Autocorrelation analysis reported no significant change in rhythmicity with MDL 72222
increasing concentration [1 - 10µM] (P>0.05, n=40, One Way Repeated Measures ANOVA).
As can be seen in figure 5.13D, the rhythmicity stays fairly stable with the exception of
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Figure 5.12: Characteristics of epileptiform activity during ACV1 application
a. 1 second trace of wave discharge extracted from 60 second epoch after 1µM applica-
tion. b. 1 second trace of spike wave complex extracted from 60 second epoch after 1µM
application. c. Spectrogram corresponding to the trace shown above in a). d. Spec-
trogram corresponding to the trace shown above in b). e. Bar chart showing the mean
occurrence of WDs and SWCs during a 60 second epoch with increasing concentration.
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the anomalies during [2µM] concentration detrimentally lowering the mean value. During
the control state, the mean height ratio was 0.41±0.04 in comparison to 0.4±0.04, 40
minutes after MDL 72222 [10µM] application.
Of the twenty experiments conducted, Wave Discharges (WDs) were present during nine
experiments, resulting in an incidence rate of 0.45 WDs per experiment. In total, 125
WDs were detected during the recorded 60 second epochs from the twenty experiments at
varying concentrations. The bar chart in figure 5.14 indicates that WDs are more likely
to occur during [2µM] application, in fact this is not the case. The data was skewed
by 21 WDs detected in one 60 second epoch and the small dataset for [1µM] and [2µM]
concentrations (n=4). The number of WDs was not significantly changed with concen-
tration (P>0.05, n=40, Friedman Repeated Measures ANOVA on ranks). An example
1 second trace of a WD extracted from a 60 second epoch recording can be seen in fig-
ure 5.14a. as can it’s respective spectrogram in figure 5.14c. The morphology of the WD
is very similar to the previous WDs seen in this chapter. As with during MG624 and
α-conotoxin AuIB, there is very little, if any, high frequency activity embedded in the
WD. Unlike some of the previous WDs, the majority of the embedded activity occurs
before the trough instead of after.
Spike Wave Complexes (SWCs) were present during four of the experiments, result-
ing in an incidence rate of 0.2 SWCs per experiment. In total, 8 SWCs were detected
during the recorded 60 second epochs from the twenty experiments, the majority being
detected during [10µM] application. The number of SWCs was not significantly changed
with concentration (P=0.09, n=40, One Way Repeated Measures ANOVA). An example
1 second trace of a SWC extracted from a 60 second epoch recording can be seen in
figure 5.14b. with it’s corresponding spectrogram in d. The morphology of the SWC is
similar to those seen during α-conotoxin PnIA application with respect to the location
of the spike within the SWC, the embedded activity preceding the spike and the ampli-
tude of the spike in comparison to the subsequent wave. Although there is some high
frequency activity, it does not have the intensity of some of the previously seen SWCs,
in particular PnIA and MDL 72222.
5.3.7 The effect of the systematic application of GABAA se-
lective receptor antagonist, Gabazine on delta frequency
oscillations.
During in vitro experimental conditions, the bath application of the GABAA selective
receptor antagonist Gabazine result in no significant change in mean power of the delta
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Figure 5.13: Antagonism of 5HT3 selective receptors using MDL 72222. A.
10 second sample recording of extracellular activity from layer V of the somatosensory
cortex after application of Carbachol[4µM] and SCH23390 [7µM], followed by increasing
concentrations of MDL 72222. B. Power spectra produced from 8 second epochs of data
in the absence of epileptiform activity. C. Autocorrelation from an 8 second epoch of
activity in the absence of epileptiform activity. D. Concentration response curves of
mean frequency, mean power and mean rhythmicity ratio of activity (control, 10µM and
20µM n=20, 1µM and 2µM n=4) during MDL 72222 applications.
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Figure 5.14: Characteristics of epileptiform activity during MDL 7222 appli-
cation a. 1 second trace of wave discharge extracted from 60 second epoch after 10µM
application. b. 1 second trace of spike wave complex extracted from 60 second epoch
after 10µM application. c. Spectrogram corresponding to the trace shown above in a).
d. Spectrogram corresponding to the trace shown above in b). e. Bar chart show-
ing the mean occurrence of WDs and SWCs during a 60 second epoch with increasing
concentration.
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band. The mean delta band power during the control state was 0.44±0.13µV2 compared
to 0.37±0.16µV2 after 40 minutes of Gabazine [1µM] application (P>0.05, n=20, One
Way Repeated Measures ANOVA).
The delta rhythm proved to be insensitive to a blockade of GABAA subunit containing
receptors (P>0.05, n=20, One Way Repeated Measures ANOVA). The mean peak fre-
quency remained fairly constant through the experiments, 1.5±0.13Hz during the control
state versus 1.36±0.14Hz after Gabazine [1µM] application, as depicted in figure 5.15D.
Autocorrelation analysis revealed a statistically significant change in rhythmicity with
Gabazine concentration (P=0.014, n=10, One Way Repeated Measures ANOVA, Fig-
ure 5.15D). As can be seen from the example, figure 5.15C, the sinusoidal appearance
was diminished with increasing Gabazine concentration. The mean height ratio of the
first peak to the central peak of the autocorrelation analysis was 0.32±0.06 during the
control state in comparison to 0.09±0.04 after Gabazine [1µM] was applied (P=0.016,
n=10, paired t-test).
Of the ten experiments conducted using Gabazine, WDs were present during all concen-
tration resulting in an incidence rate of 1. An example of the type of WD seen during the
Gabazine experiments is depicted in figure 5.16a. In total, 56 WDs were detected during
the varying Gabazine concentrations. The number of WDs was not significantly changed
with concentration, however figure 5.16e would indicate a positive trend. (P>0.05, n=10,
One Way Repeated Measures ANOVA). The type of WD seen during Gabazine appli-
cation is different from those seen during the previous drug experiments in this chapter
for the following reasons: the amplitude of the WD is approximately four times greater;
the morphology of the WD, particularly the initiation of the discharge; and although,
according to the spectrogram, the frequency of the activity embedded on the WD is
similar to the previous drug experiments, the intensity is much greater.
Spike Wave Complexes (SWCs) were present during six of the eight experiments, result-
ing in an incidence rate 0.75 SWCs per experiment. In total, 40 SWCs were detected
during the increasing Gabazine concentrations, the majority were detected during [1µM]
application. The number of SWCs present during the 60 second epochs was significantly
changed with concentration (P=0.05, n=10, One Way Repeated Measures ANOVA).
The median occurrence of SWCS during the control state was zero compared to 2 (0 →
3) SWCs per 60 second epoch after 40 minutes of Gabazine [1µM] application (P=0.03,
n=10, Wilcoxon Signed Rank Test). The same differences that applied to Gabazine WDs
also apply to Gabazine SWCs: the amplitude is at least 4 times greater; the morphology
is different to the SWC examples seen previously; the location of the spike itself within
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Figure 5.15: Antagonism of GABAA selective receptors using Gabazine. A.
10 second recording of extracellular activity from layer V of the somatosensory cortex
after application of Carbachol[4µM] and SCH23390 [7µM], followed by increasing con-
centrations of Gabazine. B. Power spectra produced from 3 second epochs of data in
the absence of epileptiform activity. C. Autocorrelation from a 3 second epoch of ac-
tivity in the absence of epileptiform activity. D. Concentration response curves of mean
frequency, mean power and mean rhythmicity ratio of activity (n=10) during Gabazine
applications.
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the SWC, and although the spectrogram shows that the activity embedded on the SWC
is similar to the WD and previous SWCs, the intensity is much greater and reaches much
higher frequencies (refer to figure 5.16d).
5.3.8 The affect of the application of AMPA receptor modula-
tor on carbachol and SCH23390 induced delta frequency
oscillations and Spike-Wave Discharges.
The systematic bath application of the positive allosteric AMPA receptor modulator, Cy-
clothiazide (CTZ) resulted in a near significant change in mean delta band power with
concentration(P=0.057, n=20, One Way Repeated Measures ANOVA). The mean power
during the control condition was 3.14±0.58µV2, this increased to 4.34±0.97µV2 during
[10µM] application, only to decrease to 1.74±0.3µV2 during CTZ [20µM] application.
This is more easily portrayed in figure 5.17D.
The mean peak frequency of the delta rhythm proved to be insensitive to the modulation
of AMPA receptors (P=0.05, n=20, One Way Repeated Measures ANOVA). The mean
peak frequency during the control state was 1.77±0.13Hz, which remained fairly constant
throughout the experiment and concluded with a mean peak frequency of 1.61±0.19Hz
after CTZ [20µM].
Autocorrelation analysis reported that no statistically significant effect of concentration
was observed for rhythmicity (P>0.05, n=10, One Way Repeated Measures ANOVA).
The mean height ratio during the control state was 0.24±0.05 compared to 0.24±0.06
after CTZ [20µM] application.
Of the ten experiments, WDs were present during six experiments, resulting in an inci-
dence rate of 0.6 WDs per experiment. In total, 33 WDs were detected during the 60
second epochs over the varying concentrations. Unlike many of the other drug experi-
ments detailed in this chapter, WDs occurred spontaneously during the control condition
in five of the ten experiments. When no epileptiform activity occurred spontaneously,
only once did they occur during CTZ concentrations. Figure 5.18a shows a 1 second ex-
ample of a WD extracted from a 60 second epoch during CTZ [20µM]. The corresponding
spectrogram is shown in figure 5.18c. CTZ concentration had no significant effect on the
mean occurrence of WDs (P>0.05, n=10, One Way Repeated Measures ANOVA).
Of the ten experiments conducted, SWCs were detected during five experiments, resulting
in an incidence rate of 0.5 SWCs per experiment. As with the CTZ WDs, spontaneous
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Figure 5.16: Characteristics of epileptiform activity during Gabazine applica-
tion a. 1 second trace of wave discharge extracted from 60 second epoch after 1µM
application. b. 1 second trace of spike wave complex extracted from 60 second epoch
after 1µM application. c. Spectrogram corresponding to the trace shown above in a).
d. Spectrogram corresponding to the trace shown above in b). e. Bar chart show-
ing the mean occurrence of WDs and SWCs during a 60 second epoch with increasing
concentration.
Pharmacological generation of epileptiform activity during cortical delta rhythm 124
1 10 0 
0.5 
1.0 
1.5 
2.0 
Carbachol [4µM] & SCH23390 [7µM] 
Cyclothiazide [10µM] 
Cyclothiazide [20µM] 
A. 
Po
w
er
 (1
02
 µ
V
2 /H
z)
  
Frequency (Hz) 
B. 
-1 0 1 -1 
0 
1 
A
ut
oc
or
re
la
tio
n 
Time (s) 
C. 
1s 
100uV 
Concentration (µM) 
D. 
1s 
500uV 
0 
1 
2 
0 5 10 15 20 
Fr
eq
ue
nc
y 
(H
z)
 
0 
2 
4 
6 
0 5 10 15 20 
Po
w
er
 (µ
V
2 /H
z)
 
0 
0.1 
0.2 
0.3 
0.4 
0 5 10 15 20 
R
hy
th
m
ic
ity
 
Figure 5.17: Inhibition of AMPA receptor desensitization using Cyclothiazide.
A. 10 second recording of extracellular activity from layer V of the somatosensory cortex
after application of Carbachol[4µM] and SCH23390 [7µM], followed by increasing con-
centrations of cyclothiazide. B. Power spectra produced from 4 second epochs of data
in the absence of epileptiform activity. C. Autocorrelation from a 4 second epoch of ac-
tivity in the absence of epileptiform activity. D. Concentration response curves of mean
frequency, mean power and mean rhythmicity ratio of activity (n=7) during Gabazine
applications.
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SWCs were also present during the control condition. In total, 39 SWCs were detected
during the 60 second epochs over the varying concentrations. CTZ is the only drug in
this chapter to have a greater number of SWCs in comparison to WDs. The number of
SWCs was significantly increased with concentration (P=0.05, n=10, One Way Repeated
Measures ANOVA, Figure 5.18e. The mean occurrence of SWCs during the control con-
dition was 0.5±0.34 compared to 2.71±1.21 after CTZ [20µM] (P>0.05, n=10, paired
t-test). The morphology of the CTZ SWCs is different from those of the previously de-
tailed drugs: the discharge part of the SWC is approximately 5 times larger in amplitude,
the spike is very late in the duration of the SWC and barely crests the wave, as shown
in figure 5.18b. The corresponding spectrogram (Figure 5.18d.) displays a high intensity
of broad spectrum frequency activity embedded in the SWC, much unlike the majority
of responses seen in this chapter.
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Figure 5.18: Characteristics of epileptiform activity during Cyclothiozide ap-
plication a. 1 second trace of wave discharge extracted from 60 second epoch after
20µM application. b. 1 second trace of spike wave complex extracted from 60 second
epoch after 20µM application. c. Spectrogram corresponding to the trace shown above
in a). d. Spectrogram corresponding to the trace shown above in b). e. Bar chart show-
ing the mean occurrence of WDs and SWCs during a 60 second epoch with increasing
concentration.
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Drug Receptor Concen- Somatosensory Cortex WD SWC
Subunit tration Frequency Power Inc. Trend Inc. Trend
(µM) rate rate
DTC nAChRs 2 ⇓ - 0.23 0
5HT3 5 ⇓ ↑ 1.29 ∼ 0.64 ↑
GABAA 10 ⇓ ↑ 0.55 3.68
MG624 α7 1 - ↓ 1.36 0.05
2 ↓ ↓ 2.33 ↓ 1.33 ↑
5 ↓ ↓ 0.5 1.5
10 ↑ ⇓ 0 3.0
Pancuronium α7
? 2 - ↑ 4.0 0.63
5 - ↑ 1.0 ∼ 0 ∼
10 ⇓ - 3.0 0.2
DHβE α4 10 ↓ ⇑ 0.71 ↑ 0 -
β2 20 ↓ ↑ 4.67 0
α-conotoxin α3 1 - ↓ 6.13 1.0
PnlA β2 2 - ⇓ 5.75 ↓ 0.88 ↑
5 - - 3.63 1.0
10 - - 3.67 2.33
α-conotoxin α3 0.2 ↓ - 0.38 0
AuIB β4 0.5 - - 0 ∼ 0 ∼
1 ⇓ - 0.25 0.13
ACV1 α9 0.2 - - 4.25 2.63
α10 0.5 ↓ - 2.75 ↓ 2.5 ↑
1 - - 1.67 3.17
MDL7222 5HT3 1 - - 0 0
2 - - 7.0 ↑ 0 ∼
5 ⇓ - 1.85 0.05
10 - - 2.89 0.33
Gabazine GABAA 0.5 - - 2.38 ↑ 1.0 ↑
1 - - 3.7 3.2
Cyclothiazide AMPA 10 - ↑ 1.38 ↓ 1.88 ↑
GABAA 20 - ⇓ 0.43 2.71
Table 5.1: A summary of the pharmacological manipulation of the induced
delta rhythm in the rodent somatosensory cortex. ⇓ = A significant decrease
observed (P ≤ 0.05), ⇑ = A significant increase observed (P ≤ 0.05), ↓ = A decrease
observed (0.1 < P < 0.05), ↑ = An increase observed (0.1 < P < 0.05), - = No significant
change.
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5.4 Discussion
5.4.1 Pharmacological manipulation of the Delta rhythm
In the previous chapter, DTC was shown to significantly decrease the frequency of the
delta rhythm with increasing concentration, whilst also increasing the mean power of the
delta rhythm, although not significantly. With regards to mirroring this response in this
chapter, very few of the agents used responded in a similar way (refer to Table 5.1). All
of the agents used, bar PnIA, Gabazine and CTZ, saw a decrease in frequency in the
delta rhythm, however only after Pancuronium, AulB and MDL 72222 application was
this statistically significant. Of particular interest is the difference in responses between
MG624 and Pancuronium (both α7 nAChRs sunbunit antagonists), and between DHβE,
PnIA and AulB (each of which has selectivity for α3, β2 and/or β4).
Firstly, the classification of neuronal and muscular nAChR subunits is not definitive,
as neuronal nAChRs have been found in non-neuronal cells [Flora et al., 2000, Grando
et al., 1995] whilst muscle subunits have been found in neuronal cells [Pugh et al., 1995].
Pancuronium dibromide is a nicotine neuromuscular antagonist with selectivity for α7
subunit containing (α7*) nAChRs [Tsuneki et al., 2003]. When the results from the ap-
plication of pancuronium bromide are compared to those from the application of MG624,
it can be assumed that MG624 is antagonising a key component of the delta rhythm that
helps maintain the rhythmicity as it’s presence results in the a decrease in delta rhythm
power as well as a decrease in frequency. In comparison, Pancuronium generated a mean
increase in power, although not significantly so. This would suggest that the neuromus-
cular variant of the α7 nAChR does not mediate the cortical delta rhythm.
DHβE, AulB and PnIA all share common nAChR subunit specificity. DHβE blocks type
II currents, which are attributed to α4β2∗ at concentrations below 100nM, whereas type I
currents which are mediated by α7 nAChRs are insensitive to DHβE concentrations of less
than 10µM [Alkondon and Albuquerque, 1993]. Therefore DHβE is generally regarded
as a non-α7 nAChR antagonist with a preference for β2 subtypes. α-Conotoxin AuIB is
currently the only toxin to have selectivity for α3β4∗ nAChRs. It is known that 1-10µM
concentrations are required for complete blockade of α3β4 nAChR subtypes [Wonnacott
and Barik, 2007]. α-Conotoxin PnIA preferentially blocks α3β2 nAChRs but also α7
nAChRs in the rat cortex with less affinity. Both DHβE and AulB see a decrease in
delta rhythm frequency. This may be linked to the partial inhibition of nicotine-evoked
[3H]-noradrenaline and [3H]-ACh release thought to be related to the blockade of α3β4∗
nAChRs by AulB, which is consistent with weak sensitivity to DHβE (DHβE weakly
blocks α3β4 [Harvey et al., 1996]). Noradrenaline and ACh are both related to wake-
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fulness, therefore the blockade of these and the decrease of delta frequency seen upon
application of these two agents would infer the further progression into deep slow-wave
sleep.
PnIA in comparison sees no change in the frequency of the delta rhythm, however the
delta frequency power is significantly decreased with increasing concentration. α3β2 con-
taining nAChRs are thought to mediate dopamine release [Luo et al., 1998]. DHβE and
PnIA share specificity for the β2 subunit however, their LFP responses are opposite, this
would suggest that the α4 and β4 subunits have a greater effect on the delta rhythm. α3
may only have a slight effect on the delta rhythm as AulB only increases the frequency,
it doesn’t effect the power of the delta rhythm.
With reference to table 5.1, the results of this chapter would suggest that nAChRs
have more influence on the delta rhythm than the 5HT and GABA receptors targeted,
however can the same be said for the epileptiform activity seen?
5.4.2 Pharmacological evocation of paroxysm activity
Of the nine agents which were used to directly antagonise specific nAChR, 5-HT and
GABA subunits, all resulted in the evocation of some form of epileptiform activity, ei-
ther wave discharges (WDs) or spike-wave complexes (SWCs). Table 5.1 in columns titled
WD and SWC, summarises the trend in epileptiform activity with increasing drug con-
centration. As the results in the previous chapter demonstrated, the application of DTC
to a delta rhythm in the somatosensory cortex resulted in a concentration dependent
response of SWCs, where the higher the concentration applied the greater the number
of SWCs recorded during each 60 second epoch. With reference to table 5.1, a similar
trend is seen for MG624 (α7 nAChR antagonist), α-conotoxin PnIA (α3, β2 nAChR an-
tagonist), ACV1 (α9, α10 nAChR antagonist), Gabazine (GABAA receptor antagonist)
and CTZ (AMPA PAM and GABAA receptor antagonist). This therefore implies that
each of these receptor subunits is important in mediating epileptiform activity, however
the questions: why these subunits? and how do they mediate this activity? still need to
be answered.
As stated in section 1.7.2, several childhood nocturnal epilepsies have been related to
mutations in the α3−5, α7, γ3, β2 and β4 nAChR subunits. The blockade of the α4β2
nAChR subunits produced very little epileptiform activity in comparison to the antago-
nistic affects of the other agents used. A similar lack of paroxysm response is seen during
the blockade of the α3β4 nAChR subunits. The AuIB results from this chapter would
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imply that the α3 subunit does not mediate SWD generation whereas, the PnlA (α3β2
subunit antagonist) results indicate that it may when it is partnered with the β2 subunit.
This may be due to the enhancement of α3 nAChR currents when the β2 subunit is also
present [Nai et al., 2003]. Mutations in these sets of subunits have been implicated in
ADNFLE, however gene mutations are rare in ADNFLE. Therefore these results suggest
that mutations in the α4β2 and α3β4 nAChR subunit pairs may not be solely responsible
for the epileptiform abnormalities observed in this idiopathic epilepsy, whilst the α3β2
nAChR subunit pair may have a greater role to play.
The α7 nAChR subunit has been linked to BECTS [Neubauer et al., 1998]. This would
coincide with the results from this chapter, as antagonism of this receptor has been shown
to evoke a significant amount of epileptiform activity at high concentration of the specific
agent. However, the chromosome location of the α7 gene is the same location of a cation-
chloride cotransporter gene [Mount et al., 1999] which play a major role in GABAA and
glutamatergic signalling [Blaesse et al., 2009]. Modulation of the metabotropic gluta-
mate receptor 5 subunit and the GABAA receptor subunit have both been implicated
in paroxysm generation [Bianchi et al., 2009], which is synonymous with the results in
this chapter as the application of an AMPA PAM and GABAA antagonising agents have
evoked huge paroxysm events. The possible role of glutamatergic signalling is discussed
further in detail in section 5.4.4.
The α9α10 antagonist ACV1 is generally considered a pain analgesic however it’s selec-
tivity for these two nAChR subunits made it attractive to this study. The α9 nAChR is
linked to cochlear hair cell development, chronic pain and breast and lung cancers [Azam
and McIntosh, 2012], hence the evocation of epileptiform activity upon application of
ACV1 was unexpected. All nAChRs belong to the family of ionotropic receptors, there-
fore it is possible to assume that the epileptiform activity upon blockade of these receptors
is linked to this status.
As stated in the previous chapter, manipulation of Na2+ currents are thought to be
responsible for SWCs in some animals models of epilepsy [Klein et al., 2004], however
due to the antagonising effects of ACV1, the epileptiform activity is not thought to be
mediated by these currents in this model. The mechanistic basis of this response to
ACV1 is currently unclear and would benefit from further investigation in the future.
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5.4.3 Possible role of Calcium Currents in childhood epilepsies
The spatiotemporal distribution of Ca2+ ions is known to play an important role in
neuronal behaviour and survival, as well as affecting the release of other neurotransmit-
ters. Many physiological and therapeutic neuronal functions are Ca2+ dependent, hence
balance needs to be maintained or cellular death may occur. The flow of Ca2+ ions is
partially controlled by the activation of ligand and voltage gated Ca2+ ion channels. α7
is known to play a fundamental role in Ca2+-dependent activation of signalling pathways
that can modulate intracellular events involved in learning and memory. This is due to
its permeability to Ca2+ and it’s ability to substantially increase intracellular calcium
levels upon activation [Gubbins et al., 2010]. In vitro studies have shown that the ac-
tivation of presynaptic α7 nAChRs induces LTP, hence disruption of this pathway via
the antagonism of these receptors may contribute to cognitive decline [Shen and Yakel,
2009], like that seen in LGS, CAE and ADNFLE.
5.4.4 Possible role of Glutamate in epileptiform activity
Glutamate is an excitatory neurotransmitter found in abundance in the CNS. It is known
to play an important role in synaptic plasticity, hence it is involved in cognitive functions
like learning and memory processes [McEntee and Crook, 1993]. Over the last several
decades, glutamate has been shown to play a role in epilepsy through NMDA, AMPA
and kainate metabotropic glutamate receptor mediated mechanisms [Chapman, 2000].
Nicotine activates α7 and β2 containing nAChRs within the mouse cortex, which has
been shown to decrease glutamate-mediated Ca2+ influx via a Ca2+-dependent signal
transduction cascade that involves the depression of L-type voltage-gated Ca2+ chan-
nels [Stevens et al., 2003]. Therefore it is possible that the blockade of α7 and/or β2
containing nAChRs may increase glutamate concentration. Within the experiments in
this chapter, the application of α7 selective antagonists (MG624 and PnIA) has resulted
in an increase in epileptiform activity, in particular, evoking SWCs like those seen previ-
ously in our epileptiform activity model in chapter 4 and also seen in EEGs of children
with nocturnal epilepsies. This would suggest that there was an increase in glutamate
within these brain slices.
An increase in glutamate via microinjection into neurons results in spontaneous depolar-
isations approximately one second apart, which is similar to the paroxysmal depolarising
shift seen during epileptic seizures [Bawari, 2010]. This change in resting membrane
potential at seizure foci could result in the spontaneous opening of voltage-activated cal-
cium channels. Which in turn would increase glutamate concentration, producing further
depolarisation. This depolarisation is analogous to a huge excitatory synaptic potential.
Pharmacological generation of epileptiform activity during cortical delta rhythm 132
Chapman (2010) states that it’s earliest component is due to activation of AMPA recep-
tors and its later component to activation of NMDA receptors. Cyclothiazide (CTZ), a
positive allosteric modulator (PAM) of the AMPA receptor, utilised within this thesis,
is known to be capable of reducing or eliminating rapid desensitisation of the receptor
and increasing glutamate currents [Bertolino et al., 1993]. Within this chapter, the ap-
plication of CTZ was shown to evoke SWCs with increasing concentration, however these
SWCs were much greater in amplitude when compared to the SWCs evoked by nAChR
antagonism. This would suggest that AMPA receptors have a more direct effect on
epileptiform activity than nAChRs alone. Muldrum (1994) reported that, glutamate an-
tagonists selective for NMDA and non-NMDA receptors are potent anticonvulsants when
given systemically in a wide variety of animal models of epilepsy [Meldrum, 1994], there-
fore adding to the argument that epileptiform activity is mediated by glutamate currents.
CTZ is also a GABAA negative allosteric modulator (NAM) which potently inhibits
GABAA mediated currents [Deng and Chen, 2003]. Due to the inhibitory nature of
GABA, the blockade of this receptor would increase excitatory responses similar to that
seen during increased glutamate mediated currents. From the results in this chapter,
it is shown that the blanket blockade of inhibition with gabazine generated far more
severe discharges than any of the nAChR or 5-HT agents tested. This would suggest
that only partial disinhibition is required to generate WD and SWC activity. So which
interneurons are selectively targeted? Both 5-HT and nAChRs are found on dendrite tar-
geting interneurons preferentially (rather than perisomatic targeting neurons). Specif-
ically, 5-HT3A receptor expressing interneurons in the somatosensory cortex make up
approximately 30% of cortical interneurons and are found predominantly in superficial
layers [Lee et al., 2010a]. These 5-HT3AR-expressing interneurons uniformly respond to
serotonergic and cholinergic modulation [Lee et al., 2010a]. Therefore it is possible that
the 5-HT and nAChR agents used within this chapter are acting directly on these in-
terneurons. Coupled with the effects of CTZ, this suggests a failure to control dendritic
AMPA-receptor mediated inputs onto pyramidal cells, particularly in superficial layers.
5.4.5 Summary
The work described in this chapter has outlined the basic pharmacological properties of
epileptiform activity during slow-wave sleep. These findings suggest that epileptiform
generation is mediated by dendrite targeting interneurons through the blockade 5-HT3
and nAChR subunits. The data in this chapter also suggests that the differences in
WDs and SWCs may simply be the degree of recruitment of superficial layers in addition
to paroxysmal events in the delta-generating layer V pyramidal cells. It is therefore
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important to observe the activity of individual neurons during paroxysmal events within
both layer V and superficial layers to investigate the interplay between the neurones
located in these regions. The next chapter will therefore explore this, through the use
of intracellular and multichannel unit recordings. When combined with results from this
and the previous chapter, these studies should provide a more definitive picture of the
network activity underlying these events.
Chapter6
Mechanisms underlying the generation of the
epileptiform activity in the cortical delta
rhythm: Cellular Recording Studies
6.1 Introduction
The results of the previous chapter outlined the complex pharmacological properties of
epileptiform activity resembling that seen in children with nocturnal epilepsies. The re-
sults from chapters 4 and 5 have demonstrated that as a network, the neurons in the deep
layers of the cortex, layer V in particular, result in epileptiform behaviour following the
application of d-tubocurarine (DTC) or selective antagonists that mimic DTC. However,
the effect on individual neurons as well as the spatial effect across the cortical layers
is currently unknown. By using intracellular methods, it aids the formation of a more
definitive picture of the mechanisms proposed in the pharmacology chapter by elucidat-
ing the input/output activity of individual neuronal cell types during delta oscillations.
Whereas the use of a multi channel electrode array allows for a greater understanding of
the distribution and spatial extent of the two individual induced paroxysmal events in
terms of their laminar distribution in the cortical column and longitudinal distribution
through the region of interest.
6.1.1 Mechanisms underlying epileptiform discharges
Local field potential and EEG recordings are readily able to distinguish between normal
brain activity and epileptiform activity in the majority of cases. However, the nature
of the recordings (i.e. gross population averages, distal electrode location and indirect
measurement of neuronal activity) often excludes the possibility of determining what
neuronal processes underlie the pathology. In contrast, intracellular studies are able to
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provide direct observations of individual neuronal subtype inputs and outputs, and the
relationship between them. This form of data is crucial for understanding the processes
underlying the pathological activity patterns associated with seizures.
It is thought that the first intracellularly identified correlate of seizure-like activity
was the so-called paroxysmal depolarising shift: A grossly exaggerated excitatory re-
sponse to synaptic input [Johnston and Brown, 1981]. Studies have suggested a range
of causal mechanisms for this; from general imbalance of synaptic excitation and inhi-
bition, alteration in the expression of glutamate receptor subunits in favour of NMDA
receptor-mediated postsynaptic events, potentiation of extracellular potassium ion con-
centration and enhanced intrinsic calcium conductance activation [Johnston and Brown,
1984, Traub, 1979, Korn et al., 1987, Whittington et al., 1995]. All of these studies were
performed on crude in vitro models of epileptiform activity and their relevance to hu-
man epilepsy is still questionable. Direct studies on human epileptic tissue, like those by
Sloviter (1991) do support - at least partially - an imbalance in inhibition due to failure
to activate local circuit interneurons. However, a study by Roopun et al (2010) reported
that in human tissue, a causal role of non-chemical synaptic transmission appeared dom-
inant.
A comparison of human and animal model studies does not necessarily negate the find-
ings of the latter. There is a remarkable diversity in the type of epileptiform discharge
observed, even within identified subgroups of epilepsy, clinically. It is therefore likely
that a broad range of mechanisms lead to a disruption of neuronal excitability, which
themselves may differentially contribute to the generation of seizures in different epilepsy
syndromes. It is therefore important to focus on the type of epileptiform activity being
studied and the specific modifications made to the system to experimentally generate it.
6.1.2 Relevance to nicotinic receptor function
Acetylcholine has been associated with both cognitively relevant brain function and
seizures [Ga¨hwiler and Dreifuss, 1982, Mansvelder et al., 2006]. The former will be de-
tailed in the following section. While the latter demonstrates the complexity of the
effects of this neuromodulatory system. In the study by Ga¨hwiler and Dreifuss (1982),
both excitatory and inhibitory effects of ACh on neurons were observed, with the excita-
tory effects predominantly mediated by the muscarinic subtype of ACh receptors (which
have been blocked by atropine). Muscarinic receptors increase neuronal excitability by
partially blocking a particular type of potassium conductance [Brown and Adams, 1980].
Thus, ‘K+ current’ is critically important for limiting the output of neurons, in terms of
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numbers of action potentials, for a given excitatory input. It is present in most neuronal
compartments but its ability to promote burst activity, which is often seen during epilep-
tiform discharges, correlates best with its presence in axonal membranes [Shah et al.,
2011].
Severe, chronic epilepsy can be pharmacologically induced experimentally by selectively
targeting muscarinic receptors in rodents through the administration of pilocarpine [Turski
et al., 1983]. The epileptiform events seen during seizures have a major components of
spike and wave discharges in this model. However, it is still not known exactly how a
muscarinic agonist generates seizures. For example, in animal models of absence seizures
(which are also associated with spike and wave discharges), the addition of pilocarpine
to the epileptic animal actually decreased these events [Danober et al., 1993]. Interest-
ingly in this study, agonism of nicotinic receptors also reduced spike and wave discharges.
Again, the story is complex though. For about 50 years, it has been known that nico-
tine central administration generates seizures [Orcutt et al., 1963]. However, a recent
study by Zerem et al (2013) has reported the potent anti-epileptic properties of small
doses of nicotine when administered transdermally to patients with epileptic encephalitis.
The previously mentioned study is of particular relevance to the model of spike and wave
discharges studied in this thesis. Other work has also shown that disrupting nicotinic
receptor function is associated with seizures: A number of studies have shown a genetic
link between disrupted nicotinic receptors and seizures (refer to Chapter 1.7.2), and ani-
mal models clearly show a seizuregenic action of nicotinic antagonists (see Chapter 4.1).
A solution to this confusing collection of findings may come from the work of Dobelis et al
(2003). These researchers noted that both agonists and antagonists of nicotinic receptors
generated epileptiform activity. But when relating these findings to GABA release ( as
a measure of inhibitory neurone function) they found that both agonist and antagonists
disinhibited the cortex - the former effect being related to receptor desensitisation. In
other words, too much nicotinic cholinergic tone was just as detrimental as having too
little owing to rapid adaptation of nicotinic receptor postsynaptic responses.
6.1.3 Relevance to physiological correlates of learning and mem-
ory
As mentioned above, nicotinic receptor agonism has strong cognitive effects. Disruption
of nicotinic receptor/ionophore assembly in rare genetic disorders is strongly associated
with learning disabilities [Chung et al., 2012]. In particular, the endogenous nicotinic
receptor agonist modulator LYPD6 has been shown to disrupt nicotinic receptor calcium
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conductance [Darvas et al., 2009] - a property which is closely related to the potentiation
of synaptic plasticity as a physiological substrate of learning and memory by nicotine [Jia
et al., 2010]. However, whether this has a direct effect on synaptic plasticity during sleep,
or whether plasticity is disrupted by the change in cortical dynamics associated with spike
and wave discharges remains to be elucidated and will be considered in this chapter.
6.1.4 Aims and objectives
This aims of this chapter are to:
• Utilize current intracellular recording methods to create a more definitive picture
of the mechanisms proposed in the previous chapter by clarifying the input/output
activity of individual neuronal cell types during delta oscillations.
• Investigate and interpret the distribution and spatial extent of the wave discharge
and spike-wave complex events in terms of laminar distribution in the cortical
column and the longitudinal distribution through the rodent somatosensory cortex
spatiotemporal activity, through the use of a multi channel electrode array.
6.2 Methods
6.2.1 Slice preparation and maintenance
Rodent brain slices from the somatosensory region were prepared as previously described
in chapter 2.3 and maintained according to the methods detailed in chapter 2.4. The
acquisition of intracellular data and it’s subsequent analysis can be found in chapter 2,
sections 2.6, 2.7 and 2.8.2. Delta rhythm oscillations were induced in the slice through the
bath application of carbachol [4µM] and SCH23390 [7µM] into the circulating oxygenated
ACSF medium. Before either intracellular or multichannel recordings were performed,
the presence of delta frequency activity in layer V was first confirmed using an extracellu-
lar field electrode. During intracellular experiments, this extracellular electrode remained
in the slice in it’s set position with the intracellular electrode being placed either adjacent
to it, which would allow for a direct comparison in the activity of the individual neurons,
or in the same cortical column but in layer II/III, which would allow for a better under-
standing of the neuronal connections between layers II/III and V. During multichannel
experiments, this extracellular electrode was removed after confirming the presence of
delta frequency activity in the slice/s.
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6.2.2 Intracellular methods
Intracellular recordings were obtained using sharp borosilicate glass electrodes containing
potassium acetate solution [2M], an electrolytic medium similar to that of the internal
composition of neurons as previously described in section 2.6. Characterisation of indi-
vidual neurons was achieved using a 0.2nA depolarising or 0.3nA hyperpolarising current
injection step with a duration of approximately 200ms. Further detail on these intracel-
lular methods can be found in chapter 2.8.2.
6.2.3 Multichannel unit recording techniques
Following the confirmation of delta activity using an extracellular electrode, a utah mul-
tichannel electrode array was positioned onto the slice ready for multichannel recordings
as described in section 2.7. The orientation of the electrode grid was noted and mapped
onto a sketch of each slice used to allow for a more accurate definition of superficial and
deep cells. The number of the utah array was also noted to allow for the correct mapping
on the array and the correct impedances of each electrode.
6.3 Results
6.3.1 Laminar distribution of field potential SWC components
The wave discharges (WD) described in the previous chapter were reminiscent of parox-
ysmal depolarising shifts seen in many models of epilepsy (see section 6.1.1). However,
spike and wave complexes (SWCs) appeared to be far more complex phenomena. In
order to understand more about them to guide intracellular recordings, a more laminar
analysis (see figure 4.6) with field electrodes was first performed.
As WD and SWC incidence was variable, only slices with a high SWC incidence rate
were used for this part of the study. In 5/12 slices deemed suitable, occasional runs of
SWCs were seems where epileptiform events of the SWC type occurred with a frequency
of 3.1 ±0.s, with 5 - 24 events per run (mean 12±4 events, figure 6.1A). These events
has the same spectral characteristics as the human EEG spike and wave recordings (Fig-
ures 3.1 and 3.2) and the SWCs quantified in the previous chapter (e.g. see figure 5.8):
Events occurred off a delta frequency baseline with a transient increase in delta power
corresponding to the ‘wave’ of the SWC and a broadband of higher frequencies corre-
sponding to the ‘spike’ components (Figure 6.1B).
Moving the extracellular recording electrode into different laminae between runs of SWCs
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Figure 6.1: Repetitive, spontaneous spike and wave discharges arising from a
delta rhythm. A. Example trace from layer 1 of association cortex showing low ampli-
tude delta rhythm interspersed with spike and wave discharges occurring approximately
every 2s. Delta was induced as described in chapter 4 and discharges generated on top
of this by bath application of 10µM DTC. Scale bar 2sec, 0.2mV. B. Spectrogram of
the data in A showing continuous ∼1Hz delta and spike wave discharges consisting of
broadband power with modal peaks in the low theta range and 10-20Hz corresponding
to the spike component of the spike and wave discharge (refer to figure 3.1A).
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allowed a crude estimate of layer origin of the wave and spike components of the SWC.
Classic, and inverted SWC shapes were seen with the electrode at the very edge of each
slice (Layer I / pail surface recording) and within Layer V (Figure ??).
These data strongly suggested that the spike and the wave components of the SWC
were generated by different mechanisms / neurons located in supra- and infragranular
layers respectively. Intracellular recordings were therefore aimed at principal neurons in
these two areas.
6.3.2 DTC effects in Layer V
DTC, and some more specific agents, effects on the delta rhythm were associated with
decreases in rhythmicity and frequency. As the principal neuron responsible for delta
rhythms has been shown to be the layer V intrinsically bursting (IB) neuron [Carracedo
et al., 2013], recordings from this cell type in the presence of DTC were studied in detail.
In general, a trend towards longer, more intense (in terms if spikes generated during the
depolarisation) burst discharges was seen as DTC concentration increased (Figure 6.3).
Quantification of depolarisation time, spike number per burst and interburst spike fre-
quency all revealed increasing mean values with 5 and 10µM DTC (Figure 6.4). However,
as DTC concentration increased so did the variance in these measures (taken from 60s
epochs of data from n=5 IB neurons). For example, DTC caused a change in depolari-
sation time from 200±20ms to 605±395ms. As the standard error increased from ∼10%
of the mean to ∼65% of the mean, no significant difference was seen despite the near
3-fold increase in mean burst duration (P>0.05, Figure 6.4A). Similarly, spike numbers
per burst changed from 5±3 in control conditions to 14±8 in the presence of 10µM DTC
(P>0.05, Figure 6.4B). Although, for the intermediate concentration of DTC, a signifi-
cant increase in spike numbers per burst was seen with the data available (5±3 vs. 13±3,
n=5, P<0.05). Despite, this significant effect, no changes in spike frequency were seen
at either of the concentrations used.
As two types of principal cell are found in Layer V, readily identified by their responses
to depolarising current injection (see Figure ??), the effects of DTC were also examined
on regular spiking (RS) neurons. During control delta rhythms RS cells do not generate
a delta frequency output. Instead, they show a range of spike profiles over a narrow
range of membrane potentials (Figure 6.5). At membrane potentials between -65mV
and -70mV RS cells generate either a single spike or none at all (mean spike incidence
0.6±0.3, n=5 cells from 5 slices, total 300 delta periods). Between -65mV and -60mV
these cells generated brief packets of 2 or 3 spikes phase locked to each delta period.
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LI/pia 
LII/III 
LV 
LVI 
Local field potential 
Figure 6.2: Detailed laminar profile of spike and wave discharges shows sep-
aration of the spike and the wave component in superficial and deep layers
respectively. Example traces for each layer were taken from the same slice under condi-
tions described in chapter 4. Note the wave component of the wave and wave discharge is
maximal in deep layers, as with pure wave discharges (WD, without the spike component,
refer to figure 4.6). Also note the wave discharge reverse in superficial layers - a prop-
erty shared with control delta rhythms, and the spike component reveres dramatically
between LII/III and LV. Scale bars 400ms, 0.2mV.
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LV#IB#neuron 
5µM#
DTC 
10µM#
DTC 
Control 
Figure#6.3.#Example#of#change#in#layer#5#intrinsically#burs?ng#(IB)#neuron#behaviour#
with# increasing# concentra?ons# of# dTC.# In# all# condi3ons# IB# neurons# were# seen# to#
generate# near:plateau# poten3als# # corresponding# to# the# nega3ve:going# part# of# each#
field#poten3al#in#layer#5.#The#dura3on#and#output#intensity#(frequency#and#number#of#
ac3on# poten3als)# increased# with# increasing# concentra3ons# of# dTC.# All# traces#
illustrated#were# from#sharp#electrode,# intracellular# recording#of#a#single#neuron#held#
throughout#the#cumula3ve#dTC#concentra3on#changes.#Scale#bars#200#ms,#15#mV.#
Figure 6.3: Example of change in layer V intrinsically bursting (IB) neuron
behaviour with increasing concentrations of DTC. In all conditions IB neurons
were seen to generate near-plateau potentials corresponding to the negative-going part
of each field potential in layer V. The duration and output intensity (frequency and
number of action potentials) increased with increasing concentrations of DTC. All traces
illustrated were from sharp electrode, intracellular recording of a single neurone held
throughout the cumulative DTC concentrations changes. Scale bars 200ms, 15mV.
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Figure 6.4: Quantification of changes in IB neuron discharge with increasing
concentrations of DTC. A. Mean ± SEM of th duration of IB cell depolari ation
(take at h lf maximal deflection - excluding ac ion potentials) plotted ag in t DTC
concentration. B. Mean ± SEM of the number of spikes per IB cell discharge plotted
against DTC concentratio . C. Mean ± SEM of the spike frequency during IB cell
discharge plotted against DTC concentration. Not that as DTC concentration increases,
the variance in these datas ts markedly increases also.
Mean interspike interval (during a spike packet) was 150±12ms, corresponding to theta
rhythm frequency [Carracedo et al., 2013]. At membrane potentials of -60mV or more
depolarised these cells spiked continuously at this theta frequency irrespective of the on-
going delta rhythm.
This continuous pattern of spiking was preserved in the depolarised state in the pres-
ence of DTC (5µM, no 10µM concentration was attempted during recordings from these
cells). However, the theta frequency was significantly slowed, with interspike intervals in-
creasing from 150±12ms (control) to 223±10ms (P<0.05, n=300 events from n=5 cells).
Interestingly, at membrane potentials more hyperpolarised than this, single or double
events were seen phase locked to the delta rhythm. Howvere, instead of single spikes,
DTC transformed spike outputs into brief intense hurts consisting of 2-5 spikes (Fig-
ure 6.5). These burst discharges were associated with the appearance of significantly
larger, longer excitatory postsynaptic potentials (EPSPs) occurring at the on-going delta
frequency (control 2.1±0.4mV, DTC 3.5±0.5mV, P< 0.05).
The changes outlined above in both cell types were seen on every delta period in the
presence of DTC. The only significant difference associated with SWC occurrence was an
increase in Layer V IB cell burst duration. In ‘normal’ delta rhythms in the presence of
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DTC burst duration was 605±395ms (see above). IB cell burst duration during a SWC
was 720±58ms, a considerably less variable measure which was highly significant different
from control delta values (200±20ms, P<0.001). In contrast, behaviour of Layer II/III
regular spiking (RS) cells changed starkly between delta and SWC events.
6.3.3 DTC effects in Layer II/III
During normal delta rhythms, Layer II/III RS cells fired very infrequently: Mean spike
rate per delta period was 0.2±0.1. The cells received weak, compound EPSPs on every
delta period which often displayed dual peaks (Figure 6.6A). This infrequent spiking was
not altered by the presence of DTC, even at the highest concentration used (10µM).
Mean spike rate with DTC present was identical to control (P>0.5, n=300 events, n=5
cells). This was seen despite a significant increase in EPSP amplitude and a qualitative
collapse in the dual peaked nature of many EPSPs seen during the control state (control
3.1±0.4mV, DTC 4.3±0.3mV, P<0.05, Figure 6.6A). In striking contrast, on every SWC
observed, Layer II/III RS cells generated intense, brief bursts seen immediately prior to
each spike in the SWC field recording (Figure 6.6B). Spike rates per burst were more
variable in Layer II/III RS cells compared to those in Layer V RS cells, with 1-7 bursts
seen. In addition, the nature of the spike in the SWC was mirrored by the burst pat-
tern in Layer II/III RS cells. Bursts were seen either early in the wave component of the
SWC, 100-150ms later in the SWC or both early and late. Om each case a field spike was
seen corresponding to the intracellularly recorded output of these cells. This behaviour
is illustrated in figure 6.6B which shows 3 types of behaviour, where field potentials from
Layer V and RS cell potentials from Layer II/III were recorded from simultaneously.
A further correlation was observed between burst behaviour in superficial RS cells and
the field spike component of the SWC (Figure 6.7A, B). Plotting the amplitude of the
field spike component of the SWC against the amplitude of the superficial RS cell EPSP,
which was held at -80mV to prevent burst generation, showed a strong correlation. Linear
regression analysis gave a line with slope=17.46 (r2=0.87). Similarly, at resting mem-
brane potential, a comparison of SWC field spike component amplitude and number of
action potential spikes generated per burst gave a linear regression line of slope=6.25
(r2=0.82).
These data strongly suggest that excessive synaptic excitation onto Layer II/III RS cells
was, at least in part, responsible for the spike component of the SWC. However, some
data was collected that suggested that other factors may also play a role. One RS neuron
was recorded in which clear spikelets were seen, as shown in figure 6.8. These increased
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Figure#6.5.#dTC#caused#an#increase#in#burst#spiking#in#layer#5#regular#spiking#neurons.##
Le#$panel$shows$data$from$a$single$layer$5$regular$spiking$neuron$(RS)$$during$control$
delta$ ac=vity$ (4$ consecu=ve$ periods$ illustrated).$ Spike$ behaviour$ is$ shown$ at$ 3$
membrane$poten=als$ $generated$by$ tonic$ injec=on$of$current$ through$the$recording$
electrode.$ Epsp$ recordings$ were$ taken$ with$ nega=ve$ current$ injec=on$ to$ hold$ the$
membrane$poten=al$at$E70$mV.$Right$panel$shows$ $the$behaviour$of$the$same$cell$30$
minutes$a#er$ $bath$applica=on$of$5$µM$dTC.$Cell$ is$ illustrated$at$approximately$ the$
same$ 3$membrane$ poten=als$ $ as$ in$ control$ condi=ons.$ Note$ the$ transforma=on$ of$
single$spikes$to$bursts$at$the$more$hyperpolarised$membrane$poten=als$and$the$large$
increase$in$epsp$amplitudes.$Scale$bars$1$s,$20$mV.$
Figure 6.5: DTC caused an increase in burst spiking in layer V regular spiking
neurons. Left panel shows data from a single layer V regular spiking neuron (RS)
during control delta activity (4 consecutive periods illustrated). Spike behaviour is shown
at 3 different membrane potentials generated by tonic injection of current through the
recording electrode. EPSP recordings were taken with negative current injection to hold
the membrane potential at -70mV. Right panel shows the behaviour of the same cell
30 minutes after bath application of 5µM DTC. Cell is illustrated at approximately the
same 3 membrane potentials as in control conditions. Note the transformation of single
spikes to bursts at the more hyperpolarised me brane potentials and the large increase
in EPSP amplitudes. Scale bars 1s, 20mV.
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in frequency immediately before an RS burst in Layer II/III during an SWC. In addi-
tion, on one occasion, the recording electrode appeared to have impaled a dendrite in
the superficial layers (see section 6.4). This recording was held during an entire experi-
ment allowing comparison of dendritic electrogenesis in control, delta rhythms and with
increasing concentrations of DTC (5 and 10µM, Figure 6.8B). During the control state,
delta rhythm EPSP amplitude appeared to be larger than that recorded from the soma
in layer II/III RS cells (6.2±0.5mV, n=120 events, n=1 cell). However, no signs of local
electrogenesis were seen on any delta period. In contrast, in the presence of 5µM DTC,
single or double bursts of small, sharp dendritic spikes were seen riding on the EPSPs.
The spike amplitude saw very little variation in amplitude with a mean of 10±0.5mV.
With further increase in DTC concentration to 10µM, these bursts became prolonged
and more amalgamated which also containing larger, broader dendritic spikes.
6.3.4 Preliminary evidence for synaptic plastic changes associ-
ated with SWC
Given the extreme changes in output of Layer II/III RS cells, from infrequent single
spikes to bursts, evidence for plastic changes in Layer II/III RS cell inputs was gathered.
Spike and wave discharges during sleep have been associated with cognitive deficits in
patients with a range of primary pathologies (refer to Chapter 1), so the identification
of the mechanisms responsible for the relationship between physiological correlates of
memory (synaptic plasticity) and the pathophysiology of SWCs would be potentially
valuable. Intracellular recording were taken from 5 superficial RS cells before, during
and after runs of SWC activity (see above) consisting of between 8 and 24 spike and
wave discharges (Figure 6.9). Cells were held at -70mV to minimise the contribution of
inhibitory postsynaptic potentials (IPSPs) to the data gathered. Layer V field potentials
were obtained simultaneously. Prior to an SWC run, the mean RS cell EPSP amplitude
was 4.2±0.5mV. During the SWC run, EPSP amplitude (per delta rhythm, excluding
those associated with each SWC) was dramatically reduced, with many delta periods no
associated with any recordable superficial RS cell EPSPs at all (asterisks, Figure 6.9).
Mean EPSP amplitude was 1.1±0.6mV (P<0.05, n=124 events from n=5 cells). Interest-
ingly, on termination of each SWC run, EPSP amplitude recovered rapidly. Amplitudes
were not significantly different from pre-run measures within 8-15s of the last SWC in
the run. However, within 30s of the termination of the SWC run, EPSPs settled at sig-
nificantly higher amplitudes that those that occurred pre-run (6.4±0.6mV, P<0.05, 10
events from each of n=5 cells starting 30s post SWC run).
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Figure$ 6.6.$ Spike$ and$ wave$ discharges$ were$ associated$ with$ burst$ discharges$ in$
superficial$ (layer$ 2/3)$ regular$ spiking$ (RS)$ neurons.$ Burst$ Kming$ corresponded$ to$
bursts$seen$in$layer$5$RS$neurons.$$A.##Example#traces#illustra1ng##the#pa5ern#of#epsps#
onto#layer#2/3#RS#cells# #in#control#condi1ons#(delta#only)#and#with#bath#applica1on#of#
10#mM#dTC.#Note#the#larger,#more#erra1c#events#in##the#presence#of#dTC.#No#spike#and#
wave#complexes#occurred#during#the#1me#epochs#shown.##Scale#bars##400#ms,#3#mv.#B.#
Illustra1on#of# the#variable#pa5ern#of#1ming#of# spikes#within#an#SWC#concurrently# in#
layer#2/3#field#poten1al#(upper#traces)#and#L2/3#RS#cell#intracellular#recordings#(lower#
traces).# #Note#spikes#can#occur#‘early’# in#the#SWC#(black),# late#(blue)#or#both#(red).#In#
each#case#the#field#spike#corresponded#to#a#burst##in#the#cell#(cf.#fig.#6.5#right#panel#U63#
mV# recording# from# layer# 5# RS# cell).# Scale# bars# 100# ms,# # 0.2# mV# (field),# 15# mV#
(intracellular).#
Figure 6.6: Spike and wave discharges were associated with burst discharges in
superficial (LII/III) regular spiking (RS) neurons. Burst timing corresponded
to bursts seen in layer V RS neurons. A. Example traces illustrating the pattern
of EPSPs onto layer II/III RS cells in control conditions (delta only) and with bath
application of 10µM DTC. Note the larger, more erratic events in the presence of DTC. No
spike and aves complexes occurred during the time epochs shown. Scale bars 400ms, 3mV.
B. Illustration of the variable pattern in timing of spikes within an SWC concurrently in
layer V field potential (upper traces) and LII/III RS cell intracellular recordings (lower
traces). Note that spikes can occur ‘early’ in the SWC (black), late (blue) or both (red).
In each case the field spike corresponded to a burst in the cell (refer to figure 6.5 right
panel -63mV recording from layer V RS cell). Scale bars 100ms, 0.2mV (field), 15mV
(intracellular).
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Figure$6.7.$The$spike$amplitude$in$a$spike$and$wave$discharge$correlated$with$layer$
2/3$RS$ac6on$poten6al$burst$ intensity$and$excitatory$postsynap6c$poten6al$ (EPSP)$
amplitude.$A.$Pooled"data"showing"60"paired"recordings"of"SWC"events"in"layer"5"field"
poten@al"and" layer"2/3RS" intracellular" recordings."Spike"amplitude"was"derived" from"
lowHpass"filtered"field"data"(panel$C$upper"traces)."Epsp"amplitude"was"taken"from"H80"
mV" (panel" C" lower" traces)." Note" Epsp" amplitude" correlated" well" with" field" spike"
amplitude"up"to"0.4"mV"before"plateau."B."Pooled"data"showing"74"paired"recordings"
of"SWC"events"in"layer"5"field"poten@als"and"ac@on"poten@al"numbers"per"SWC"from"
concurrent" layer" 2/3" RS" intracellular" recordings" from" res@ng" membrane" poten@al."
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Figure 6.7: The spike mplitude in a spike and wave di charge correl ted with
layer II/III RS action potential burst intens ty and excita ory postsynap-
tic potenti l (EPSP) amplitude. A. Pooled data showing 60 paire recordings of
SWC events in layer V field potential and layer II/III RS intracellular recordings. Spike
amplitude was deriv d f om low-pass filtered field data (pan l C upper traces). EPSP
amplitude was taken from -80mV (panel C l w r tr ce ). Note the EPSP amplitude
correlated well with field spike amplitude up to 0.4mV before plateau. B. Pooled data
showing 74 paired recordings of SWC ev nts i layer V field potentials and action po-
tential numbers per SWC from concurrent layer II/III RS intracellular recordings from
resting membrane potential. Note the similar relationship to A.
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Figure( 6.8.( Evidence( for( non( synap3c( excitability( changes( in( layer( 2/3( RS( neurons(
associated(with(spike(genera3on(in(spike(and(wave(discharges.(A.(Example+of+a+single+
spike+ and+ wave+ complex+ recorded+ as+ layer+ 5+ field+ poten:al+ concurrently+ with+
intracellular+ recording+ from+ a+ layer+ 2/3+ RS+ neuron+ at+ res:ng+ membrane+ poten:al.+
Note+the+occurrence+of+spikelets+which+increase+in+frequency+prior+to+the+epsp/ac:on+
poten:al+burst+ associated+with+ the+field+ spike+ (expanded+ sec:on+ in+ the+ lower+ trace.+
Scale+ bars+ 1s+ (upper+ traces),+ 50+ms+ (expanded,+ lower+ trace),+ 0.5+mV+ (field),+ 15+mV+
(intracellular+ trace),+ 5+ mV+ (expanded+ trace).+ B.+ Recording+ from+ a+ puta:ve+ apical+
dendrite+ in+upper+ layer+2.+Example+traces+are+shown+during+control+condi:ons+(delta+
only,+two+consecu:ve+periods+shown)+and+with+increasing+concentra:ons+of+dTC.+Note+
only+compound+epsps+are+seen+in+control+condi:ons,+but+these+transform+into+simple+
and+then+complex+spike+bursts.++Scale+bars++200+ms,+10+mV.+
Figure 6.8: Evidence for non synaptic excitability changes in layer II/III RS
neurons ssoci ted with spike gener tion in spike and wave discharges. A. Ex-
ample of a single spike and wave complex recorded as layer V field potential concurrently
with intracellular recording from a layer II/III RS neuron at resting membrane potential.
Note the occurrence of spikelets which increase in frequency prior to the EPSP/action
potential burst associated with the field spike (expanded section in the lower trace). Scale
bars 1s (upper trace), 50ms (expande , lower trace), 0.5mV (field), 15mV (intracellular
trace), 5mV (expanded trace). B. Recording from a putative apical dendrite in upper
layer II. Example traces are shown during the control state (delta only, two consecutive
periods shown) and with increasing concentrations of DTC. Note that only compound
EPSPs are seen in control conditions, but these transfor into simple and then complex
spike bursts. Scale bars 200ms, 10mV.
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6.3.5 Further Evidence for selective superficial layer recruit-
ment during SWC from electrode arrays
A small number (n=5) of slices were placed under Utah micro electrode arrays to de-
termine a more detailed map of layer specificity with SWC and WD. Unfortunately the
majority of these slices failed to yield delta rhythms to allow fro baseline comparison
(perhaps owing to the severity of so many concurrent electrode placements). However,
recordings showing WDs and those showing SWCs could be spatially reconstructed from
local field potential and unit activity recorded.
Figure 6.10 shows a typical wave discharge in the presence of 5µM DTC. Of 14 channels
showing spontaneous activity, 13 of these demonstrated an overt, transient increase in
spike rate corresponding to the WD. Increased spike rates were seen across all layers in
the cortex simultaneously with maxima in layer II and layer IV-VI. The profile of the
spike rate changes with time appeared to wax and wane in all active layers simultaneously
(Figure 6.10a-e). In contrast, during an SWC in neocortex, spike rates increased first in
deep layers, then peak activity switched to superficial layers (Figure 6.11a-e). In addi-
tion, overall spike rates were much higher with SWC than with WD, though insufficient
replicates were taken to quantify this.
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Figure 6.10: The spatiotemporal progression of unit activity during a DTC
induced wave discharge. A. A 2 second epoch of a typical wave discharge following
the application of DTC [5µM] in the somatosensory cortex. The spatiotemporal maps
labeled a - e correspond with the points marked on the WD. Each spatiotemporal map
displays the spike intensity during a 50ms window of activity. B. Spike timing of units
which correspond to the WD in A. C. Displays the approximate location of the 96 channel
electrode array in the somatosensory cortex, shows activity map ‘d’ displaying activity
in the deep layers of the cortex.
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Figure 6.11: The spatiotemporal progression of unit activity during a DTC in-
duced spike-wave complex. A. A 2 second epoch of a typical spike-wave complex fol-
lowing the application of DTC [10µM] in the somatosensory cortex. The spatiotemporal
maps labeled a - e correspond with the points marked on the SWC. Each spatiotemporal
map displays the spike intensity during a 50ms window of activity. B. Spike timing of
units which correspond to the SWC in A. C. Displays the approximate location of the 96
channel electrode array in the somatosensory cortex, shows activity map ‘d’ displaying
activity in the deep layers of the cortex.
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6.4 Discussion
The data presented in this chapter tentatively suggests that spike and wave discharges
represent the interplay between excessive deep layer cortical excitability (the ‘wave’ com-
ponent of the SWC) and excessive excitation in superficial layers (the ‘spike’ component
of the SWC). Interplay between these deep and superficial layers has been proposed to
represent a substrate for unsupervised learning in neocortex during sleep [Carracedo et al.,
2013]. DTC appears to ‘hijack’ the subtle interplay between delta and theta rhythms
shown in this work, transforming infrequent single spiking in superficial layers into overt
burst discharges. The difference between WDs and SWCs quantified in previous chapters
in this thesis may therefore represent the ability of the model to increase excitation in
either deep, or in both deep and superficial layers respectively.
Transforming infrequent single spikes into burst discharges would be expected to have
profound effects on synaptic plasticity. The interplay between single spike and spike-
burst discharges has been shown to be critical for network homeostasis [Buzsa´ki et al.,
2002]. Transition from single spiking to burst discharges changes the entire landscape
of spike timing dependent synaptic plasticity, with timing dependant generation of both
potentiation and depression largely disrupted (e.g. [Queiroz and Mello, 2007, Harvey-
Girard et al., 2010]). Both of these reported effects would be expected to disrupt the
‘synaptic rescaling’ associated with memory consolidation during sleep. The preliminary
data presented in this chapter suggest both processes may be occurring: A short term
decrease in EPSPs onto Layer II/III pyramidal cells was directly associated with SWC
generation, and a longer term potentiation of these inputs followed by runs of SWCs.
It is therefore not surprising that the delicate balance of network function required for
synaptic rescaling may be disrupted in patients with deep sleep-associated spike and wave
discharges, with a consequent disruption in cognitive performance.
What is not clear, however, from the work presented here is what the locus of the changes
in inputs to superficial layer neurons may be. Nor is it clear, as of yet, which synaptic
pathways are important for sleep-associated rescaling. For example, is the interlaminar
pathway more important? Or is it equally as important as the intralaminar pathway in
superficial layers? Further work is required to resolve this issue but sufficient data were
gathered here to at least attempt to suggest a mechanism for the enhanced excitation to
pyramidal cells leading to SWC generation.
The timing of the enlarged EPSPs observed in superficial pyramidal cell somata sug-
gested that they were, at least in part, generated by enhanced outputs of deep layer RS
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cells. The timing of burst generation in these deep layer neurons would predict enhanced
inputs in superficial layer neurons early and/or late in the wave discharge, but not in
the middle. This was the pattern observed (Figure 6.6). However, changes in intrinsic
excitability may also have a role to play. Tentative evidence for an increase in axonal
excitability, leading to partially back propagated action potential (spikelets) was seen in
superficial pyramidal cells in the presence of DTC but not during the delta rhythms seen
during the control state. Nicotinic receptors are present on axons and may directly affect
axonal excitability [Lin et al., 2010]. Similarly, the intrinsic excitability of dendrites of
these cells may contribute to the excessive response to excitatory input. Dendrites re-
ceiving large excitatory synaptic inputs can generate a range of electrogenic phenomena,
often called ‘compound spikes’ [Andreasen and Lambert, 1995]. While there is little data
of relevance collected here that does not allow for a separation of intrinsic and synaptic
processes on dendrites, it is interesting to suggest that enhanced dendritic electrogenesis
may play a role in the hyperexcitability leading to the spike component of the SWC. But
how might this occur?
In terms of direct excitatory effects on dendrites, nicotinic receptor activation has been
shown to enhance calcium spikes and electrogenesis in dendrites [Szabo et al., 2008].
These findings would suggest that reduced nicotinic receptor tone (as expected in the
presence of DTC) would reduce dendritic excitability. But the opposite was seen in the
present work. However, presynaptic nicotinic receptors, and nicotinic terminals adjacent
to dendritic inhibitory terminals also have a profound effect on phasic and tonic GABA
release. Phasic GABA release is potentiated by presynaptic nicotinic receptor activa-
tion via T-type calcium channels [Tang et al., 2011]. Similarly, tonic GABA release is
facilitated by nicotinic terminals on Layer V pyramidal cells [Aracri et al., 2010]. This
latter observation may be directly relevant to the enhanced excitability of deep layer
neurons leading wave discharges seen with DTC. In addition, the dominant (in terms
of number) inhibitory neuronal population in superficial cortical layers are neuropeptide
Y-expressing, dendrite targeting cells arising from the central ganglionic eminence [Lee
et al., 2010b]. These interneurons express both 5-HT3 and nACh receptors and both are
strongly excitatory. As DTC blocks both these receptors, it is interesting to suggest that,
at least, the superficial layer hyperexcitability associated with SWCs may be primarily
mediated by a lack of appropriate excitatory tone in this inhibitory interneuron subtype.
This, in turn leading to disinhibition, spike generation and disruption of the interplay
between deep and superficial layers which has been suggested to be important for sleep-
associated synaptic plastic changes.
To investigate the spatiotemporal properties of cortical networks during sleep and its
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pathologies, the use of arrays of extracellular electrodes proved reasonably useful in the
work presented in this chapter. However, as mentioned in section 6.1, this approach is
limited by uncertainty about what mechanisms underlie the dynamics and any changes
in them. If it were possible to combine the advantages of multichannel, simultaneous
recording with the detail afforded by intracellular recording, a much richer, more infor-
mative picture would emerge. The following chapter of the thesis details attempts to
provide a device to address this need.
Chapter7
Fabrication and Design of Intracellular
Electrode Array
7.1 Introduction
The research detailed in the preceding chapters has highlighted limitations in under-
standing the local communications between neurons within a particular region of a tissue
slice. As has been shown, monitoring cells and networks can be achieved with a variety of
methods. The main methods being: extracellular recordings of local field potentials and
unit activity; intracellular recordings of single cells; and patch clamping of ion channels
of single cells, all of which, bar the latter, have been utilised in the compilation of this
thesis. However, it is not currently possible to record from multiple single cells simultane-
ously without using many single glass pipette electrodes, which can become cumbersome
and manipulation of multiple pipette electrodes is time consuming and doesn’t produce
a high yield for the time dedicated to the task. Detailed below is a brief introduction
to the theory of cellular recordings, as well as some of the current methods used within
electrophysiology, which have been utilised during this research.
7.1.1 Principles of Cellular Recording
Several types of electrodes are used for electrophysiological recording, but before being
able to discuss the types of electrodes used, it is firstly necessary to explain what is be-
ing recorded and why. Communication between neurons is at the core of how the brain
operates and understanding the signalling is vital to understanding the complexities of
how the brain functions. Therefore to be able to understand cellular recording, a basic
knowledge of the electrical properties of cells and their connections is necessary.
Neurons are electrically excitable cells that process and transmit information via elec-
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trical and chemical signalling. They consist of a cell body, nucleus, dendrites and an
axon which are all surrounded by a thin fatty lipid layer forming the cell membrane
(figure 7.1). Inputs from other neurons are delivered from the axon via chemicals known
as neurotransmitters diffusing across the synapse from one or more presynaptic neurons
as is shown in the inset in Figure 7.1. There are many different neurotransmitters, many
of which have been detailed in Section 1.2.1, which can either instigate or modify an
electrical response within that particular system.
Figure 7.1: The neuron is comprised of a cell body, nucleus, dendrites and an axon. The
dendrites and the cell body receive input signals across synapses and the cell’s response
then propagates down the axon on to other neurons synapses at the terminal. The inset
shows a more detailed diagram of how the neurotransmitters are released into the synapse
and how they are received by the next neuron in the signal flow. Taken from [Carey and
McCoy, 2006]
The arrival of the electrical impulse causes a dramatic reversal of the membrane potential
at one point on the cell’s membrane resulting in an action potential. The action potential
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causes a depolarisation in the membrane potential as it passes down the membrane, caus-
ing voltage gated sodium channels to open allowing Na+ ions to flow into the cell. The
sodium channels close while potassium channels open and K+ ions flow out of the cell
into the extracellular fluid causing the cell to hyperpolarise. The cell is then stabilised
by the Na+/K+ pump which allows the cell to return to resting potential. The action
potential travels along the membrane and down the axon where the electrical impulse
causes the release of more neurotransmitters to diffuse across another synapse to the next
neuron. Axons vary in length from a tiny fraction of a inch to more than three feet long
in some cases [Carey and McCoy, 2006], allowing signals to be sent to different regions
of the brain and CNS. These axons are covered in an insulated myelin sheath made up
of oligodendrocytes (in the brain) or Schwann cells (in the Peripheral Nervous System
(PNS )), which speeds up the transmission of the signals, sometimes reaching up hundred
metres per second [Carey and McCoy, 2006].
Figure 7.2: The cell membrane is a thin fatty layer that electrically separates the interior
and exterior walls of the cell body. Hence, it can be modelled as a capacitor with addi-
tional voltage sources and resistors representing the many ion channels in the membrane.
The equivalent circuit of the membrane based on the Hodgkin-Huxley approach can be
seen above. Taken from [Hanein et al., 2002].
7.1.2 Cellular recording methods
Electrodes are used by neuroscientists to observe, measure and record how neurons work
individually and as a network. Two methods are used: the intracellular method can be
used to record postsynaptic potentials, both inhibitory and excitatory, and action po-
tentials; and the extracellular method can be used to record local field potentials from
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the extracellular fluid. As previously stated, the current methods utilised in electrophys-
iology are detailed below, the majority of which were employed in the research for this
thesis.
Patch Clamp Electrodes
Neher and Sakmann developed the patch-clamp method during the late 1970s as an ad-
vancement of the voltage clamp technique. This resulted in an increase in the knowledge
of fundamental cell processes, resulting in Neher and Sakmann receiving the Nobel Prize
in Physiology or Medicine in 1991.
Patch-clamp uses a pulled pipette with a finely polished end with a diameter of ap-
proximately 1µm, which is large enough to encompass a region of the cell membrane
containing several ion channels. The electrode can be gently attached to the cell mem-
brane, and by applying negative pressure through the electrode, a piece of the membrane
is sucked into the electrode as shown in figure 7.3. This is also known as the ‘Patch’.
This results in the section of the cell being electrically and mechanically isolated from
the extracellular fluid due to the high resistance of the seal (in excess of a giga Ohm). By
applying a short low pressure pulse through the electrode, the ‘patch’ can be punctured
resulting in a direct connection between the electrolytic fluid in electrode and the inside
of the cell [Buzsaki, 2006]. Current waveforms can be applied to the electrode to allow
some of the intracellular fluid to flow up into the electrode which allows for information
to be learnt about the cell.
There are several variations of Patch Clamp recordings: Whole cell recordings, where
the electrode remains sealed to the whole cell during the recording process; Outside-out
patch, where the electrode is slowly pulled away from the membrane allowing a bulb of
membrane to bleb out of from the cell. When detached from the membrane, the bleb re-
forms inside out so that the original outside of the membrane is now facing the electrode.
This method is useful when the experimenter wished to manipulate the extracellular sur-
face of the isolated ion channels; Inside-out patch, is similar to the outside-out patch, but
where the original outer of the membrane is facing the electrode, instead it is the inner
membrane facing the electrode. This method is useful when the experimenter wishes to
manipulate the environment at the intracellular surface of the ion channels.
One problem with whole cell recordings, the electrolytric fluid in the electrode will slowly
diffuse into the intracellular fluid causing the cell to become ‘dialyzed’. Thus changing
the internal environment of the cellular structure. Therefore, recording should only be
taken during the first 10 minutes to achieve successful recordings before the cell is dia-
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Figure 7.3: Patch-Clamp electrode at-
tached to the cell membrane to enable
recording from the inside of the cell.
lyzed. This method of cellular recording was not used during the research for this thesis
as the facilities were not available and to allow for a comparison between previous work
by Carracedo (2010) and others, this method was deemed redundant.
Extracellular Electrodes
Despite the fact that recordings had been made from many locations in the brain since
1875 by Richard Caton [Finger, 1994], extracellular microelectrodes were only readily
available from the 1950s. At this time, Vernon Mountcastle and his colleagues were de-
veloping techniques for recording from the cerebral cortex at the cellular level [Kandel
et al., 2000]. Extracellular electrodes can record two types of responses: Unit recordings;
and Local Field Potentials. When electrodes are placed near cells it is possible to record
action potentials - single unit recordings - at the millisecond temporal resolution that they
occur [Montgomery, 2002]. Although this method can be informative of how a neuron
responds to stimulation either electrically or pharmocologically, it is not able to show the
synaptic activity of the cell, excitatory post-synaptic potentials (EPSPs) or inhibitory
post-synaptic potentials (IPSPs) except under specific conditions. Whereas, if the elec-
trode is placed in the extracellular space, the electrode can record the summation of all
the dendritic synaptic responses in the local field, hence a local field potential recording.
This type of recording, as seen in chapters 4 and 5, offers the ability to understand the
combined synaptic inputs into the cell population [Montgomery, 2002]. Importantly for
this research, the summation of dendritic responses leads to an oscillating signal which
can be monitored and manipulated through the application of specific chemicals depend-
ing upon the frequency of the oscillation.
Extracellular electrodes are typically constructed from one of three types of electrodes:
Metal electrodes, glass micropipette electrodes, and solid-state microprobes as shown in
figure 7.4.
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Figure 7.4: Biopotential elec-
trodes: a) glass micropipette
electrode; b) insulated metal elec-
trode; and c) solid-state multisite
recording microprobe. Taken
from [Enderle et al., 2000]
Metal Electrodes
Metal electrodes are one of the simplest methods of recording from the cortex is the use
of insulated wires with small tip diameters that have been stripped of the insulator, as
shown in figure 7.4b). This is also one of the oldest techniques used for recording from
many cells. Strumwasser (1958) implanted several 80µm tipped stainless-steel microwire
electrodes into the brain of a live ground squirrel and successfully recorded firing neurons .
Microwires are frequently used in in vivo studies due to it’s flexibility compared with both
glass electrodes and solid-state electrodes. Microwire electrodes are also easily arranged
into arrays to allow for multiple recordings from one localized site. These microwires
are usually produced from either tungsten or platinum, and have an insulative layer of
polyimide.
Glass micropipette electrodes
Glass micropipette electrodes are typically made from borosilicate glass capillary tubes
that have been heated to near melting point at the middle within a small filament and
pulled sharply by a Flaming/Brown micropipette puller. This process creates two similar
capillary electrodes with an open tip that has diameter of 1-10µm, which typically have
a resistance of 2-5MΩ. The larger end of the electrode is then filled with an electrolyte,
which is biologically compatible with the tissue sample, usually artificial cerebrospinal
fluid (ACSF)(see chapter 2. Bare Ag/AgCl wire is inserted through the larger end of
the electrode to provide an electrical connection with the electrolytic solution. One
limiting factor of extracellular electrodes is the reproducibility, as the exact dimensions
of the tapered end of the electrode cannot be strictly controlled, although variations
can be made to the ‘pulling’ program to modify the tip dimensions. Glass capillary
electrodes are also very fragile, hence they can only be used once and this also impacts
reproducibility.
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Extracellular Solid State Electrodes
Michigan Array
Since 1970, when Wise et al first designed the silicon multi-electrode array, numerous
studies have been undertaken to improve upon and modify the original design. These
planar multi-electrode arrays are more commonly known as Michigan Arrays. These
arrays are composed of planar probes with multiple recording sites located along the
shank of each structure. Hence these probes provide a greater recording density whilst
minimising tissue damage compared to microwire arrays.
A typical design consists of one to four probes with four recording sites with the thickness
of the probes aiming to be 25µm but is dependent on SOI wafer specification. The length
of the probe is typically 3mm with the distance between the probes being 200µm [Chen
et al., 2009]. The process for michigan array fabrication is shown in detail in figure 7.5
below.
Figure 7.5: Fabrication process for michigan array probes. Taken from [Chen et al.,
2009]
Michigan Arrays are usually used as an in vivo recording device [Kipke et al., 2003,Chen
et al., 2009, Csicsvari et al., 2003, Bai et al., 2000, Cheung et al., 2007, Anderson, 2008]
as they are able to easily penetrate tissue without doing excessive residual damage and
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also their ability to record from multiple sites in the same plane, enabling the tracking
of neural signals. Michigan Arrays are not typically used for in vitro recordings due to
the size of the probes compared to the size and thickness of the brain slice (∼450µm).
Brain slices would also not to able to ‘sit’ on the probes as when the brain is cut into
slices, many neuronal connections are severed. This results in the first 100µm of tissue
not being a viable recording site.
sim
The Utah Electrode Array
The Utah Electrode Array (UEA), which was briefly described in chapter 6. is a three-
dimensional electrode array consisting of 100 needle-like conductive electrodes approx-
imately 1.5mm in length, where each electrode is electrically isolated from it’s neigh-
bours. The sharpened tip of each electrode is coated in platinum to facilitate charge
transfer [Campbell et al., 1991] and then coated with polyimide for electrical isolation,
excluding the tip. These arrays are fabricated from a thick n-type silicon wafer, through
which highly conductive p+ trails are created via thermomigration resulting in electrical
isolation by opposing pn junctions. The wafers are then micro-machined to expose the
pillars of p+ trails, followed by a spun acid etch to produce the needle-like tips (Fig-
ure 7.6). The electrical contacts to the electrodes are made from the reverse side using
gold wire bonded to aluminium contact pads.
These arrays have had many uses over the last decade, since they were first fabricated
and published by Campbell et al in 1990 [Campbell et al., 1990]. They have been used in
vivo in the cat somatosensory cortex [Rousche and Normann, 1998], visual cortex [Nor-
mann et al., 1999], the dorsal root ganglion [Aoyagi et al., 2002] and electrophysiological
in vitro studies in the neocortex, including those detailed in this thesis.
As described in Chapter 6, when utilised during experiments, the UEA was able to
record a magnitude of data, including both local field potentials and unit recordings
from the same electrodes which allows for correlation and spatial analysis. These are of
particular interest when investigating the relationship between cellular layers, as was the
aim of Chapter 6.
Intracellular Electrodes
Microelectrodes have been used greatly over the last 60 years or so in the field of electro-
physiology to aid in the understanding of many electrochemical biological processes. For
example, in 1951 Brock, Coombs and Eccles succeeded in the first intracellular recordings
from nerve cells in the CNS with the use of microelectrodes [Eccles, 1953]. These were
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Figure 7.6: A simplified process flow for the fabrication of a UEA.
(left) Aluminium pads are created on one side of an n-type silicon wafer. During the
process a temperature gradient is applied to the silicon wafer which drives Si-Al eutectic
droplets through the wafer. After the process, highly doped p+ silicon trails result from
the eutectic droplet passage through the n-type substrate [Campbell et al., 1991].
(centre) A dicing saw is used to micro-machine the high-aspect ratio columns from the
p+ trails in the n-type silicon by creating deep orthogonal cuts.
(right) Array is then slowly spun in acid etchant to smooth and sharpen the columns.
The needle-like tips are then pushed through a metal foil layer and sputtered with a thin
layer of Pt/Au. (Figures taken from US Patent 5,215,088 [Normann et al., 1993]).
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able to record the electrical responses seen during excitatory and inhibitory postsynaptic
potentials.
Today in electrophysiological studies, the most common method of recording intracel-
lular potentials is via a sharp glass capillary electrode filled with Potassium Acetate
(CH3CO2K). Potassium acetate is the electrolytic fluid used as potassium is the chief
cation of intracellular fluid, therefore allowing effective signal propagation. This signal is
then detected by the Ag/AgCl wire immersed in the electrode where the signal crosses
the electrolyte/metal interface. The signal is then fed into data acquisition and analysis
software where it is recorded.
Intracellular recording methods are rather limited as only one or two electrodes can
be recorded from simultaneously when using capillary electrodes, as previously stated.
Therefore a way to record from multiple cells simultaneously would be to employ a simi-
lar device as the UEA, albeit on a much smaller scale. This would not be possible using
capillary electrodes, although it may be possible using solid state electrodes.
Intracellular Solid State Electrodes
In the past, it would have been difficult to fabricate large solid structures with features
of less than 1µm. In 2001, Hanein et al designed and fabricated one of the first individ-
ual intracellular solid state electrodes. The method was based on the UEA fabrication
method, pillars were diced into a silicon wafer, and sharpened with SF6 via RIE fabri-
cating needle-like electrodes approximately 250µm in height and with sub-micron tips.
A sea slug brain was used to test the viability of the electrode due to the large size
of the brain cells (∼400µm in diameter) and the comparative size of the electrode tip.
The electrodes were successful in recording action potentials, albeit small signals (10mV
instead of ∼100mV) from Tritonia diomedea.
Hanein et al have since improved the fabrication method [Hanein et al., 2003]. This
other method used sacrificial satellite pillars to improve protection of the central pillar
from unwanted SF6 etching during the self-sharpening process. This method resulted in
needle-like electrodes, 230µm in height and with a 200nm tip diameter. The efficacy of
this method with regards to intracellular measured voltage potentials is unknown as no
electrophysiological results were published.
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7.1.3 Aims and Objectives
Thus, the aim of this chapter is to investigate the possible methods for producing an
array of electrically active, isolated, solid state intracellular electrodes. This will begin
with the design and fabrication of a single electrode to understand what is required to
achieve the necessary dimensions and to understand the mechanical properties required.
This preliminary research will also influence the design of the subsequent, electrically
active single electrode or array of electrodes.
7.2 Efficacy of Mechanical Properties
7.2.1 Design Specifications
Before a design can be drawn or a process flow be discerned, the required dimensions of
the desired intracellular solid state electrode first need to be understood.
Tip dimensions
Pyramidal cells are prevalent in the cortex and are the largest neuron in both the human
and rodent brain, with the soma averaging approximately 20µm in diameter. The cell
membrane is typically less than 10nm in thickness, hence the thickness of the membrane
does not affect the electrode tip design, however the lipid structure of the membrane
does (i.e. the elasticity, see figure 7.7). The glass capillary electrodes which have been
traditionally used for intracellular recordings have a tip diameter ranging from 0.06-
0.7µm (60-700nm). Based on this information, the diameter of the electrode tip would
have to be less than 200nm, ideally less than 100nm. This would be to ensure that when
the cell membrane was pierced, it would close around the tip as would happen during a
successful impalement by a glass capillary electrode.
Electrode
Cell Membrane
Nucleus
~ 20μm
Figure 7.7: Schematic diagram depict-
ing the bending of the cell membrane
during penetration of a sharp elec-
trode. The electrode cannot penetrate
the lipid layer that forms the cell mem-
brane if the tip of the electrode is too
dull, or too short to compensate for the
bending of the membrane. Adapted
from [Hanein et al., 2001].
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Electrode shaft dimensions
When preparing the rodent brain slices as detailed in chapter 2, the first 50µm of the top
and bottom surfaces of the slice are abundant with broken connections between neurons.
This needed to be taken into account when considering the required electrode length as
to make sure the electrode tip would have the range to penetrate through this layer. The
dimensions of the electrically active tip would also have to be considered, as to ensure
that the electrode would only be recording from inside the cell and not from the extra-
cellular fluid simultaneously.
The typical slice thickness used in the electrophysiology labs is 140µm. Therefore to
be able to penetrate the majority of the slice (ignoring the bottom 50µm), the electrode
shaft length had to be greater than 90µm in height. To allow for ease of manipulation
(i.e. to be detectable by the human eye), the electrode shaft length would ideally need
to be greater than 500µm. Several limitations meant that this shaft length would not be
achievable with the facilities or materials available, therefore a modest target of 300µm
was the desired length of the electrode shaft during these trials.
As described previously, the desired tip dimensions are known, however the base di-
ameter of the shaft required to achieve this tip dimension is not. The diameter of the
base would have to be larger enough that it would withstand the etching process and also
retain it’s structural integrity when inserted into the brain slice, particularly if this was
not conducted perpendicular to the slice surface. Therefore the electrode base diameter
would have to be investigated to understand the optimal dimension for the desired tip
and shaft dimensions.
Substrate Biocompatibility
A further initial consideration was, which substrate the array would be fabricated from?
Due to the nature of the end application, the substrate would need to be biocompatible.
When developing a cell based biosensor, the biocompatibility of the materials used is
fundamental to the project. Biocompatibility is a fairly ambiguous term as it reflects the
ongoing development and insights into how materials interact with the human body and
therefore determines whether a medical device will be a clinical success [Mahmoodi and
Ghazanfari, 2011]. In the case of this project, during the mechanical efficacy phase, the
level of biocompatibility of the material was not considered to be of high importance,
provided that biocompatibility was enough that the substrate could be in contact with
living tissue for several hours without causing adverse damage. Several semi-conductor
substrates were considered including: Silicon, Silicon Carbide and Diamond.
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Diamond, although having immense biocompatibility characteristics [Freitas Jr, 1999],
the dimensions needed to create a successful electrode would not be achievable through
the application of etch chemistry via the use of a reaction ion etching (RIE) machine.
Previous studies have shown that using a mixture of CF4 and O2 plasmas can produced
a perpendicular etch rate of 50nm/min [Leech et al., 2001]. For the purpose of under-
standing the efficacy of the mechanical properties of a needle-like intracellular electrode,
the use of the substrate would be costly, in terms of time, money and resources.
Silicon Carbide (SiC) is a wide-band gap semiconductor which has many applications,
including use in high frequency, high power, high voltage and high temperature de-
vices [Wright and Horsfall, 2007]. It is also known to be biocompatible in it’s single-crystal
cubic form and as a coating deposited by chemical vapour deposition (CVD) [Kotzar
et al., 2002,Frewin et al., 2011]. With the utilisation of microelectromechanical systems
(MEMS) machining methods, large aspect ratios have been achieved with SiC. Tanaka
et al (2001) reported an etch depth of approximately 120µm with 5 hours of etch time,
however this was achieved by ICP and not RIE alone, which is one of the limiting factors
for this project. Therefore it was decided that SiC would also be too time intensive due
to the lack of an inductively coupled plasma (ICP) machine being available.
Silicon has been employed by many research groups over the past several years in the
biomedical field due to the extensive knowledge of fabrication methods available. Of
particular interest to this work, silicon has the ability to be mass produced to produce
neural electrodes with high accuracy and reproducibility [Ji et al., 1989,Olsson III et al.,
2005,Muthuswamy et al., 2005]. This therefore shows that the efficacy and biocompati-
bility of this substrate as a sensor for biomedical purposes has already been proved. Not
all silicon has the same properties. The level of electrical conductance a substrate has
depends on the ‘doping’ level. For example the substrate used in this mechanical efficacy
study has a doping level of ND = 10
14cm−3. Reading off Figure 7.8, the resistivity of this
N type substrate is 40Ωcm. Using Equation 7.1, the conductance of the silicon substrate
is 25mS.
σ =
1
ρ
= q(µnn+ µpp) (7.1)
Where σ is the conductivity, ρ the materials resistivity, µn and µp the minority carrier
mobilities and n and p the carrier concentrations.
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Figure 7.8: Resistivity versus carrier concentration for silicon at 300K [Beadle et al.,
1985]. Increasing the carrier concentration would result in a more conductive substrate.
For the purpose of a mechanical study, an electrically conductive substrate is not
necessary as it would increase both resource and machining costs. Hence a lowly doped
silicon substrate will be used.
Manipulation
To be able to appropriately test the electrodes produced during the mechanical study,
the backplate would need to be attached to an object which would allow for greater
control and manipulation of an electrode of less than 500µm in height. The experimental
results achieved using an utah electrode array detailed in chapter 6, were possible partly
due to the manipulation setup. The array was attached to a rod (8mm in diameter and
150mm in length) using either araldite or epoxy, hence allowing greater ease during array
placement. A similar method of manipulation would be ideal for the electrodes produced
within this research, although due to the size of the backplate, a rod with a smaller
diameter would be needed.
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7.2.2 Process Design
It is known that during a deep reactive ion etching (DRIE) process, the sidewall angle
depends on the mask geometry and loading effects. Single free stranding pillars tend to
develop a more negative profile, hence the use of the sacrificial satellite pillars surrounding
the central pillar, as used by [Hanein et al., 2003]. However, due to the equipment
and materials available, the configuration, dimensions and process flow needed to differ
significantly from this previous work. Figure 7.9 shows a schematic of the layout of the
sacrificial pillars with reference to the central pillar.
(a) (b)
Figure 7.9: Schematic of pillar configuration. a) The central pillar measures ‘x’ in
diameter, the satellite pillar measures ‘y’ in diameter and the outer diameter of the ring of
satellite pillars is measure as ‘z’. b) The spacing distance between 2 pillar arrangements
measures as ‘d’.
A photolithography mask was designed to investigate the optimal dimensions and
spacing needed to create a mechanically viable electrode suitable for impaling a pyramidal
cell. The mask design measurements Hanein et al (2003) used to fabricate their pillars
(pre-sharpened electrodes) with respect to figure 7.9, were x=70µm, y=30µm, z=250µm
and the diagonal distance between the central pillars was 400µm due to the hexagonal
nature of the mask layout [Hanein et al., 2003]. The mask design related to this thesis
contained a 3x3 repeating matrix, each individual cell consisted of a 6x6 array of central
pillars with 12 sacrificial satellite pillars surround them (subcells). Each of the 9 cells
had varying: central pillar dimeters (x, varying between 50 - 100µm), satellite pillar
dimensions (y, varying between 20-50µm), outer diameter of the ring of sacrificial pillars
(z, varying between 200-300µm). However, all 9 cells had the same distance between
subcells (d, 300µm ).
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7.2.3 Fabrication
To fabricate spike electrodes, that were mechanically suitable for intracellular recording,
<100> oriented lightly doped N-type (Phosphorus doped, 1014cm−3) 6inch silicon wafers,
approximately 650µm thick were used. The wafers were patterned using an SiO2 mask,
as photoresist was not been able to withstand the etching process (see figure 7.10a).
The wafer was then placed in a DRIE to etch pillar approximately 350µm tall, the
result is shown in figure 7.10b. The pillar fabrication was undertaken at the Scottish
Microelectronics Centre (SMC), University of Edinburgh.
a) Lightly doped silicon 
substrate 
b) Thermal Oxidation c) Photolithography 
d) DRIE to depth of 350µm e) RIE self sharpening 
process  
(a)
(b) (c)
Figure 7.10: Pillar Design a) Process flow used to fabricate spike electrodes from a
silicon substrate wafer b) SEM of DRIE etched central and sacrificial pillars. Tilt = 60◦,
Magnification = x100. c) Variation of x in µm in every cell. The other parameters of
this particular schematic are a follows: y = 50µm and z = 300µm.
After the DRIE process, the wafers were cleaved and an array of 6x6 pillars, of varying
dimensions, as shown in Figure 7.10c (random sized samples followed by ∼5mm x 5mm
samples), were placed in the reactive ion etcher (RIE) chamber (PlasmaTherm 790).
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Using an optimised self-sharpening etch process using 80% sulphur hexafluoride (SF6)
and 20% oxygen (O2), the samples were etched for varying degrees to time, between 1
and 2 hours, to achieve optimal spike electrode dimensions. Table 7.1 details the 2 hour
etch program used by the PlasmaTherm790, as an example.
No. Process Pressure RF Power SF6 O2 Time Σ Time
(mTorr) (W) (sccm) (sccm) (mm:ss) (h:mm:ss)
1 Initial Set Up 0.1 0 00:10 0:00:10
2 Purging 50 0 72 18 20:00 0:20:10
3 Evacuation 0.1 0 15:00 0:35:10
4 Set Pressure 50 0 20 5 00:10 0:35:20
5 Set Flow 50 0 72 18 00:10 0:35:30
6 Etch 0.5 50 150 72 18 30:00 1:05:30
7 Evacuation 0.1 0 0 0 20:00 1:25:30
8 Set 50 0 72 18 00:10 1:25:40
9 Etch 1 50 150 72 18 30:00 1:55:40
10 Evacuation 0.1 0 0 0 20:00 2:15:40
11 Set 50 0 72 18 00:10 2:15:50
12 Etch 1.5 50 150 72 18 30:00 2:45:50
13 Evacuation 0.1 0 0 0 20:00 3:05:50
14 Set 50 0 72 18 00:10 3:06:00
15 Etch 2 50 150 72 18 30:00 3:36:00
16 Evacuation - end 1 10 0 0 0 00:10 3:56:10
17 Purge - end 1 100 0 0 0 00:10 3:56:20
18 Evacuation - end 2 10 0 0 0 00:10 3:56:30
19 Purge - end 2 100 0 0 0 00:10 3:56:40
20 End 0.1 0 0 0 00:10 3:56:50
Table 7.1: Step by step recipe for a 2 hour etch of silicon pillars using the PlasmaTh-
erm790 RIE machine.
7.2.4 Results
The initial etch optimisation experiments used set etch times of a) 1 hour, b) 1 hour 30
minutes and c) 2 hours. The outcome of experiment a) can be seen in figure 7.11a. As
the SEM image shows, the sacrificial pillars have been etched away whilst only the top of
the central pillar has begun to etch isotropically (etching the side walls) and the bottom
of the pillars retains the original profile. This therefore justifies the original reasoning
to include the sacrificial pillars to protect against creating a negative profile. Although
a greater etch time was needed to achieve the desired electrode dimensions. The results
of experiment b) can be seen in figure 7.11b. The etch time of 1hour and 30 minutes
saw further sidewall etching of the central pillars. Although two of the central pillars in
figure 7.11b have a spike-like form, the base diameter was determined to be too small and
the pillar could easily be broken by applying a very small force. Hence, only the central
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a) 1hour etch b) 1hour 30minute etch
c) 2hour etch
Figure 7.11: Outcome of initial etch experiments - SEM images. All images with
85◦ tilt and x100 magnification.
pillar with a diameter of 80-100µm would be considered during the following etches.
Experiment c) produced promising results with regards to the 90 and 100µm pillars as
shown in figure 7.11c. However, after considering the size of the sample used in the
previous experiments, it was decided that two cells on separate pieces of silicon would be
etched simultaneously in the RIE in place of the random sizes used during experiments
a - c. Due to this change in methodology, it was assumed that the etch times taken from
these three experiments would be incorrect due to the amount of silicon that would be
etched. This was shown to be true after a second 2 hour etch using the newly proposed
sample sizes, as all pillars had been etched away completed (no SEM image available).
To further control the reproducibility of the etching process, two specific cells were chosen
to be used for all subsequent experiments. The two cells chosen were:
• 30y 300d (cell 6)
• 50y 300d (cell 9)
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These cells were chosen to allow for an effect of satellite pillar diameter (y) on the central
pillar. An iterative approach was utilised to achieve the optimum etch time. Figure 7.12
portrays the outcome of the iterative approach. As etch time increased the shaft length
(right hand side axis), the shaft length decreased, however a rapid exponential decrease
was observed after an etch time of 1hour 52minutes and 30 seconds. A similar response
was observed for the tip diameter, however this was seen to be decreasing before 1hour
50 minutes. Where the lines cross could be considered the optimal etch time, however as
stated in section 7.2.1, the tip diameter needs to be <200nm and the shaft needs to be
as long as possible, therefore an etch time of 1hour 54 minutes and 30 seconds would be
considered to be the optimum etch time.
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Figure 7.12: Outcome of Iterative approach to optimal etch time.
To test the mechanical properties of these spike electrodes, all electrodes bar the elec-
trodes with an original base diameter of 100µm were removed from the substrate. The
baseplate was then fixed to a plastic rod with a diameter of 4mm using araldite. This
was allowed to cure overnight to ensure a strong bond was formed. The rod was clamped
to a micro-manipulator, with the spike electrode being perpendicular to a petty dish con-
taining agar (depth ∼15mm), a solid gelatinous substance used in electrophysiology to
stabilise tissue during slicing which has a similar surface rigidity to brain tissue. The rod
was lowered down until the base plate was nearly touching the agar, therefore resulting
in the spike electrode being inserted into the medium. The spike was examined using
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(a) (b)
Figure 7.13: Optimum etch time for Mechanical purposes - 1hour 54 minutes and
30 seconds. a)100µm diameter spike measuring approximately 220µm in height. b) tip
diameter of spike shown in a) measuring approximately 125nm.
SEM and no damage was found to be present (no image available).
7.2.5 Summary of the mechanical testing
The silicon wafer used for the initial spikes was not sufficiently doped for the spikes to
be electrically conductive. However it did possess the mechanical properties required
to fabricate an electrode with a base diameter of approximately 100µm, a shaft length
of approximately 220µm and a tip diameter of approximately 125nm. It was also able
to sustain insertion into a tissue-like medium without damage. To successfully record
intracellularly, the active region of the electrode requires an impedance of less than
100MΩ at 1kHz. The typical impedance of a typical glass capillary intracellular electrode
capable of successfully recording from a cell is ∼70MΩ. To ensure that the electrode is
recording exclusively from inside the cell, the shaft of the electrode needs to be electrically
isolated from the tip. The current electrode design does not allow for the electrodes to
be individually isolated, hence any signal detected by one electrode will be seen across
all electrodes which will impede in the understanding of the cellular network. Therefore,
every electrode needs to be electrically isolated whilst also having a back contact to
allow for ease of connectivity and addressability in arrays. The electrical and isolation
properties required of a solid state silicon electrode will be discussed in section 7.3.
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7.3 Efficacy of Electrical Properties
7.3.1 Design
Addressability
Previous studies have utilised thermomigration to create electrically isolated electrodes.
For example, Campbell et al (1991) used thermomigration to define p-doped columns in
an n-doped substrate. Due to the nature of P-N junction isolation, no electrical current
will pass from the ‘p’ region to the ‘n’ region, hence resulting in an electrically active and
isolated column.
The height of the pillars that were required for this test dictated that thermomigra-
tion would not be suffice. To achieve the height required for the pillars, it was decided a
thick, highly doped n-type wafer and a thin, lowly doped p-type wafer would be bonded
together to create a type of SOI (Silicon on Insulator) wafer. The layer between the two
wafers would be SiO2, therefore as well as separating the two wafers, it would act as a
stop etch when etching the pillars from the highly doped wafer. Hence each electrode
would be electrically isolated.
To be able to record from each individual electrode, the addressability had to be consid-
ered. A via would be wet etched through the thin wafer, using KOH, to correspond to
the location of each central pillar. Once the wafers were bonded together, the vias would
undergo metal deposition. This would then be patterned to create a back contact large
enough to bond to. The addition of interconnects would allow for a manipulating device
to be attached to the back of the array without sitting directly on the back contacts in
the middle of the array.
Insulation Medium
The conductive nature of the material used to allow for a biological signal to pass through
the electrode tip has previous been discussed, however to record from only the tip, it is
necessary for the majority of the electrode shank to be coated in an insulating medium.
Thin film chemistry can be used to create both conductive and insulative surfaces, al-
though for the purpose of this research only insulative films will be detailed. For an
insulative material to be viable, it needs to be biocompatible. As previously stated to
be considered biocompatible, a material needs to have a non-toxic or injurious effect on
biological systems. Another important consideration needs to be whether the insulative
material used is etch-able. Due to the nature of the electrode, the tip would need to
be bare of insulative material to allow an electrical signal to be sent to the recording
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Figure 7.14: Addressable array mask design. This basic mask design shows a 3 x
3 array of central pillars surrounded by sacrificial pillars (Blue), the pattern for the via
to be used during the wet etch (Red) and the interconnects from the centre of the 5mm
square substrate to the outer edges to allow for easy access and addressability (Green).
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software. Both wet and dry etch methods may be viable, however due to the microsmall
area of the tip, a controllable process such as dry etching may be more viable. Several
criteria need to be investigated before the insulative material is chosen:
• Biocompatibility
• Dielectric Properties
• Tensile Strength
• Adherability
• Etchability
Polyimide
Aromatic polyimide (PI) has been at the forefront of microelectronics encapsulation for
many years due to its resistance to solvents, strong adhesion to metal oxides and dielectric
properties. Photolithography and dry etching methods can be utilised to pattern PIs,
which allows them to be very versatile. PIs exhibit high electrical resistivity, thermal sta-
bility, chemical inertness and good adhesion to common substrates [Beebe and Denton,
1994]. PI has been shown to have a lower dielectric constant than Si3N4 and SiO2 (refer
to table 7.3) however PI is an organic polymer and hence it is not as durable [Borkholder,
1998]. Repeated use may result in the degradation of the thin film layer and hence the
deterioration of the biological signal. Until recently, PIs would have been the obvious
choice for isolating sterilizable medical devices due to its biocompatibility [Richardson
et al., 1993] and dielectric properties. PI has a Young’s modulus of 2.8GPa which would
allow the thin film to provide support to a structure whilst also allowing for a degree of
flexibility before fracturing. One disadvantage would be the etch rate of PI. It is well
documented that PI can be etched in a fluorinated oxygen plasma, however the etch
rates are >1µm per minute [Turban and Rapeaux, 1983, Bagolini et al., 2002]. To be
able to control the etch rate of the insulative material covering the tip, a much lower
etch rate is needed. Another disadvantage of PIs is their tendency towards moisture up-
take.Consequently, the use of alternative biocompatible thin film materials with improved
moisture absorption and dielectric properties, such as Parylene or Benzocyclobutene.
Silicon Dioxide
Silicon Dioxide (SiO2) has been used for many years in the microelectronics industry as a
thin film insulator. It is considered an almost perfect insulator with a resistivity in excess
of 1016Ωcm. SiO2 can be thermally grown or deposited via chemical vapour deposition.
These films are smooth and coherent, with no pin holes, ranging in thickness down to
a single atomic layer, although it is known that to be insulative, SiO2 needs to be at
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least five atoms thick [Schulz, 1999]. Unlike PI, SiO2 does not have a tendency towards
moisture uptake therefore making it suitable for biomedical applications. However, it is
not at durable as several of the following materials detailed, hence it is not the primary
choice. It is however, easily and controllably etched via both wet (e.g. Potassium hydrox-
ide ∼8nm/minute) and dry (RIE, SF6 + O2 ∼25nm/minute) etching methods [Williams
et al., 2003].
Silicon Nitride
A convenient way to achieve insulation is by using sputtered silicon nitride (Si3N4). It is
often used as an insulator and a chemical barrier in manufacturing. Owing to superior
durability, Si3N4 is better suited for thin film dielectric coatings than SiO2 or PI. SI3N4
deposited via CVD experiences strong tensile stress which can result in cracks in films
thicker than 200nm. However, it does have a superior resistivity and dielectric strength
when compared to other insulators commonly used in the micro-fabrication industry. A
study by Neumann et al (2004) confirmed that Si3N4 adhered to a variety of surfaces and
acted as a physiochemical barrier allowing cell cultures to survive on non-biocompatible
mediums. The biocompatibility of Si3N4 was greater on polished surfaces [Neumann
et al., 2004]. However, due to fabrication method employed to produce the needle-like
electrodes in this thesis, the exterior surface of the electrodes are unlikely to be smooth
or uniform hence the use of Si3N4 as the insulative medium may not be suitable.
Parylene
Parylene is a type of CVD unique polymer which is used widely as a moisture barrier
and an electrical isolator. There are currently three types of parylene films: Parylene
N (poly-para-xylylene) is the base member first reported in 1947 [Tracton, 2007], which
can sustain high temperatures (>220◦C) vacuum environments; Parylene C is produced
from the same monomer but replaces an aromatic hydrogen atom with a chlorine atom.
It is the most widely used polymer due to it low permeability to moisture and gases
while also retaining exceptional electrical properties; Parylene D, which is very similar to
Paylene C in characteristics but can withstand higher temperatures, albeit not the the
same magnitude as Parylene N.
One of the benefits of using parylenes is that they can be used to form very thin layers.
Table 7.2 demonstrates the excellent dielectric properties of Parylene for coatings with a
depth of less than 1µm. It is well documented that both Parylene C and N can be etched
in an oxygen-based plasma [Callahan et al., 2003,Callahan et al., 2001].
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Properties (1) Parylene Parylene Epoxy Silicone Polyurethane
N C
Dielectric Strength,
V/mil 7,000 5,600 2,200 2,000 3,500
Dielectric Constant
60Hz 2.65 3.15 3.3 - 4.6 3.1 - 4.2 4.1
1KHz 2.65 3.10 - - -
1MHz 2.65 2.95 3.1 - 4.2 3.1 - 4.0 3.8 - 4.4
Dissipation Factor
60Hz 0.0002 0.020 0.008 - 0.011 0.011 - 0.02 0.038 - 0.039
1KHz 0.0002 0.019 - - -
1MHz 0.0006 0.013 0.004 - 0.006 0.003 - 0.006 0.068 - 0.074
Surface Resistivity
(Ω) 1013 1014 1013 1013 1014
Volume Resistivity
(Ω/cm) 1.4x1017 8.8x1016 1012 - 1017 1015 1011 - 1015
Youngs Modulus
(GPa) 2.41 2.75 2.41 0.0062 0.0068 - 0.068
Gas Permeability
at 25◦C N2 3.0 0.4 - - 31.5
(cc.mm)/ O2 15.4 2.8 - 19,685 78.7
(m2.day.atm) CO2 84.3 3.0 - 118,110 1,181
H2 212.6 43.3 - 17,717 -
Table 7.2: Electrical Properties of Parylene. Data taken from [SCS, b]
To be considered biocompatible, a material needs to have superior chemical resis-
tance, barrier properties and insolubility when placed in living tissue for a length of
time. Parylene solubility in organic or other media is very low, less than 0.1% after 24
hours. Due to the method of deposition, Parylene produces pin-hole free films which
provide an excellent barrier to both liquids and gases. Table 7.2 shows gas permeability
values have been measured at thicknesses below 0.1µm. Parylene is also resistant to chem-
ical at room temperature and is also insoluble in all organic solvents up to 150◦C [SCS, a].
Although Parylene C has all the attributes required of a biocompatible insulation layer,
it does not adhere to substrate metals sufficiently to withstand the necessary lifetime re-
quired for many implants [Stark, 1996]. With regards to the needle-like electrodes in this
thesis, the lifetime of parylene is not paramount provided that it can withstand multiple
uses. To improve parylene adhesion to the silicon substrate, A174, an adhesion promo-
tor, can be initially applied to the inorganic silicon surface [Stark, 1996]. This presents
an organic face to Parylene C monomers, allowing for satisfactory adhesion. A-174 is
also biocompatible, hence as a consequence of these combined properties, Parylene C is
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considered to be a viable candidate for the electrical insulation layer.
Benzocyclobutene
Benzocyclobutene (BCB) polymers have been used since the late 1980’s in the micro-
electronics industry for packaging and interconnect applications. BCB is a material
widely used in the electronics industry due to its low dielectric constant, low moisture
absorption, excellent chemical resistance and low electrical current loss factor at high
frequencies. It has also recently been used in preference to PI for medical devices due to
its greater tensile strength [Lee et al., 2005]. Lee et al (2005) reported that BCB coated
electrodes passed stringent biocompatibility tests when cells were cultured on the top
surface of the planar electrodes, as no change of morphology was seen and hence were
considered non-toxic. BCB can be etched through the use of plasma processes, however
some fluorinated etch gas component must be present as BCB cannot be asked in pure
oxygen [FIRST, 2001]. The gas mixture used to etch the silicon spikes would be suitable
for etching BCB. However, trials would need to be performed to understand both the
adherability to the spike electrode due to the small tip dimensions, in conjunction with
etch rate trials to calculate the etch rate in the machines available; and whether using
RIE will result in the BCB being removed from the sidewalls of the electrode. Due to
the nature of the needle-like electrodes in this thesis, BCB is an insulative medium to
consider due to the superior tensile strength, biocompatibility, ease of fabrication and
low dielectric constant.
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Properties Benzocyclobutene Polyimide
Dielectric Constant
60Hz - -
1KHz 2.65 3.5
1MHz 2.65 3.5
Dissipation Factor
60Hz - -
1KHz 0.0008 -
1MHz 0.0008 0.005
Breakdown Voltage
(V/cm) 3x106 3x106
Volume Resistivity
(Ω/cm) 1x1019 1x1016
Youngs Modulus
(GPa) 3.1 2.8
Water Uptake
(23◦C and 84% relative humidity) 0.14% 4%
Table 7.3: Electrical Properties of BCB
Fabrication Process
All pre-sharpening fabrication was to be undertaken by SMC, Edinburgh. Figure 7.15
shows a schematic of the fabrication process to be used to create the conductive, address-
able spike electrodes. To fabricate spikes suitable for intracellular recording, a thin lightly
doped silicon (6inch, (100), p-type 10-20 Ω cm, 150µm thick) wafer was to be coated in
a silicon nitride (Si3N4) film via low pressure chemical vapor deposition (LPCVD), as
shown in Figure 7.15b. Photolithography was to be used to pattern the nitride film to
create the back contact cavities. The dimensions of Mask 1 (see figure 7.15c) were chosen
to allow for a Potassium Hydroxide (KOH) etch to create a cavity with a 20µm square
base at the Si3N4 etch stop layer (see figure 7.15d). The base of the cavity was to be
opened by striping the nitride from the thin p-type silicon (Figure 7.15e) that was to be
replaced with a thermally grown silicon dioxide (SiO2) layer. The thin wafer was then
to be bonded to a highly conductive silicon (6 inch, (100), n-type, 0.0015 Ω cm, 500µm
thick) wafer. Once bonded the vias and the edges of the cavity were to be deposited
with aluminium (Al). The Al is patterned via photolithography to produce the back
contacts for the pillars (see figure 7.15i). The top surface was then to be patterned to
create the mask for the central (100µm diameter) and sacrificial (50µm diameter) pillars
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to be etched using DRIE. The Bosch process was to be used to etch the pillars until the
SiO2 etch stop was reached; hence pillars would have been approximately 500µm tall (see
figure 7.15j).
The process described below would have initially been used for producing an individ-
ual spike, then further developed to enable the production of addressable arrays.
As with the preliminary samples, the wafer would have been cleaved into 5mm x 5mm
samples that would have been placed in the RIE chamber and etched to spikes (see fig-
ure 7.15k). Due to the doping level of the wafer used to produce the spike electrodes in
the second batch, the etch time to produce the required tip dimensions would be different
from that of the preliminary spike electrodes described in section 7.2. It is well known
that the dry etch rate of lightly doped silicon is independent of dopant type and doping
concentration, however the etch rate for heavily doped silicon is dependent on dopant
type and doping concentration [Kojima et al., 1994]. The etch rate of heavily doped n-
type silicon is increased with an increase in donor impurity concentration [Kojima et al.,
1994] hence, the dry etch time of the secondary electrodes is likely to be greater than
the etch time previously used in the preliminary fabrication. Therefore, several test runs
would have to have been undertaken to determine the etch rate of the heavily doped
n-type wafer.
Manipulation
As with the mechanical efficacy electrodes discussed in section 7.2.1, manipulation of the
electrical efficacy electrodes must be considered. The aspects considered in this previous
section can all be applied to the manipulation of the electrically conductive electrodes,
however a robust method for attaching the rod is required due to the fragility of the elec-
trode tips and the electrical contacts that would be on the reverse side of the substrate.
Two methods were considered. The first would involve bonding a gold wire to each
contact on the reverse side of the substrate followed by a coating of epoxy to protect and
strengthen the bond. The electrode would be carefully inserted, electrode side down, into
a hollow jig approximately the same size as the electrode base, this would allow for the
electrode base to be perpendicular to the rod. The rod would be attached to the reverse
side with epoxy, ensuring it remained perpendicular to the base during curing. The wire
would be wrapped loosely around the wire and fed into the electrical recording system.
The second method would utilise sprung gold contact pins and clips attached to the
four corners of the electrode base plate. This method allows for a efficient transference
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Figure 7.15: Schematic of process steps involved in fabrication of intracellular electrode
array
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from one electrode/array to another as the rod is not permanently attached to the base
plate. The pins instead make the contact with the mapped location of the base con-
tact pads of the electrodes. This method would be more appropriate when dealing with
an array than a single electrode as it removes the possibility of cross talk between the
electrodes due to wires touching.
7.3.2 Summary
The aim of the electrical testing was to produce a viable solid state intracellular electrode,
whether it be a single electrode or an array of multiple addressable electrodes. Due to
unforeseen fabrication difficulties by SMC, University of Edinburgh, this was not possible
during the time available. However, the design of these electrode arrays may still be used
in the future to fabricate electrically conductive arrays given time and resources.
7.4 Conclusions
The ability to record from multiple channels simultaneously has greatly improved the
understanding of spatio-temporal effects of pharmacological agents in in vitro studies. It
is also allowing for advances in medical systems linked to giving sight to blind people
and giving quadriplegics control over the muscles in their hands and arms through the
implementation of this technology in vivo. It was therefore realistic to presume that the
fabrication of an intracellular electrode array would also be hugely beneficial to not only
to those working in the field of electrophysiology but to those researching rehabilitation
technologies. The mechanical efficacy test results detailed in this chapter have shown that
it is possible to create solid state electrode from a silicon substrate with the dimensions
necessary for penetrating a pyramidal cell in the neocortex. Although timing constraints
and unforeseen difficulties removed the possibility of achieving a functional intracellular
electrode array, the designs, research and materials used within this chapter would allow
for future work to be conducted without delay.
Chapter8
Conclusion
8.1 Overview
Sleep has been extensively studied through the use of EEG, in vivo and in vitro ex-
perimental methods, as has the pathophysiology of epilepsy and neurological disorders
related to deep sleep. The mechanisms responsible for the EEG traits, particularly the
spike-wave complex or otherwise known as the spike and wave discharge, were previ-
ously unknown. Hence, the aims of this thesis were to establish an in vitro model of the
spike-wave complex (SWC) and to elucidate the pharmacological properties of the SWC.
Following this, the aim was to establish the contribution of specific types of neurons
to this phenomenon in order to determine the cellular basis of the pathology and the
interactions between local neuronal populations in superficial and deep layers of the neo-
cortex. The final aim of this work was to design a method for improving current in vitro
intracellular recording methods to allow for improved understanding of the interactions
between the individual neurons in a local population.
The general introduction to this thesis presented a detailed introduction and literature
review of the knowledge and previous work relating to the neurobiology of sleep, con-
centrating particularly on the neuromodulators; acetylcholine, serotonin and dopamine.
Also reviewed, due to it’s importance in sleep research, was electroencephalography and
the frequency ranges relating to the sleep-wake cycle typically seen when large popu-
lations of neurons are recorded simultaneously. Due to nocturnal idiopathic epilepsies
in childhood being the basis of this theses, a number of the most prevalent types are
also detailed in this chapter. Of particular interest was the paroxysmal events typically
observed in EEGs from these individuals as well as the genetic mutations present.
Chapter 3 provided clinical data from an 11 year old female with a history of learn-
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ing difficulties from the age of 4. The patient presented with sleep-associated generalised
seizures which had gradually worsened over the previous year. Spectrographic analysis
conducted demonstrated the relationship between delta frequency activity and spike-
wave complexes. This analysis displayed the peak of the SWC activity to be located
along the left temperoparietal axis. This provided a direct comparison with results from
the experimental model detailed in the subsequent chapters. This analysis supported the
parietal dominance of general epileptiform abnormalities observed in disorders such as
benign childhood epilepsy with centrotemporal spikes (BECTS) and Continuous spike
and wave during sleep (CSWS), which in turn defined the most suitable region of the
cortex to conduct the research in - the somatosensory cortex.
Several genetic models of spike and wave related epilepsy have been establish. The
two which dominate the literature are the Genetic absence epilepsy rat from Strasbourg
(GAERS) and the wistar albino Glaxo rat from Rijswilk (WAG/Rij), both of which
spontaneously develop non-epileptic spike and wave seizures which persist into adult-
hood. Many of the neuromodulatory systems have been linked to spike and wave seizures
through the use of these models, of which the cholinergic system was of particular interest
due to the complex role of nicotinic receptors in seizure generation. As a result of this,
the aim of Chapter 4 was to investigate whether the disruption of the cholinergic system
would be sufficient to generate epileptiform activity from delta rhythms similar to that
seen in patients during deep sleep. Due to the in vitro nature of the experiments and in
the absence of an intact thalamocortical system in the slice, the aim was to see whether
the local circuitry in neocortex alone was sufficient to support such pathology.
D-tubocurarine (DTC), a competitive non-selective nAChR antagonist, was selected due
to the agents ability to generate epileptiform activity [Carracedo, 2010]. Laminar profiles
of the cortical column of the somatosensory cortex reported a typical reversal in phase
angle when the local field potential was recorded from Layer I during both the control
state and following the application of DTC. As expected from [Carracedo, 2010], Layers
IV/V displayed the most robust delta rhythm, which also remained true upon applica-
tion of DTC. Whilst DTC did not effect the delta frequency band power of the LFP, it
did significantly reduce the frequency of the rhythm. As has previously been seen with
tuber sclerosis [Nishida et al., 2008], the slowing of the delta rhythm coincided with the
generation of epileptiform activity. The epileptiform activity was split into two different
types due to morphology and embedded frequencies: wave discharges - an exaggerated
delta wave with little embedded high frequency activity, and spike-wave complexes - as
per the wave discharge but with a positively reaching spike situated within the wave with
high frequency activity occurring at the time of the spike.
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Where Chapter 4 had successfully demonstrated the abilities of the model to mimic
epileptiform activity observed in nocturnal epilepsies and sleep related neurological dis-
orders, the basic pharmacological properties of the epileptiform behaviour were not un-
derstood. Chapter 5 therefore characterised this behaviour. The results from Chapter 4
strongly indicated that nAChRs were involved in the generation of epileptiform activity
however the particular subunits responsible for this was unknown. Therefore due to this,
as well as the known antagonist nature of DTC on 5-HT3 and GABAA receptors, specific
subunit blocking agents were chosen to understand the impact these subunits had on the
generation of the epileptiform activity. Hence the aims of this chapter were to understand
which subunits responded similarly to DTC application, to understand the mechanisms
underlying DTC-induced epileptiform activity and to understand the variation in epilepti-
form activity and how it varies depending upon the blockade of specific receptor subunits.
To understand whether a change in the rhythm of slow-wave sleep was seen with this
epileptiform activity, the frequency and power of the delta rhythm was monitored sep-
arately from the epileptiform activity. 6 out of the 9 agents used resulted in a decrease
in delta frequency, whilst only 2 of those 6 saw an increase in delta band power as was
seen upon DTC application. Interestingly, these two agents (Pancuronium and DHβE)
resulted in the generation of WDs but very few, if any SWCs. Four of the agents, with
increasing concentration, were found to, after initially generating WDs, decrease the
number of WDs whilst increase the number of SWCs per 60 second epoch.
The results from this chapter suggest that the disruption of the Ca2+- dependent pathway
via the blockade of presynaptic α7 nAChRs may result in a decrease in long term potenti-
ation [Shen and Yakel, 2009], contributing to cognitive deficits in disorders like CAE and
ADNFLE, due to the the epileptogenic effect of the α7 antagonist, MG624. This result
paired with the blockade of α3β2 nAChR subunits [Stevens et al., 2003] and the appli-
cation of the AMPA receptor PAM [Bertolino et al., 1993], suggests that epileptiform
activity is mediated by glutamate currents which is consistent with the use of glutamate
antagonists as anticonvulsants [Meldrum, 1994]. The severe discharges generated upon
GABAA antagonist and GABAA negative allosteric modulator application are thought to
be due to the blanket blockade of inhibition, hence hugely increasing excitatory response.
This suggest thats only a partial disinhibition is required to generate WDs and SWCs as
both nAChRs and 5-HT3 receptors are located on dendrite targeting interneurons. These
results indicate a failure to control dendritic AMPA receptor mediated inputs onto pyra-
midal cells, particularly in superficial layers.
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The results from Chapter 5 imply that the difference between the two types of epilep-
tiform activity seen in this thesis may simply be due to the degree of recruitment of
superficial layers in addition to paroxysm events in the delta-generating Layer V pyra-
midal cells. Hence the aim of Chapter 6 was to elucidate the input/output activity of
individual neuronal cell types during delta oscillations and paroxysm events. As well as
investigating the spatiotemporal distribution of the individual paroxysm events through
the cortical column and somatosensory cortex.
The results from this chapter suggest that enhanced dendritic electrogenesis may re-
sult in the hyperexcitability responsible for the generation of the spike component of
the SWC. As DTC blocks both 5-HT3 and nACh receptors it may be possible that this
hyperexcitability is mediated by a lack of excitatory tone in these receptor expressing
inhibitory interneuron subtypes. This, in turn may lead to disinhibition, spike genera-
tion and disruption of the interplay between deep and superficial layers, all of which is
thought to be associated with changes in synaptic plasticity.
The limiting factor in chapter 6 was the ability to obtain definitive insight of what
mechanisms underlie the spatiotemporal dynamics of the cortical networks. The aim of
Chapter 7 was to investigate the efficacy of fabricating an array of electrically active, ad-
dressable, solid state intracellular electrodes to aid in this insight. This involved an initial
study to acknowledge if the necessary dimensions required to successfully penetrate the
membrane of a pyramidal cell (typically ∼20µm in diameter) without rupturing the cell,
were achievable through fabrication methods available. Single electrodes were fabricated
from mildly conductive n-type silicon substrate. These electrodes were ∼220µm long,
conical in appearance with a base diameter of ∼100µm and a tip diameter of ∼125nm.
All of which were theoretically sufficient to penetrate the membrane of a pyramidal cell
however due to the low conductivity of the substrate used these electrodes were not elec-
trical conductive enough to record from a cell. A subsequent design process was derived
to fabricate the desired array based upon the knowledge obtained during the preliminary
study. Due to time constraints and unforeseen fabrication technicalities, these electrically
active electrode were not completed.
8.2 Future Work
The future work which can build upon this thesis can be split into two clear stages. The
first would be to complete the fabrication of the electrically active electrodes described in
Chapter 7.3 using the process flow and the photolithography masks. These were designed
based on what was learnt during the mechanical efficacy study of these electrode arrays
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as well as extensive research into previous studies on this topic [Hanein et al., 2002].
The second stage would be to complete comparison studies between the fabricated single
solid state electrodes and the current glass capillary electrodes utilised in current intra-
cellular studies. This would allow for further improvement in the fabrication methods
used to create a reliable and comparable electrode to the current techniques utilised in
electrophysiology. A direct comparison between the current extracellular multichannel
arrays and the fabricated intracellular arrays would also be of interest. If this work were
to be carried out and completed, it could have a huge impact on electrophysiological
research resulting in a greater understanding of the roles individual neurons play in the
local neuronal population.
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